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ABSTRACT 
 Noncanonical amino acids are tools for expanding and altering the chemical 
functionalities available within proteins. Much recent work has focused on developing 
biosynthetic means for incorporating noncanonical amino acids into proteins, and 
applications of noncanonical amino acids to many problems in science and engineering are 
emerging. The first portion of this thesis describes established methods to incorporate 
noncanonical amino acids into proteins and efforts to exploit the properties of noncanonical 
amino acids in areas such as protein structure determination, protein and organism 
evolution, modulation of the immune system, and proteomics. Researchers’ creative and 
successful use of this growing toolkit suggests that noncanonical amino acids will continue 
to be a valuable asset for dissecting biological problems and imparting proteins with new 
chemical and physical properties. 
 Biophysical studies with noncanonical amino acids provide a platform for studying 
the effects of atom-by-atom manipulations of amino acid side chains on protein properties. 
The middle portions of this thesis describe work to better understand how protein 
properties are affected by subtle amino acid side chain manipulations. This work was aided 
greatly by the establishment of homoisoleucine as a translationally active analog of leucine 
in bacterial cells. The small side chain differences between leucine, homoisoleucine, and 
the fluorinated amino acid trifluoroleucine allow for detailed studies on how amino acid 
side chain size and fluorination affect protein stability and hydration dynamics. 
Replacement of leucine by homoisoleucine in coiled-coil peptides stabilizes these proteins, 
as shown by elevation of the coiled coil thermal denaturation temperature. The stabilization 
observed when homoisoleucine replaces leucine in the peptides is greater than when 
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trifluoroleucine replaces leucine, suggesting that expansion of side chain volume may play 
a role in protein stabilization irrespective of hydrocarbon or fluorocarbon character. 
 Studies of water-protein interactions using designed coiled coils containing surface-
exposed leucine, homoisoleucine, or trifluoroleucine residues enabled systematic 
examination of the roles that side chain size and fluorination play in dictating solvation 
dynamics. Fluorinated side chains appear to exert a large electrostatic drag on nearby water 
molecules. These results have important implications for the design and engineering of 
fluorinated proteins due to the critical role water-protein interactions play in many protein 
properties and functions. 
 The final portion of this thesis details efforts to engineer the binding properties and 
chemical reactivity of antibody fragments with noncanonical amino acids. The properties 
of the single chain variable fragment form of a model anti-digoxin antibody have been 
studied after replacement of the protein’s methionine residues with methionine analogs 
containing alkyne, azide, and aliphatic side chains. Experiments with antibody fragments 
displayed on the surface of Escherichia coli cells revealed that replacement of the 
methionine residues of the fragment with an analog containing an alkyne side chain 
reduced the fluorescence levels of cells treated with a fluorescently labeled antigen to 
background levels, indicating loss of binding function. Replacement of methionine with 
analogs containing aliphatic and azide side chains left the fluorescence of cells unchanged 
and reduced by a factor of 0.6, respectively. Fluorescence-activated cell sorting of libraries 
of cell surface-displayed antibody fragments enabled the isolation of clones functional in 
multiple amino acid contexts. Cells displaying variants containing alkyne, azide, and 
aliphatic analogs and treated with fluorescently labeled antigen were more fluorescent than 
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cells displaying the methionine form of the parent antibody fragment by factors of roughly 
1.7, 3.5, and 1.3, respectively. Furthermore, the amino acid context used during high-
throughput screening experiments appears to affect the frequencies of mutations occurring 
at various positions within the antibody fragment construct. High-throughput sequencing 
revealed that populations isolated in different amino acid contexts exhibit mutational rates 
differing by greater than twenty percent at some residues in the protein. 
 Characterization of soluble fragments indicated that each noncanonical amino acid 
used in this study modulates the binding kinetics of antibody fragments in a distinct 
fashion. Perhaps most interestingly, fragments containing the azide-containing analog 
azidohomoalanine exhibit improved binding kinetics relative to their methionine-
containing counterparts. Replacement of methionine by azidohomoalanine in several 
variants lowers the dissociation constant of the fragment by up to a factor of two. Chemical 
conjugation of azide-containing fragments to fluorescent dyes and biotin proved facile with 
strain-promoted cycloaddition reactions. Quantifications of the extent of reaction using 
fluorescent dyes revealed that approximately 0.4 dyes had been conjugated per protein, and 
the resulting conjugates were found to retain their binding function in kinetic and Western 
blotting assays. Experiments in which azide-containing fragments were displayed on the 
surface of Escherichia coli cells and subjected to strain-promoted cycloadditions 
demonstrated that the extent of chemical modification and antigen binding can be 
monitored simultaneously and used to isolate cells displaying functional, modified proteins. 
These experiments demonstrate how noncanonical amino acids can be used to modulate 
multiple properties of antibody fragments and illustrate the feasibility of developing and 
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screening libraries of chemically modified proteins. Evolved, functional bioconjugates may 
be applicable to a variety of outstanding diagnostic and therapeutic problems. 
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CHAPTER 1 
Expanding the Scope of Protein Science and 
Engineering with Noncanonical Amino Acids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been adapted from a review in preparation by James A. Van Deventer, 
Ying Y. Liu, Jeremiah A. Johnson, and David A. Tirrell. 
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Abstract  
 Noncanonical amino acids (ncAAs) have the potential to greatly expand the 
chemical functionalities available within proteins. Methodologies for the genetic encoding 
and incorporation of ncAAs into proteins using the protein synthesis machinery from living 
organisms are now quite common, and applications of proteins containing ncAAs are 
emerging in a variety of fields. In this review, we highlight the most widely used 
methodologies for biosynthetic incorporation of ncAAs into proteins. We then discuss 
applications of ncAA incorporation to areas that include protein structure determination, 
protein and organism evolution, modulation of the immune system, and proteomics. 
Numerous successes in these and other fields suggest that biosynthetic ncAA incorporation 
will continue to be a valuable tool for biological science and engineering in the future. The 
ease of incorporation and large functional toolkit available with ncAAs will continue to 
enable researchers from many disciplines to tailor the use of ncAAs to their specific needs. 
 
Introduction  
 Proteins perform an astonishingly broad range of functions in biological systems, 
yet they are usually synthesized from no more than twenty amino acid monomers. While 
the templated synthesis of polypeptide chains provides access to an enormous sequence 
space (1), and posttranslational modifications significantly expand the available functional 
space (2), the chemical diversity of natural amino acid side chains is rather limited from a 
chemist’s perspective. Thus, researchers have focused much effort on the development of 
new methodologies for incorporation of amino acids that are not normally specified by the 
genetic code, or noncanonical amino acids (ncAAs), into peptides and proteins. 
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 Methods for the incorporation of ncAAs into peptides and proteins are either 
chemical, biosynthetic, or some combination of the two. In the area of chemical synthesis, 
solid-phase peptide synthesis has enabled the routine incorporation of virtually any suitably 
protected amino acid into synthetic peptides (3, 4). Small peptides can then be coupled 
together to give full-length synthetic proteins via techniques such as native chemical 
ligation (5, 6). The combination of chemical ligation strategies and biological protein 
production methods in the form of techniques such as expressed protein ligation (7-9) 
further enhances researchers’ abilities to incorporate new chemical functionalities into 
proteins. These nontemplated chemical approaches for incorporation of ncAAs into 
proteins continue to grow in importance to the scientific community. 
 Despite the successes of chemical methods, the natural protein biosynthetic 
machinery of living organisms remains unparalleled in its ability to produce complex, 
genetically templated polypeptide chains in large quantities. For many years scientists have 
imagined that a reworking of the genetic code or the protein biosynthetic machinery could 
enable the biological production of proteins containing a nearly endless variety of ncAAs 
(10) and perhaps even other non-amino acid monomer structures (11). Sequence-specific, 
monodisperse polymers, which are currently challenging or impossible to synthesize using 
traditional synthetic techniques, would be expected to display a wide range of chemical and 
physical properties. Methodological developments over more than fifty years have 
facilitated the biosynthetic incorporation of an ever-increasing number of ncAAs and other 
monomers into proteins. These techniques have begun to allow scientists to investigate a 
vast range of subjects in biology, biological chemistry, and engineering. 
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 In this review, we aim to highlight some of the ways in which scientists have 
employed biosynthetically produced proteins containing ncAAs to study and manipulate 
proteins and biological systems. The section “Biosynthetic Methodologies for the 
Incorporation of Genetically Encoded Noncanonical Amino Acids into Proteins” will 
summarize some important historical and methodological underpinnings of ncAA 
incorporation into proteins using enzymatic machinery found in living organisms. In the 
“Applications” section, we will discuss a number of research topics that have been 
impacted substantially by the use of ncAAs. The subjects highlighted in this review are 
meant to emphasize the creative approaches enabled by manipulation of the genetic code 
and are not intended to cover all areas of application. Finally, in the “Outlook” section, we 
will briefly speculate about potential future uses of ncAAs. 
 
Biosynthetic Methodologies for the Incorporation of Genetically Encoded 
Noncanonical Amino Acids into Proteins  
 Methodologies for biosynthetic incorporation of ncAAs into proteins can be divided 
into “residue-specific” and “site-specific” strategies. An overview of these strategies is 
presented in figure 1.1. In a “residue-specific” strategy, a single canonical amino acid is 
replaced by a ncAA wherever the mRNA encoding the protein specifies the canonical 
amino acid. Figure 1.1a illustrates the resulting “reprogramming” of protein translation. In 
contrast, “site-specific” strategies (figure 1.1b) involve the replacement of a single amino 
acid with a ncAA at a desired location within the polypeptide chain. Usually, this approach 
utilizes suppression of a stop, or nonsense, codon with an appropriately charged suppressor 
tRNA, although some additional approaches have also been explored. 
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Background: key advances that enabled modern ncAA incorporation methodologies. 
Characterization of the components of the biosynthetic protein translation apparatus has 
provided insights into how the genetic code functions and how the code can be manipulated 
to perform unnatural functions. Among the key results in this area are Chapeville and 
coworkers’ “Raney Nickel” experiments (12), which provided strong support for Francis 
Crick’s adaptor hypothesis (13). The adaptor hypothesis proposed that small nucleic acids 
(now called transfer RNAs, or tRNAs) could provide a means by which a sequence of 
nucleic acids could be translated into a corresponding polypeptide sequence, with the 
specific pairing of amino acids and tRNAs ensuring the fidelity of the genetic code. 
Chapeville and coworkers were able to show for the first time that chemical manipulation 
of aminoacyl-tRNAs can alter the way in which an RNA transcript is decoded. The 
researchers treated cysteinyl-tRNACys with Raney Nickel to convert cysteinyl-tRNACys to 
alanyl-tRNACys and compared the results of polypeptide synthesis after supplementing 
ribosomal preparations with cysteinyl- or alanyl-tRNACys and an RNA transcript coding for 
cysteine. Polypeptide synthesis was supported in each case, and polypeptides produced in 
reactions containing cysteinyl-tRNACys and alanyl-tRNACys contained only cysteine and 
alanine, respectively. These results showed conclusively that misacylated tRNAs remain 
substrates of the ribosome and that they support protein synthesis. The ability of the 
ribosome to use misacylated tRNAs in translation implies that ncAA incorporation into 
protein is possible in theory. If a ncAA can be attached to a particular tRNA, the protein 
translation apparatus will likely accept the “misacylated” tRNA as a substrate and place the 
ncAA into a growing polypeptide chain in response to a particular codon. 
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 The “Raney Nickel” experiments also demonstrated the feasibility of performing 
chemistry directly on tRNA molecules, and many groups have since extended the types of 
chemistry that can be performed on tRNAs. In the 1970s, experiments performed in the 
Menninger group demonstrated that (i) Lys-tRNALys could be acetylated specifically at the 
ε-amino group of lysine, and (ii) AcLys-tRNALys could be incorporated into proteins in a 
cell-free protein synthesis system in response to lysine codons (14). These experiments 
were the first to show that chemically synthesized aminoacyl-tRNAs containing a ncAA 
could be utilized by the biosynthetic protein synthesis machinery. Hecht and coworkers 
expanded on the work of Menninger and coworkers by developing a general route to the 
chemical acylation of tRNAs (15, 16). Their method involved chemical synthesis of the 
acylated dinucleotide pCpA, the generation of tRNA missing its last two RNA bases, and 
enzymatic attachment of the acylated pCpA to the truncated tRNA. Further improvements 
to chemical acylation techniques were elucidated in the 1980s (17, 18). These synthetic 
methods have proven crucial in the generation of tRNAs bearing a wide variety of ncAAs 
for use with site-specific ncAA incorporation into proteins. 
 The identification and detailed characterization of aminoacyl-tRNA synthetases 
(aaRSs), the enzymes responsible for joining together amino acids and tRNAs in living 
organisms, have also been crucial for enabling incorporation of ncAAs into proteins. Early 
work (19, 20) by Berg and others established that aaRSs are responsible for catalyzing the 
attachment of tRNA and amino acids using the free energy gained from hydrolysis of 
adenosine triphosphate (ATP) to adenosine monophosphate (AMP) in a two-step process: 
Amino Acid (AA) + ATP
aaRS
AA-AMP
AA-AMP + tRNAAA aaRS AA-tRNAAA + AMP
(Activation)
(Aminoacylation)
(1.1)
(1.2)  
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Characterizations of the enzymatic activities of aaRSs have established that these enzymes 
are extremely important for maintaining the fidelity of protein translation (21) and that 
ncAAs can serve as kinetically efficient substrates of aaRSs (22). These findings imply that 
understanding how to manipulate the enzymatic activities of aaRSs can facilitate the 
specific, enzymatic linkage of ncAAs and tRNAs. 
 Additional characterizations of aaRSs and tRNAs laid the groundwork for adding 
amino acids to the genetic code by adding new translational components to living cells. 
One of the important ways in which aaRSs maintain the fidelity of the genetic code is by 
selectively recognizing and aminoacylating their cognate tRNAs. For example, the 
methionyl-tRNA synthetase (MetRS) must conjugate methionine specifically to tRNAMet 
without aminoacylating any other tRNA (21). This specific recognition is critical for 
maintaining genetic code fidelity, but the mechanisms of specificity are not conserved from 
species to species. As early as 1963, researchers started to realize that the aaRSs from 
different species recognize their cognate tRNAs by distinct mechanisms. Doctor and Mudd 
first observed this phenomenon when they discovered that an aaRS from one species 
cannot always aminoacylate the corresponding tRNA from another species (23). Smith and 
coworkers proposed that the structural basis for these observations is aaRS recognition of 
structural features in tRNA molecules that differ from species to species (24). This 
hypothesis has since been investigated thoroughly using structural and biochemical 
experiments, resulting in the detailed characterization of how cognate aaRSs and tRNAs 
are properly paired in different organisms (25). Another early breakthrough that eventually 
facilitated adding new amino acids to the genetic code was the discovery and 
characterization of suppressor mutations in E. coli (26-28). These mutations, which result 
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in the conversion of a “stop” message into a message coding for an amino acid, were found 
to mutate the tRNA anticodon sequence from nucleotides specifying a sense codon into 
nucleotides specifying a termination codon (24). These findings suggested that using 
codons normally reserved for the termination of protein synthesis to instead specify an 
amino acid could be a way to add an amino acid to the genetic code. The combined 
exploitation of the species specificity of aaRS-tRNA recognition and suppressor tRNAs 
eventually enabled researchers to dictate the coding of a 21st amino acid, first in vitro and 
later in living cells and organisms (see below). 
 
Residue-specific incorporation strategies. Conceptual advances. Even before the 
components of the translation apparatus were characterized, scientists recognized that 
ncAAs could be incorporated into the proteins of multi- and single-celled organisms. These 
earliest examples employed ncAAs that were isosteric or structurally similar to canonical 
amino acids. During the 1950s and 1960s, ncAAs were employed extensively in studies 
that involved microorganisms; this work was reviewed thoroughly in 1962 (29). These 
early experiments, especially those performed in the laboratory of Georges Cohen, laid the 
foundation for later advances in the field. Cohen and colleagues were the first to use a 
medium replacement strategy that we now refer to as a “medium shift.” They also 
demonstrated the utility of auxotrophic strains for achieving high levels of ncAA 
incorporation into proteins. Furthermore, the Cohen laboratory recognized that, “these 
analogs [and surrogates] become powerful tools for the study of: (a) the specificity of the 
protein-forming mechanism and (b) the variation of enzyme activity and affinity that 
occurs with increasing numbers of incorporated analog molecules” (30). These 
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observations are still relevant today. We now know with some level of detail that 
incorporation of a particular amino acid into proteins depends on the ability of the protein 
translation apparatus of a particular cell or organism to tolerate noncanonical substrates. 
“Variation of enzyme activity” by the incorporation of ncAAs is still studied today and 
now forms part of a larger effort to perturb protein structure and function with ncAAs. 
 After the relatively sparse application of ncAAs to scientific problems in the 1970s 
and 1980s (31, 32), researchers began seriously revisiting the idea of incorporating ncAAs 
into proteins residue-specifically in 1990. Hendrickson and coworkers demonstrated the 
complete replacement of methionine by selenomethionine (1, scheme 1.1) in thioredoxin in 
1990 (33). Their approach involved growing methionine-auxotrophic bacteria in medium 
containing a limited supply of methionine but ample amounts of selenomethionine. As the 
bacteria grow, they use up the supply of methionine, forcing incorporation of 
selenomethionine in place of methionine. Induction of protein expression after the 
depletion of methionine in the medium enabled a high level of selenomethionine 
incorporation into proteins. This method for incorporating selenomethionine into proteins 
has been adapted for use with a number of other ncAAs by the Budisa laboratory (22). The 
Tirrell laboratory and others have utilized an alternative approach involving extensive 
washing of bacterial cells in between growth in a medium containing all canonical amino 
acids and protein expression in medium containing ncAAs (34). With these protocols, 
scientists have developed methods for the incorporation of a large set of ncAAs into 
proteins residue-specifically, primarily by engineering E. coli expression hosts and 
aminoacyl-tRNA synthetases. These contemporary residue-specific incorporation 
techniques will be described in the following subsection. 
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Experimental approaches. In most cases, efficient aminoacylation of a tRNA with a 
noncanonical L-amino acid is sufficient to enable the residue-specific replacement of a 
canonical amino acid with the ncAA of interest. Thus, the genetic code can be intentionally 
“reinterpreted” to code for one or more ncAAs by controlling what substrates get attached 
to specific tRNAs. The conceptual approach is depicted in figure 1.1a, and specific 
strategies for intentional tRNA misaminoacylation are shown in figure 1.2. 
 The simplest approach to ncAA incorporation involves replacement of a canonical 
amino acid with a close structural analog in E. coli. With an appropriate analog, a cell 
strain auxotrophic in the amino acid to be replaced, and a technique for depleting the 
canonical amino acid from the medium prior to expression of proteins of interest, 
incorporation of a ncAA at genetically encoded positions can be essentially quantitative (if 
the ncAA is recognized efficiently by the protein translational machinery of the host). 
Figure 1.2a illustrates a typical procedure for the incorporation of homopropargylglycine 
(Hpg, 2, scheme 1.1) in place of methionine in proteins produced by E. coli. Methionine-
auxotrophic E. coli cells are first grown in minimal media containing all twenty canonical 
amino acids. Upon reaching a sufficient optical density, cells are washed to remove 
methionine from the medium and resuspended in the expression medium, which usually 
contains high concentrations of ncAA (in this case, Hpg). Alternatively, cells can be grown 
in medium that contains both methionine in small quantities and a ncAA in large quantities. 
By the time cells have reached an optical density sufficient for protein expression, the 
concentration of canonical amino acid has been depleted, resulting in the same effect as 
removal of the canonical amino acid through washing (this is sometimes called selective 
pressure incorporation). After the medium is depleted of the canonical amino acid to be 
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replaced and supplemented with large amounts of the ncAA, all proteins synthesized within 
the cells will contain ncAAs. If a particular protein is to be studied, standard expression, 
purification, and characterization techniques can be employed to isolate the desired protein. 
On the other hand, if a proteome-wide response to a particular stress or signal is to be 
studied, the set of newly synthesized proteins can be isolated and studied using approaches 
to be described in the “Applications: Proteomics” subsection. 
 Researchers have employed several variations of medium shifts and selective 
pressure incorporation in recent years. The techniques have been extended to mammalian 
cell lines for monitoring the production of newly synthesized proteins (35), and attempts 
have also been made to extend the procedure to yeast expression systems (36, 37). 
Recently, reports have indicated that two or three canonical amino acids can be replaced by 
ncAAs simultaneously in E. coli, allowing for more drastic reinterpretations of the genetic 
code (38, 39). 
 While the medium shift procedure can enable the incorporation of a number of 
ncAAs into proteins, further expansion of the number of translationally active amino acids 
available requires additional engineering of expression hosts. To date, most work in the 
field has focused on altering aminoacyl-tRNA synthetase (aaRS) activity in E. coli to 
enable additional ncAAs to serve as protein building blocks. These approaches, which are 
performed in combination with medium shifts, are summarized in figure 1.2b–d. The 
kinetics of amino acid activation appear to dictate the translational activity of most ncAAs 
(40). When amino acid activation kinetics are slow, ncAAs cannot be joined to tRNA 
molecules at a high enough rate to support protein synthesis. Increasing the concentrations 
of an aaRS by outfitting an E. coli expression strain with a plasmid-borne copy of an 
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endogenous aaRS raises the aminoacylation activity of the host strain, enabling some rather 
poor aaRS substrates to support protein synthesis in the host. Figure 1.2b illustrates this 
strategy for the leucine analog hexafluoroleucine (Hfl, 3) (41). LeuRS overexpression in E. 
coli cells auxotrophic in leucine production enables quantitative replacement of Leu by Hfl. 
 Sometimes simple overexpression of an aaRS is not enough to overcome poor aaRS 
activity toward noncanonical substrates. However, the judicious mutation of an aaRS can 
greatly improve the activation kinetics of nonstandard substrates and thereby lead to more 
ncAAs that can be quantitatively incorporated into proteins. Computational and screening 
approaches have proven useful in this regard (42-44). For example, as shown in figure 1.2c, 
the bulky methionine analog azidonorleucine (Anl, 4) has only very weak translational 
activity in an E. coli host overexpressing wild-type methionyl-tRNA synthetase (MetRS) 
(45). However, when E. coli is outfitted with one of several MetRS active site mutants 
identified in high-throughput screens for translational activity in the presence of Anl, the 
bulky azide amino acid can quantitatively replace Met (46, 47). Kinetic characterizations of 
the mutant MetRSs revealed vastly improved activation of Anl. 
 Occasionally, efficient activation of an amino acid substrate is not sufficient to 
enable the incorporation of a particular ncAA into proteins because of proofreading 
mechanisms in aaRSs. Several aaRSs have a second active site responsible for ensuring 
that tRNAs are aminoacylated with their cognate amino acids; these editing active sites can 
discriminate between amino acids that differ by as little as a methyl group (e.g., valine 
versus isoleucine) and cleave incorrectly aminoacylated substrates (21). However, 
attenuation of aaRS editing activity can substantially increase the promiscuity of the 
enzyme, enabling aminoacylation of a greater pool of substrates. Figure 1.2d portrays such 
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an approach with leucyl-tRNA synthetase (LeuRS) and the substrate norleucine (Nrl, 5). 
Mutation of a critical threonine to a much bulkier tyrosine in the editing active site of 
LeuRS greatly impairs the editing function of the enzyme, leading to high translational 
activity of amino acids known to be activated by LeuRS (48-51). 
 In some ways, manipulating the editing and aminoacylation activities (through 
overexpression and/or mutation) of aaRSs represent complementary approaches to ncAA 
incorporation. These techniques for manipulating aaRSs for residue-specific incorporation 
were all developed in E. coli, but work from the Hang laboratory suggests that mutant 
aaRSs from E. coli can be employed in other microbes such as Salmonella typhimurium 
(52). Site-specific incorporation approaches using mutated aaRS (discussed below) have 
been very successful in mammalian cells, suggesting that residue-specific ncAA 
incorporation approaches in mammalian cells with mutated aaRSs are also worth 
investigating. While most aaRS manipulations are performed via the introduction of 
additional copies of aaRS genes on plasmids, genomic manipulations of aaRSs also hold 
some promise, as evidenced by the recent report of Abdeljabbar et al. (53). Manipulations 
of aaRS activities through aaRS overexpression, mutation, and genomic manipulation and 
the application of these techniques to additional organisms will continue to increase the 
power of methods for the residue-specific incorporation of ncAAs into proteins. 
 
Combining residue-specific incorporation and in vitro protein synthesis. The key 
requirement for achieving the global replacement of a canonical amino acid in a protein is 
usually the efficient aminoacylation of the appropriate tRNA. Several groups have 
approached this aminoacylation problem in conjunction with cell-free protein synthesis, 
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forming a powerful combination because of the precise control over the components of the 
translational machinery possible in cell-free environments. Cell-free protein synthesis with 
chemically acylated tRNAs (54), aaRS-catalyzed tRNA aminoacylation (55), and 
ribozyme-catalyzed tRNA aminoacylation (56, 57) have all been demonstrated with 
residue-specific ncAA incorporation. Several groups have also shown that sense codons 
can be reassigned to residues containing noncanonical backbones such as α-hydroxy acids, 
N-methyl amino acids, and N-substituted glycines (poly N-substituted glycines are also 
called peptoids) (58-63), and the Hecht group has made some progress in engineering E. 
coli ribosomes to accept D-amino acids as translationally active substrates (64, 65). 
Furthermore, powerful nonribosomal methods to synthesize genetically encoded small 
molecules and polymers are also emerging (11, 66). All of these approaches enable the 
production of genetically encoded polymers with compositions that are substantially 
different from those of naturally occurring proteins, and these polymers may have 
properties that are vastly different from naturally occurring biopolymers. Future 
applications of these genetically encoded polymers could prove to be very powerful. 
 
Site-specific incorporation approaches. Conceptual advances. The first examples of site-
specific ncAA incorporations into proteins combined the use of chemical aminoacylation 
techniques, stop codon suppression, and species-specific recognition of tRNA molecules 
using cell-free protein synthesis (67, 68). In 1989, the groups of Chamberlain and Schultz 
each reported strategies for the in vitro incorporation of a single ncAA into polypeptide 
chains in response to amber codons contained within genes coding for proteins of interest. 
A key component in each of these systems was the combination of an in vitro translation 
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system from one species and a suppressor tRNA molecule from another species that was 
not recognized by the aaRSs of the in vitro translation system. The inability of the aaRSs of 
the in vitro translation system to recognize the tRNA (chemically acylated with the ncAA 
of interest) makes the tRNA orthogonal to the translation system, a recurring concept in 
site-specific incorporation of ncAAs into proteins. 
 Although powerful and quite general, chemical aminoacylation techniques used 
with in vitro suppression are limited by the amount of the acylated suppressor tRNA that 
can be generated in a somewhat technically demanding process. For this reason, 
researchers in several laboratories initiated research aimed at the development of stop 
codon (or nonsense) suppression techniques for the incorporation of ncAAs into proteins 
inside living cells or organisms. The move from in vitro to in vivo suppression systems 
required the development of additional orthogonal components to ensure both the fidelity 
of the genetic code and the fidelity of ncAA incorporation at specified locations (69-71). 
Figure 1.3 illustrates the three key criteria that must be met in order to establish the 
orthogonality of additional translational components for nonsense suppression in living 
cells. First, the suppressor tRNA to be added to the cell (figure 1.3a) must not be a substrate 
for any of the wild-type aaRSs already present in the cell in order to ensure that only the 
ncAA of interest is used to decode nonsense codons. Next, the aaRS to be added (figure 
1.3b) must specifically recognize both its suppressor tRNA and ncAA substrates. Finally, 
the ncAA (figure 1.3c) to be added to the genetic code must not be a substrate for any of 
the wild-type aaRSs in the cell. Failure to meet these strict criteria may result in ncAA 
incorporation in response to sense codons, or canonical amino acid incorporation in 
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response to stop codons; both of these situations reduce the fidelity of protein translation. A 
properly functioning orthogonal pair is illustrated in figure 1.3d. 
 This challenging orthogonality problem was solved partially by a number of groups 
before an integrated solution was reported. First, the RajBhandary group reported a system 
in which an orthogonal tRNA-aaRS pair was required for in vivo synthesis of full-length 
genes containing an amber codon (69). In this work, E. coli tRNAGln and GlnRS were 
adapted for use in mammalian cell lines as an orthogonal tRNA-aaRS suppressor pair. 
Differences in tRNA recognition between E. coli and mammalian cells enabled E. coli 
GlnRS to selectively aminoacylate E. coli tRNAGln with glutamine and suppress an amber 
codon in a CAT reporter gene in multiple mammalian cell lines. In 1997, the Schultz group 
reported the first attempt to evolve an orthogonal tRNA-aaRS pair in E. coli (71). They 
described the rational design of an E. coli tRNAGln variant and directed evolution of a 
GlnRS mutant with improved selectivity for the tRNAGln variant compared to wild-type 
tRNAGln in E. coli. Though they did not find a GlnRS variant that could recognize the 
mutant tRNAGln better than the wild-type tRNAGln, their work demonstrated the feasibility 
of engineering recognition patterns in an aaRS-tRNA pair. Efforts to use an S. cerevisiae 
tRNA-aaRS pair in E. coli were also undertaken during this time period (72). While the 
tRNA-aaRS pair was found to be orthogonal in E. coli, no suitable GlnRS mutant capable 
of selectively charging a noncanonical glutamine analog was identified. Furter 
demonstrated the first functioning suppression system able to incorporate a ncAA in 
response to an amber codon in E. coli (70). This system utilized a yeast phenylalanine 
tRNA-aaRS pair to incorporate p-fluorophenylalanine (6) into proteins site-specifically in 
response to an amber codon. Although this system was site-specific with respect to the 
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incorporation of the ncAA, the system fell short of being fully orthogonal because the yeast 
PheRS still recognized phenylalanine (Phe) and incorporated Phe in place of 6 in 
approximately thirty percent of the model proteins expressed, and small amounts of 6 were 
found at other Phe positions within the protein, also. 
 In the late 1990s and early 2000s, researchers developed additional translationally 
active tRNA-aaRS pairs by exploiting kingdom-specific tRNA-aaRS recognition elements. 
While early efforts to establish almost completely orthogonal pairs in mammalian cells 
were achieved with rational design alone (73, 74), most work in E. coli employed directed 
evolution techniques to improve the orthogonality of existing tRNA-aaRS pairs imported 
from other organisms (74, 75). The efforts of Schultz and coworkers were particularly 
important in this regard. Wang and Schultz established a general selection system for 
isolating tRNA-aaRS pairs orthogonal to the translational machinery of E. coli (75). This 
selection system was used with a nearly orthogonal Methanococcus jannaschii tRNATyr-
TyrRS pair to further improve its suppression of amber stop codons in E. coli. The Schultz 
group was also the first to establish high-throughput selection and screening methods for 
isolating aaRSs with altered amino acid specificities (76). Researchers have performed site-
specific incorporation of several dozen ncAAs into proteins produce in E. coli via 
combination of these methods for the generation of orthogonal tRNA-aaRS pairs and aaRS-
amino acid pairs. Early work by the group of Yokoyama demonstrated that the “orthogonal 
pair” strategy could be applied in mammalian cells (77) without the use of evolutionary 
methods. Additional engineering work has enabled the development of site-specific 
incorporation methods in yeast (78) and improvement of strategies applicable to 
mammalian cells (79, 80). These techniques will be described in more detail below. 
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Experimental approaches. Site-specific incorporation of ncAAs into proteins requires the 
use of specialized translational components in conjunction with codon suppression in order 
to “add” an amino acid to the genetic code. Figure 1.4 outlines various ways to achieve this 
goal; most of these approaches involve a suppressor tRNA that is aminoacylated with a 
ncAA of choice. This tRNA, which uses a “nonstandard” codon, is appropriately decoded 
during protein synthesis in either an in vitro or an in vivo translation system. 
 Chemical acylation provides researchers with the most general strategy for 
incorporating ncAAs site-specifically into proteins. If an appropriately designed, 
orthogonal suppressor tRNA is available for a given translation system, it can be 
chemically acylated with a very broad range of ncAAs. When coupled with a gene 
containing the codon to be suppressed, nearly any protein can be synthesized containing the 
ncAA of choice at a specific site. Figure 1.4b depicts this process in an in vitro translation 
system. The in vitro translation system, gene expression, and protein purification are 
essentially the same as in systems lacking the chemically acylated suppressor tRNA. The 
protein yields achievable by using chemically acylated tRNAs in an in vitro translation 
system are usually in the microgram range. However, a number of scientific questions can 
be thoroughly studied even with a small amount of protein containing noncanonical amino 
acids (81). Extensions of chemical acylation to cellular systems have also proven to be 
quite fruitful. As an example of one elegant approach, the Dougherty and Lester groups 
have studied ion channels and other membrane proteins in Xenopus oocytes at length using 
chemical acylation techniques. In their system, depicted in figure 1.4c, an mRNA 
containing a nonsense codon at the site specified for ncAA incorporation and an orthogonal 
suppressor tRNA acylated with a ncAA of choice are injected into the oocyte. 
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Electrophysiology and other techniques can be used to interrogate channel function and 
will be discussed below in the “Applications: Membrane proteins” subsection. 
 The enzymatic, site-specific incorporation of ncAAs into proteins in living cells or 
organisms is technically simpler than chemical acylation-based methods if appropriate 
genetic components are available. Enzymatic approaches in living systems require an 
orthogonal aaRS-tRNA pair that can be expressed in the host cells or organism of interest. 
This pair, and the ncAA to be incorporated in response to the “nonsense” codon (or other 
nonstandard codon), should meet the strict requirements for orthogonality discussed above. 
The ncAA should also be able to access the cytoplasm of the expression host by means of 
passive or active cellular transport mechanisms. If these conditions are met, site-specific 
methodologies become quite powerful. Figure 1.4d depicts the incorporation process in E. 
coli. A plasmid-based system encoding constitutively expressed orthogonal tRNA and 
aaRS genes is transformed into an appropriate strain along with an inducible gene that 
codes for the appropriate “nonsense” or other specialized codon. For strategies related to 
the development of orthogonal tRNA-aaRS pairs the reader is referred to several recent 
reviews (82-87). The resulting system can then be treated essentially like any bacterial 
expression system. After cell growth in minimal (76) or rich medium (88), the ncAA is 
added to the medium and protein expression is induced. Cells are harvested after induction, 
and the protein of interest can then be isolated using standard purification methods. One of 
the primary advantages of this method over residue-specific methodologies is that no 
medium shift is required before expression; the genetic code is manipulated by adding 
translational machinery to cells rather than by manipulation of the extracellular 
environment. However, cellular suppression-based incorporation techniques can sometimes 
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suffer from low protein yields. Incomplete suppression in these systems is very common 
and leads to a reduced amount of full-length protein compared to similarly expressed genes 
encoded entirely by sense codons. Typical yields reported in the literature are in the 1–10 
mg/L range, although improved expression systems have recently been described (88-93). 
 Extensions to the basic strategy of employing an orthogonal tRNA-aaRS pair have 
expanded approaches to incorporating ncAAs into proteins site-specifically. Methods for 
evolving orthogonal tRNA-aaRS pairs in Saccharomyces cerevisiae have been developed 
and applied to site-specific incorporation in this eukaryotic model organism (78). 
Subsequent systems have improved on early work by using genes coding for orthogonal 
tRNAs that incorporate the A and B box elements required for high-level transcription in 
yeast (94, 95). Recent reports have demonstrated that orthogonal tRNA-aaRS pairs can also 
be introduced into the organisms Pichia pastoris and Mycobacterium tuberculosis and used 
to incorporate ncAAs site-specifically into proteins (96, 97). Similar methodological 
extensions have been made to mammalian expression systems. While orthogonal tRNA-
aaRS pairs have not been directly evolved in mammalian systems, they have been imported 
and used for nonsense suppression successfully (77, 98, 99). Again, improvement of tRNA 
expression has facilitated the development of more tRNA-aaRS pairs for incorporation of 
noncanonical amino acids into proteins in mammalian cells (79, 80). 
 Researchers have investigated many additional strategies for improving or 
expanding the scope of site-specific ncAA incorporation into proteins produced in vitro or 
in living cells or organisms. Extensive work to improve the types of ncAAs that can be 
incorporated in response to nonsense codons have focused on the development of new 
aaRS variants, including those based on the recently discovered pyrrolysyl-tRNA 
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synthetase (100-103) and by employing aaRSs possessing expanded or altered editing 
capabilities (104-106). A systematic approach to the creation of mutually orthogonal aaRSs 
has been reported (107), and this methodology may prove especially useful if the genetic 
code is expanded to include large numbers of ncAAs in addition to the twenty canonical 
amino acids. Both in vitro and in vivo attempts to use four-base codons to incorporate 
ncAAs into proteins have proven somewhat successful (108-111), as have attempts to 
incorporate either two of the same or multiple, chemically distinct ncAAs into a single 
protein (109, 112-114). However, the limitations of organism survival place constraints on 
the manipulations that can be made to the protein biosynthesis machinery. The Chin 
laboratory has recently developed a system in which a large portion of the protein 
biosynthesis machinery has been relieved of its requirements to support cellular viability 
(115). Using the same orthogonality concept described above, a set of mRNA-ribosome 
pairs that are separate from the wild-type ribosome and mRNA pools were isolated. By 
freeing the ribosome from its usual responsibilities of supporting all cellular protein 
synthesis, researchers have successfully evolved ribosome variants that enable more facile 
expansion of the genetic code. The most notable of these variants is a ribosome capable of 
efficiently decoding quadruplet codons (116). Building on a previously successful 
improvement of suppression efficiency in orthogonal ribosomes (117), this quadruplet-
decoding ribosome is capable of incorporating multiple ncAAs into a single protein with 
very high efficiency: one amino acid is introduced in response to a four-base codon, and a 
second amino acid is incorporated in response to an amber codon. Future work in 
engineering the ribosome appears to be a very promising approach for improving efforts to 
site-specifically incorporate ncAAs into proteins. 
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Applications  
 Scientists have been extremely successful in inventing and refining techniques for 
genetically encoding ncAAs and incorporating them into proteins. However, developing 
incorporation strategies does not always answer scientific questions, except possibly in 
areas directly related to the study of aminoacyl-tRNA synthetases and the protein 
translation apparatus. In this section of the review, we will describe approaches to protein 
science and engineering that have either been significantly impacted or that could be 
significantly impacted in the future by the employment of ncAAs. We will focus on select 
recent areas of study and refer the reader to earlier reviews (29, 31, 32) and other recent 
reviews (22, 84-87, 118-121) for additional uses of ncAAs. Scientists have developed 
applications of genetically encoded ncAAs covering an extremely broad range of topics. 
 
Protein crystallography. The determination of protein crystal structures using X-ray 
crystallography is an extremely important part of molecular biology and biochemistry. 
While reflection data can be collected from any high-quality protein crystal, the lack of 
heavy atoms in naturally occurring proteins prevents researchers from learning phase 
information from these samples without additional information. This dilemma, known to 
crystallographers as the phase problem, has been solved using a number of approaches over 
the years (122, 123). In the past twenty years, one of the methods of choice for resolving 
the phase problem has become the direct incorporation of heavy atoms into the structure of 
proteins and the application of multiwavelength anomalous dispersion (MAD). This 
technique can be used on proteins by residue-specifically replacing of one of the canonical 
amino acids in the molecule with an amino acid containing a heavy atom. In 1990, 
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Hendrickson and coworkers rediscovered Cowie and Cohen’s 1957 work in which 
quantitative replacement of methionine by selenomethionine (SeMet, 1) was reported (30). 
SeMet is nearly perfect for X-ray crystallography applications because it is almost identical 
in shape to Met and possesses a heavy atom appropriate for MAD phasing techniques. 
Using selective pressure incorporation, Hendrickson et al. were able to demonstrate the 
near-quantitative replacement of Met by SeMet in T4 thioredoxin. Furthermore, reflection 
data acquired with the SeMet-containing proteins indicated, “…that MAD phasing of 
prospective selenomethionyl proteins should be readily feasible since diffraction ratios are 
in excess of those that have proven adequate for related problems” (33). Indeed, the 
application of MAD to SeMet-containing proteins was used successfully twice in 1990 to 
solve the structures of previously uncharacterized proteins (124, 125). Extensions to 
proteins expressed in mammalian (126, 127) and baculovirus expression systems (128, 
129), and other improvements to expression procedures over the years have led to the 
establishment of MAD phasing on SeMet-containing proteins as a method of choice in 
protein crystallography (130-133). MAD has become an indispensible technique for 
modern protein crystallography. 
 Several additional ncAAs containing heavy atoms have been introduced into 
proteins with the aim of improving crystallographic techniques. Residues 7–10 have been 
incorporated residue-specifically into proteins with high replacement of the corresponding 
canonical amino acids. Telluromethionine (7) has been shown to enable the multiple 
isomorphous replacement (MIR) phasing strategy using laboratory radiation sources (134-
136), while selenocysteine (8) can be used in place of (137) or in combination with 1 to 
enable MAD phasing (138). The feasibility of using residues 9 and 10 for structure 
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determination has also been demonstrated (139, 140). Iodinated ncAAs also appear to be 
promising for aiding structure determination efforts. Proteins containing site-specifically 
incorporated p-iodophenylalanine (11) and 3-iodotyrosine (12) have been crystallized and 
used to produce reflection data on laboratory radiation sources (141, 142). Iodine-generated 
single-wavelength anomalous dispersion (SAD) enabled the data to be properly phased, 
and high-quality structures have been determined from these crystals. Although these 
emerging approaches to incorporating heavy atoms into proteins have yet to impact X-ray 
crystallography in the same way as selenomethionine, they may aid future structure 
determination efforts, especially those that can be accomplished in the laboratory rather 
than at a synchrotron. 
 
Nuclear magnetic resonance spectroscopy. Like X-ray crystallography, nuclear magnetic 
resonance (NMR) spectroscopy is a crucial tool for the structural and biophysical 
characterization of proteins. Using isotopic labeling techniques enabling the incorporation 
of 13C, 15N, and/or 2H, into all or part of proteins of interest enables a vast range of studies 
to be performed on proteins of increasing sizes (143-145). These experiments, however, 
can be quite complex due to the number and similarity of chemical shifts present in a single 
experiment. Judicious incorporation of ncAAs residue- and site-specifically into protein 
samples can eliminate some of the complexities inherent in NMR studies of proteins. 
 The lack of fluorine in most biological systems and the ready availability of 
fluorinated amino acid analogs makes 19F NMR an attractive option for simplifying some 
protein NMR experiments (146, 147). Methods for the residue-specific biosynthetic 
incorporation of fluorinated ncAAs into proteins have been used extensively in the 
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generation of 19F NMR samples (147). Fluorinated aromatic residues 6, 13–20 and 
difluoromethionine (21) are examples of some of the probes that have been used in 
experiments (147-150). Aided by the extreme environmental sensitivity of fluorine, 
researchers have used proteins containing these residues to explore several protein 
properties including structure, folding, and ligand binding. Rule, Pratt, Ho, and coworkers 
performed a number of structural studies on D-lactate dehydrogenase (LDH) protein 
samples labeled with fluorinated aromatic amino acids in the late 1980s and 1990s (151-
153). Changes in the 19F NMR spectra of the protein in the presence of ligand or spin-
labeled lipid molecules gave the researchers a better idea of which residues of the protein 
were sensitive to ligand and which residues were involved in membrane contacts. 
 Fluorine NMR has been used in conjunction with folding studies on a number of 
proteins. Ropson and Frieden were the first to report the use of 19F NMR to study protein 
folding (154). They conducted equilibrium folding experiments on the intestinal fatty acid–
binding protein labeled with 6-fluorotryptophan (15). Interestingly, their spectra showed 
the appearance of some peaks only at intermediate urea concentrations, indicative of a 
previously unrecognized folding intermediate in this biomolecule. Since 1992, this general 
technique has been used with numerous proteins in the context of protein folding and 
ligand binding, suggesting that the method is useful for studying proteins with a variety of 
structures (150, 155-162). An important extension of 19F NMR on proteins has been the 
combination of this sensitive spectroscopic method with stopped-flow experimental 
techniques. Hoeltzli and Frieden studied the kinetics of E. coli dihydrofolate reductase 
(DHFR) in the first report of stopped-flow NMR experiments with fluorinated proteins 
(163). In combination with complementary fluorescence and circular dichroism refolding 
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experiments, the researchers determined that DHFR appears to unfold through a pathway 
involving an intermediate state in which individual amino acid side chains gain a large 
amount of mobility while the majority of secondary structural elements remain intact. 
 Although residue-specifically fluorinated proteins enable a wide range of 
experiments, they can sometimes be complicated by sample heterogeneity (fluorination at a 
particular residue is usually no higher than 95%), difficulties in the peak assignments of 
individual fluorine atoms, and perturbations of protein structure and/or function (147, 164). 
Site-specific incorporation of fluorinated amino acids provides an alternative approach to 
the generation of isotopically labeled NMR samples. Furter was the first to report one such 
technique using p-fluorophenylalanine (6), which was substituted site-specifically in 
dihydrofolate reductase (DHFR) expressed in E. coli (70). The Frieden laboratory has 
employed Furter’s method as a complementary approach to global fluorination. Bann and 
Frieden used a combination of site- and residue-specific incorporation of 6 into the 
bacterial periplasmic chaperone PapD and used these proteins to identify at least three 
distinct steps in the folding landscape (165). 
 Two groups have recently developed very efficient expression systems that improve 
on Furter’s method for protein fluorination at aromatic residues, enabling essentially 
quantitative site-specific incorporation of fluorinated amino acids 22 and 23 into proteins 
for NMR studies (91-93). Hammill et al. demonstrated that, like previous 19F NMR work, 
22 serves as an extremely sensitive monitor of the environment surrounding the amino 
acid. Incorporation of the noncanonical residue into nitroreductase and histidinol 
dehydrogenase enabled both short- and long-range detection of ligand binding events. 
Cellitti et al. have employed 19F NMR on site-specifically labeled proteins in combination 
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with other NMR techniques, and in this work the environmental sensitivity of fluorinated 
amino acids is again evident in ligand binding experiments. Li et al. have demonstrated that 
the exquisite sensitivity of 19F NMR also enables site-specifically fluorinated proteins to be 
probed in intact E. coli cells (166). 
 While fluorinated protein samples can help answer many scientific questions, site-
specifically labeled, native proteins would provide scientists with the opportunity to 
investigate a much wider scope of problems. A consortium of scientists at The Scripps 
Research Institute and The Novartis Research Foundation led by Peter Schultz and Bernard 
Geierstanger has developed some very promising approaches to introducing site-specific 
13C, 15N, or 2H labels into proteins (also discussed by Jones et al. (167)). Deiters et al. first 
used 15N-labeled 24 to study sperm whale myoglobin, and isotopically labeled derivatives 
of 24 have since been used to study a thioesterase domain of human fatty acid synthase 
(FAS-TE) (91) and a cytochrome P450 enzyme (168). Cellitti et al. demonstrated the 
incorporation of isotopically labeled, photocaged tyrosine 25 into FAS-TE and showed that 
UV irradiation allowed for essentially complete decaging at multiple amino acid positions 
(91). The group also went on to label FAS-TE at eleven different amino acid positions with 
19F-labeled 23, 15N- and 13C-labeled 24, and 15N-labeled, decaged 25 in order to 
exhaustively study protein-tool ligand interactions. Figure 1.5 depicts a summary of the 
chemical shift data acquired in these studies, which indicates that a number of residues are 
affected by the binding of a tool compound, including amino acids located in disordered 
loops that may have been difficult to identify using other methods. This impressive, 
detailed work indicates a promising future for biosynthetically produced, site-specifically 
labeled proteins in NMR studies. The precedent for studying protein folding and ligand 
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binding has been firmly established using fluorinated amino acids. The advent of improved 
site-specific ncAA incorporation techniques for insertion of fluorinated and native, 
isotopically labeled amino acids should allow for many more detailed protein 
characterizations via NMR in the future. 
 
Protein folding and stability. Proper protein folding and robust maintenance of a specific 
three-dimensional structure oftentimes dictate a protein’s ability to perform additional 
functions such as catalysis or binding. Understanding and quantifying the phenomena 
responsible for maintaining proteins in a specified conformation can provide insight into 
how to stabilize folded structures and how to design and/or engineer proteins with various 
functions. Because folded proteins are oftentimes only thermodynamically stable by only a 
few kilocalories per mol, individual noncovalent interactions such as hydrogen bonds and 
van der Waals contacts can greatly influence whether or not a protein is able to assume a 
folded conformation and the kinetics that dictate the speed at which this conformation is 
reached. Conventional mutagenesis allows for the study of many of the noncovalent 
interactions that govern protein folding and stability, but the limited side chain structures of 
the canonical amino acids do not always allow for a full exploration of these phenomena. 
Incorporating ncAAs into proteins allows for more subtle perturbations than many 
canonical amino acid mutations allow. Researchers have perturbed proteins both locally 
and globally with ncAAs in order to study factors governing protein folding and stability. 
 
Local perturbations. The subtle mutations possible with ncAAs allow investigators to 
perturb a single noncovalent interaction within a large protein structure and study the 
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perturbation’s effects on the overall protein characteristics. In the 1990s, the Schultz 
laboratory published a series of studies demonstrating the utility of in vitro unnatural amino 
acid mutagenesis for studying local aspects of protein stability. Mendel et al. incorporated 
structural variants of leucine, including ncAAs 26–31, at position 133 of T4 phage 
lysozyme (T4L) in order to systematically study several effects including enlargement and 
shrinking of the cavity into which leucine 133 points (169). The researchers discovered that 
sequential removal of methyl groups from position 133 reduced the overall stability of the 
protein in a nonlinear fashion, a phenomenon that could also be reproduced in 
computational studies. These and other findings led the authors to suggest that many 
noncovalent interactions are important in determining protein stability and that a 
combination of modeling and unnatural amino acid mutagenesis could be used in the future 
to shed light on the factors leading to stable, folded proteins. Ellman et al. reported a related 
study examining the effects of backbone mutations at position 82 of T4L (170). In this 
work, the thermal stabilities of T4L variants containing ncAAs 32–42 at position 82 were 
measured used CD spectroscopy and heat inactivation assays. The results indicated that 
both protein backbone conformational restriction and the angle of the restriction are 
important factors in determining protein stability. Cornish et al. investigated the effects of 
β-branched amino acids on the stabilities of two α-helices in T4L using ncAAs and 
computational models (171). Incorporation of β-branched amino acids at two positions in 
T4L resulted in protein stabilization in one case and substantial destabilization in another. 
These findings emphasize the fact that context appears to play a role in the effect a β-
branched amino acid has on protein stability. 
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 Substantial efforts have also been devoted to the study of hydrogen bonds in 
proteins using systematic mutations. Thorson et al. used ncAAs 6 and 37–39 in order to 
study mutations to particular hydrogen bonds in Staphyloccocal nuclease (SNase) (172). 
Mutations of two glutamates to the weak hydrogen bond acceptor 37 and two tyrosines to 
weaker hydrogen bond donor 38 and repulsive lone pair interactor 39 confirmed the 
existence of two glutamate-tyrosine hydrogen bonds. Stability measurements on protein 
variants confirmed that the hydrogen bonds in question were responsible for one to two 
kilocalories per mol stabilization of the folded protein state, confirming previous estimates 
of hydrogen bond strengths. Studies on hydrogen bonds in α-helices, β-sheets, and β-turns 
with α-hydroxy acid analogs of leucine and isoleucine (40 and 41, respectively) 
demonstrated that hydrogen bonds in key secondary structural features can be investigated 
by changing the hydrogen bonding character of the backbone (173-175). These studies all 
demonstrate the utility of backbone variations in assessing the thermodynamic 
contributions from hydrogen bonds involving polypeptide main chain atoms. Thorson et al. 
used noncanonical amino acids to perform a linear free energy analysis on a hydrogen bond 
in SNase (176). The authors focused on the importance of the hydrogen bond mediated by 
the hydroxyl group of tyrosine 27. Substitution of tyrosine by amino acids 16, 42, and 43, 
which have increasingly acidic pKas, confirmed that the side chain of tyrosine 27 serves as 
a hydrogen bond donor in SNase. The use of a series of tyrosine analogs eliminated 
context-dependent, confounding factors that oftentimes complicate the direct assessment of 
the importance of a particular hydrogen bond in a protein. 
 The above studies illustrate the power of atomic-level mutations in the analysis of 
protein stability. However, systematic local perturbation of soluble proteins using ncAAs 
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has become less common in recent years, perhaps because of difficulties in achieving high 
protein yields using in vitro protein production methods, or the availability of alternative 
protein production techniques such as protein semisynthetic methods. The recent site-
specific incorporation of α-hydroxy acids into proteins produced in E. coli may lead to new 
possibilities for protein stability studies in the future (177). Regardless of the future of local 
perturbations of globular proteins, the work outlined above was crucial in setting the stage 
for the study of membrane proteins using extensive unnatural amino acid mutagenesis, a 
topic to be discussed below. 
 
Global perturbations. Global changes in the amino acid composition of a protein allows 
for the study of aggregate effects that may be too small to study individually. The 
fluorination effect has been a heavily studied topic for quite some time (178), including in 
the context of biological systems (179-181). Coiled coils have been a particularly useful 
protein-based system for studying the fluorination effect because the residues mediating 
protein-protein interactions in this system are well defined. Tang et al. have studied 
variants of one such multimeric α-helical protein, A1, containing different degrees of 
fluorination within its hydrophobic core. The investigators found that increasing the 
amount of fluorine-fluorine contacts within the hydrophobic core by substituting leucine 
with trifluoroleucine (44) or hexafluoroleucine (3) led to peptides that were increasingly 
resistant to thermal and chemical denaturation (41, 182). Son et al. found similar trends in a 
model coiled coil system in which isoleucine residues were replaced with 
trifluoroisoleucine (45) residues or valine residues were replaced with trifluorovaline (46) 
residues, although the degree of stabilization differed depending on whether isoleucine or 
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valine was converted into its trifluorinated form (183). Montclare et al. also recently 
reported that stabilization of the model protein A1 is relatively insensitive to the 
stereochemistry of fluorinated amino acids incorporated into the protein (184). Upon 
fluorination, amino acid side chain volumes increase by a significant amount, and size 
increases may be responsible in part for the improved stabilities of fluorinated coiled coils. 
In order to investigate this possibility in more detail, Van Deventer et al. utilized the amino 
acid homoisoleucine (Hil, 29) (185). Hil has a nearly identical side chain molecular surface 
area to trifluoroleucine but retains the aliphatic character of canonical amino acids. 
Interestingly, replacing the leucines in A1 with 29 results in stabilization that is equal to or 
better than the stabilization of A1 that results from replacement of Leu with 
trifluoroleucine. These results suggest that side chain size does play a role in dictating 
protein stability in the context of hydrophobic interactions. However, femtosecond 
timescale experiments performed on proteins containing solvent-exposed fluorinated and 
aliphatic amino acids indicate that solvation dynamics near a protein surface change 
drastically depending on the absence or presence of nearby fluorinated groups (186). Future 
experiments using size-matched aliphatic and fluorinated amino acids may continue to 
enable the elucidation of the unique properties of fluorinated biomolecules. 
 Perturbing the amino acid composition of large proteins can alter protein folding 
and stability significantly, especially when the proteins in question assume more 
complicated structures than coiled coils. Although sometimes global replacement of a 
canonical amino acid within a protein can yield biomolecules with reduced thermal 
stabilities (187, 188) or an increased propensity for aggregation (189), these effects are 
quite dependent on the identity of the protein and the ncAA substitutions made. Oftentimes, 
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such substitutions are tolerated quite well in proteins. For example, Wang et al. report that 
fluorination of murine interleukin-2 (IL-2) at isoleucine residues results in IL-2 molecules 
that are nearly as effective as their nonfluorinated counterparts in mammalian cell 
proliferation assays (190). Budisa and coworkers have proposed using ncAAs as general 
probes of protein folding (191). In one report out of the Budisa laboratory, researchers 
investigated the effects of incorporating (4R)- and (4S)-fluoroproline (47, 48) in place of 
proline in enhanced green fluorescent protein (eGFP) (192). Incorporation of 47 into eGFP 
resulted in proteins located in inclusion bodies of E. coli that could not be refolded. On the 
other hand, incorporation of 48 into eGFP resulted in a protein with significantly faster 
refolding kinetics and overall refolding yields than nonfluorinated eGFP, which the authors 
attributed to 48’s higher Cγ-endo puckering and cis isomerization preferences compared to 
proline. This work provides one of the first examples of a protein that has improved folding 
properties when a ncAA is incorporated throughout its structure. The properties of single-
chain Fv fragments of antibody fragments have also been subjected to proline fluorination 
with 47 and 48 (193). Interestingly, the stability of the scFv was found to be improved 
when proline was replaced with 47, the stereoisomer that was found to be detrimental to 
eGFP folding. Budisa and coworkers recently employed methionine analogs 5 and 49 in the 
study of protein misfolding leading to prion disease (194). In this work, they used 5 and 49 
because of their increased hydrophobicity and hydrophilicity, respectively, relative to 
methionine. Global replacement of methionine by 5 in recombinant human prion protein 
(rhPrPC) resulted in less protein aggregation than in rhPrPC containing methionine. On the 
other hand, replacement of methionine by 49 yielded a much more aggregation-prone 
version rhPrPC than the methionine version of the protein. CD spectroscopy also revealed 
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significant differences in secondary structure and unfolding behavior as a function of 
temperature. These results can be seen in figure 1.6. These interesting experiments suggest 
that the hydrophobicity of the moieties present at positions in the rhPrPC normally occupied 
by methionine can significantly impact how well the protein maintains its folded state, and 
that hydrophilic moieties appear to substantially impact the proper folding of the protein in 
question. Because methionine oxidation results in the formation of more hydrophilic 
functionalities at methionine positions, this work suggests that oxidative stresses may play 
a role in the development of prion disease and other diseases caused by protein misfolding. 
These techniques may also be applicable to studying a number of other cellular proteins 
that can undergo oxidation at methionine residues (195-197). Studying protein stability 
using global perturbations introduced with ncAAs appears to be useful in a variety of 
settings. Both model proteins and more complex proteins can be perturbed in ways such 
that protein stability is either negatively or positively affected. Observing these changes in 
stability provides fundamental information regarding how changing molecular properties 
results in changes to protein properties as a whole and also provides ideas for engineering 
proteins with altered stabilities. Thus, global perturbations provide a complementary 
approach to local, site-specific perturbations. These two approaches add substantial 
capability to researchers’ toolkit for assessing factors contributing to protein stability and 
engineering more stable, faster folding proteins. 
 
Membrane proteins. Membrane proteins play extremely important roles in organisms 
from all classes of life and may comprise upwards of one quarter of all open reading frames 
in the genomes of fully sequenced organisms (198). These proteins also form a large 
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portion of “druggable” protein targets (199-201). However, structural characterization of 
this important set of proteins has continued to be plagued by problems with overexpression 
and crystallization, although there have been some recent advances (for example, see (202-
204)). The dearth of detailed molecular information has necessitated the adaptation of other 
experimental techniques for studying membrane proteins, including the very powerful 
combination of conventional mutagenesis and the patch clamp technique (205). Several 
laboratories have found that employing ncAAs in studies of receptors and ion channels 
further augments the power of more traditional biochemical characterization methods. 
Investigations of topics including channel architecture, the functional significance of 
individual amino acids and noncovalent interactions, and mechanisms of ligand binding 
have been aided significantly with the use of ncAAs. 
 
Exploiting unique functionalities of noncanonical amino acids. Several studies of 
membrane proteins have employed ncAAs to learn about structural and mechanistic 
features of particular channels and receptors. Surprisingly, many of these investigations 
have utilized techniques that take advantage of “highly unnatural” features of noncanonical 
amino acids, an observation that Dougherty made in a recent review (206). Gallivan et al. 
employed biocytin (50) in order to detect surface-exposed residues in muscle-type nicotinic 
acetylcholine receptor (nAChR) (207). This work used information on protein expression 
and the binding of streptavidin probes to proteins present in intact Xenopus oocytes to 
reveal the orientations of several amino acids within the main immunogenic region of the 
nAChR. England et al. employed ultraviolet light-cleavable amino acid 51 and base-
cleavable α-hydroxy acids 32, 40, and 52 in order to investigate characteristics of a portion 
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of the muscle-type nAChR known as the Cys-loop (208, 209). These experiments 
confirmed the functional significance of the Cys-loop in signaling and helped to establish 
the disulfide bond connectivity within the loop. 
 Spectroscopically active ncAAs have proven very useful for studying structural 
features of G protein-coupled receptors (GPCRs). Fluorescent amino acid 53 has been 
employed in FRET studies of the GPCR tachykinin neurokinin-2 (NK2) in order to study 
the structure of the protein (210, 211). In vitro preparations of NK2 containing the 
fluorescent amino acid were exposed to a ligand labeled with a FRET partner. Distance 
constraints within the receptor were determined from measured FRET effects, leading to a 
more accurate picture of the general structure of the receptor. Local mechanistic features of 
the GPCR rhodopsin were recently probed using p-azidophenylalanine 54 as a vibrational 
spectroscopic probe (212). The unique vibrational signature and sensitivity of the azide to 
changes in the local electrostatic environment enabled Ye et al. to investigate structural 
changes in the receptor upon light activation. Placement of 54 at different sites within 
rhodopsin enabled the elucidation of the order of several sequential helix movements as the 
protein assumes its active conformation, leading to a general model for GPCR activation 
(213). This work appears to be extremely promising and should be applicable to any 
number of membrane proteins due to the exquisite sensitivity of azides to local 
environment. 
 Noncanonical amino acids of various sizes have also been employed to examine the 
properties of voltage-gated potassium channels. The mechanism of channel inactivation in 
potassium channel Kv1.4 has been studied in mammalian cells using amino acids bulkier 
than tyrosine (80). The authors observe slower channel inactivation times when a naturally 
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occurring tyrosine residue is replaced by 24 or 55. They argue that these observations 
provide support for a mechanism in which the N-terminus of the channel moves through a 
side pore in the channel to inhibit the flow of ions through the inner pore. A series of 
phenylalanine analogs of various sizes (56–59) was used to examine the importance of a 
particular Phe residue at position 233 within the Shaker voltage-gated potassium channel 
(214). Interestingly, channels containing the large aliphatic amino acid cyclohexylalanine 
60 in place of Phe still retain function, indicating that the size of Phe is the most important 
functional characteristic of the residue in question. Phe analogs of various sizes also affect 
channel behavior in a systematic way, supporting the hypothesis that a Phe to Trp mutation 
at position 233 alters channel function primarily on the basis of its increased bulk. The 
above examples exploit properties of ncAAs that make these residues distinct from 
canonical amino acids. The use of these unique functionalities has enabled the study of a 
wide variety of structural and mechanistic aspects of membrane proteins, and several of 
these techniques should continue to provide insights into the functions of numerous 
receptors and channels. 
 
Atomic-level perturbations. In the absence of three-dimensional structural information, 
meaningful characterization of the role of a particular amino acid or noncovalent 
interaction within a protein oftentimes requires atom-by-atom perturbations. Since the 
Dougherty and Lester laboratories first described the incorporation of noncanonical amino 
acids into membrane proteins in Xenopus oocytes (215), much work involving ncAAs in 
membrane proteins has exploited very subtle perturbations to study aspects of channel and 
receptor function (206, 216). 
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 Atomic-level mutations have revealed important information about the roles that 
individual amino acids play in receptor gating. Hanek et al. reported studies on the nAChR 
investigating the role of a particular valine in the gating of the receptor (217). These studies 
uncovered a “pin-into-socket” binding mechanism within the channel by examining dose-
response curves of channels substituted with amino acids 61–63. Another investigation 
authored by Lummis et al. investigated the role of a particular proline in the gating of a 5-
hydroxytryptamine type 3 (5-HT3) receptor (218). The authors hypothesized that a proline 
residue located in between two transmembrane helices was involved in the gating 
mechanism of the receptor. Although conventional mutagenesis of the channel resulted in a 
loss of receptor gating activity, introduction of amino acids 33, 47, 48, and 64–66 in place 
of proline resulted in functional channels. Interestingly, the effector concentration for half 
maximal response (EC50) of the resulting channels correlate very strongly with the 
propensity for each ncAA replacing proline to assume a cis protein backbone conformation. 
Figure 1.7 depicts the linear relationship observed between cis-trans isomerization and 
receptor activation. Based on this striking correlation and additional studies, the authors 
conclude that the relatively facile cis-trans isomerization of proline, and not any other 
properties of this cyclic canonical amino acid, is responsible for the gating characteristics 
of the 5-HT3 receptor. The data from their studies also led to a proposal of a new model for 
the gating mechanism of the receptor (figure 1.7c). 
 Atomic-level mutations have also provided insight into the importance of particular 
noncovalent interactions within receptors and channels. Hydrogen bonds involving main 
chain and side chain interactions have been particularly well studied. In 1995, Nowak et al. 
made mutations to three tyrosine residues in muscle-type nAChR that included analogs of 
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tyrosine with varying hydroxyl side chain pKas and other amino acids lacking hydroxyl 
groups altogether. Based on dose-response curves of the mutant channels, the authors 
concluded that only one of the residues examined was involved in a hydrogen bonding 
interaction through the hydroxyl group (215). Beene et al. used similar atomic 
perturbations to study four different tyrosine residues present in the 5-HT3 receptor binding 
site (219), finding that each residue plays a unique functional role within the channel. More 
recent work with the 5-HT3 receptor and ncAAs has determined the roles of two highly 
conserved residues within loop A of the ligand binding site, one of which appears to form a 
critical hydrogen bond with the ligand (220). Last, the nicotinic pharmacophore of the 
α4β2 neuronal nAChR was investigated with the help of 40 (221). 
 Hydrogen bonds with main-chain atoms can be perturbed effectively with the aid of 
α-hydroxy amino acids and other ncAAs. Studies of a conserved proline residue within the 
M1 region of ligand-gated ion channel receptors using amino acids 32, 33, 40, 52, and 67 
have suggested that proline is favored for its hydrogen bonding characteristics (222, 223). 
Gleitsman et al. used double-mutant cycles with ncAAs to study hydrogen bonding 
networks in the muscle-type nAChR (224). Their detailed investigations were instrumental 
in correcting homology models that had incorrectly predicted the hydrogen bonding 
patterns based on structures of the acetylcholine-binding protein. Similar studies on an 
aspartate residue participating in several hydrogen bonds (225) and the hydrogen bonds in a 
beta sheet structure (226) of the muscle nAChR have also provided information regarding 
the functional significance of particular hydrogen bonding patterns. 
 Additional ncAAs have been used to examine other important noncovalent 
interactions that play important roles in agonist and antagonist binding events (227, 228). 
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Numerous receptors and channels have a very large number of aromatic residues that 
directly line the binding site, and as early as 1990, aromatic residue-mediated cation-π 
interactions were proposed in acetylcholine-binding proteins (reviewed in (229, 230)). The 
use of ncAAs has contributed greatly to the investigation of potential cation-π interactions 
between ligands and the ligand binding sites of membrane proteins. Zhong et al. first 
described the use of a series of aromatic ncAAs to study ligand binding in the muscle 
nAChR in 1998 (231). Experimental measurements of EC50 values of channels containing a 
number of tryptophan analogs at three positions of the ligand binding site showed very little 
dependence on the tryptophan analog incorporated. However, at the α149 position, the 
EC50 value varied widely depending on the analogs used. Remarkably, comparison of 
experimentally determined EC50 values with fluorinated tryptophan analogs 13–15, 68–70 
and quantum mechanical calculations of cation-π binding strengths of each of these analogs 
revealed a very strong correlation. This strong relationship between ligand binding and 
cation-π binding strength at a single amino acid, depicted in figure 1.8, clearly established 
the presence of a single cation-π interaction in the nAChR. Subsequent studies have 
continued to reveal important characteristics of numerous cation-π interactions in nAChR 
binding events, including differences in the binding of nicotine, acetylcholine, and 
epibatidine to the receptor (232). Cashin et al. compared nicotine and acetylcholine binding 
to the nAChR with the drug epibatidine and established that epibatidine has a cation-π 
interaction similar to acetylcholine (233). Xiu et al. investigated differences between the 
muscle nAChR and the A2B3 form of the α4β2 neuronal nAChR that likely plays a role in 
nicotine addiction (234). One key finding that they reported was the existence of a strong 
cation-π interaction between nicotine and a tryptophan residue in α4β2 homologous to 
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tryptophan α149 in muscle nAChR, which they confirmed with the same series of 
fluorinated tryptophan analogs described above. This cation-π interaction between nicotine 
and tryptophan is absent in the muscle nAChR, explaining a longstanding mystery 
regarding the selectivity of nicotine for neuronal receptors over the muscle nAChR. 
 In addition to the extensive studies on cation-π interactions in nAChRs, researchers 
have employed ncAAs to study potential cation-π interactions in other integral membrane 
proteins. Studies on the Cys-loop family of receptors have revealed that many proteins 
within the Cys-loop family bind ligands using cation-π interactions, but utilizing aromatic 
residues at different structural locations (232, 235-238). Studies on the voltage-gated 
sodium channel Nav1.4 involving ncAAS have also proven fruitful, identifying cation-π 
interaction binding sites for tetrodotoxin, calcium binding, and local anesthetics (239-241). 
Use of ncAAs in the voltage-gated potassium channel Shaker yielded insights into the 
location of a cation-π interaction and the structural conformation of the channel, and these 
findings helped to resolve discrepancies between computational structural predictions and 
previous experimental work (242). Last, McMenimen et al. have demonstrated that the 
tryptophan thought to be responsible for cation-π-mediated magnesium ion blockade in the 
N-methyl-D-aspartate receptor is instead favored for its large, hydrophobic, and flat 
characteristics (243). 
 Research efforts highlighted above demonstrate that investigations of membrane 
proteins with ncAAs can provide a wide variety of structural and mechanistic information 
ranging from atomic to whole-protein distance scales. To date, the majority of 
investigations in this area have focused on ligand- and voltage-gated ion channels, but 
recent reports employing ncAAs in the study of GPCRs (212, 244-246) suggest that efforts 
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to broaden the applicability of ncAAs to a wider range of membrane proteins are underway. 
As long as three-dimensional structural information about membrane proteins remains 
scarce, ncAAs should continue to play an important role in the study of these complex 
biomolecules. 
 
Posttranslational modification mimicry. Although only twenty amino acids are usually 
genetically encoded in proteins, nature has devised a huge number of posttranslational 
modifications that modulate the structure, activity, and localization of proteins (2). The 
precise effects that these modifications have on proteins can be extremely difficult to study 
due to the dynamic nature of many of these modifications in living cells and the challenges 
in purifying or preparing uniformly modified proteins to study in vitro. Proteins bearing 
authentic posttranslational modifications or close structural mimics of these modifications 
can be prepared in conjunction with ncAAs. Both chemical routes and direct incorporation 
of amino acids mimicking posttranslational modifications have been explored and applied 
to the study of posttranslationally modified proteins. 
 
Chemical approaches. Performing chemistry on proteins forms one major approach to 
generating molecules containing posttranslational modifications found in naturally 
occurring proteins. Many protein modification techniques have been developed for the 
chemical transformation of residues found in naturally occurring proteins (247), and some 
of these methods have been exploited in the generation of structures mimicking 
posttranslational modifications. For example, the Shokat laboratory has developed an 
elegant method for modifying cysteine residues in recombinantly produced proteins in such 
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a way that they resemble methyl-lysines (248). Semisynthetic methods such as native 
chemical ligation and expressed protein ligation also provide another efficient chemical 
route to proteins containing posttranslational modifications (5-9). NcAAs provide a 
complementary approach to these methods because of the improved yields that biosynthetic 
protein production offers compared to other preparations of posttranslationally modified 
proteins. Approaches to employing bioorthogonal chemistry for the selective modification 
of biomolecules have recently been reviewed from the perspectives of the range of 
bioorthogonal chemistries explored (249), the particular utility of azide-alkyne click 
chemistry (250), and chemistries that can be performed on ncAAs in proteins (251). 
 Several groups have utilized chemistries introduced by the incorporation of ncAAs 
in order to create mimics of posttranslationally modified proteins. Three separate groups 
have found chemical transformations that lead to dehydroalanine-containing proteins, two 
of which (Seebeck et al. and Wang et al.) involve the use of ncAAs (252-254). The Schultz 
laboratory has demonstrated that analogs of methyl- and acetyl-lysine (71–73) can be 
chemically installed in proteins by performing chemistry on dehydroalanine-containing 
proteins (255), and using dehydroalanine (74) as a chemical handle has been proposed as a 
general starting point for protein modification (256). The Chin laboratory has demonstrated 
the utility of protecting groups in the development of a method for preparing site-
specifically and quantitatively methylated histones. They installed dimethyllysine (75) by 
site-specific incorporation of the protected lysine Nε-tert-butyloxycarbonyl-L-lysine (76) 
and an ingenious protection-deprotection scheme (257, 258). Using the same ncAA (76), 
Virdee and coworkers combined genetic code expansion, intein chemistry, and 
chemoselective ligation to create a method termed GOPAL (genetically encoded 
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orthogonal protection and activated ligation) to synthesize diubiquitin chains that have not 
been chemically accessible by previous means of synthesis (259). The resulting proteins 
were used to solve the structure of a previously uncharacterized diubiquitin conjugate and 
to study the specificities of human deubiquitinases. Eger et al. have also demonstrated the 
utility of a combination of site- and residue-specifically incorporated azide and alkyne 
amino acids 77 and 78 to chemically synthesize diubiquitin molecules using copper-
catalyzed azide-alkyne cycloadditions (CuAAC) (260). This method might be simpler and 
more versatile than the methods described by the Chin laboratory, but the resulting 
structures contain unnatural triazole ring linkages rather than authentic linkages found in 
nature. 
 The complexities of protein glycosylation have inspired a number of approaches to 
the chemical and enzymatic synthesis of sugar-decorated proteins (recently reviewed by 
Gamblin et al. (261)). Part of the appeal of chemical approaches to adding glycans to 
proteins is the ability to precisely define the structure of a glycan prior to attaching it to a 
protein without having to worry about the enzymatic efficiencies of glycosyltransferases or 
potential constraints within the protein translation machinery. Davis and coworkers have 
recently reported two alkene-based routes to glycosylated proteins using chemistry 
described above. Each of these methods leads to the construction of quantitatively 
glycosylated model proteins, although they require the use of proteins containing only one 
cysteine and one methionine each, respectively (254, 262). The Schultz laboratory 
demonstrated the modification of ketone-containing amino acid 79 in the Z-domain of 
staphylococcal protein A with an aminooxy analog of N-acetylglucosamine (263). After 
nearly quantitative reaction with the first sugar, the protein could be enzymatically 
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modified at the glycan with subsequent sugars to produce more complex carbohydrate 
structures. Chemical attachment of multisugar structures to ketone-containing proteins was 
also achieved, although not in quantitative yields. Van Kasteren et al. have used 
azidohomoalanine (77) and homopropargylglycine (2) to “click” sugar structures to model 
proteins using CuAAC (264, 265). Unlike the ketone-mediated couplings, CuAAC 
afforded nearly quantitative yields when complex carbohydrate structures were ligated to 
proteins. CuAAC-mediated glycosylation was also combined with cysteine modification to 
generate doubly glycosylated proteins, although this required the use of proteins containing 
only one methionine and cysteine residue each. Despite these drawbacks, these chemically 
produced glycan mimics were used to study glycan recognition and as probes of glycan-
binding activity in vivo. One especially interesting observation was that neuronal cells in 
rat brain tissue sections appear to selectively bind proteins containing GlcNAc 
modifications, while nearby glial cells do not appear to possess the same binding 
capabilities. Chemical approaches to the generation of posttranslationally modified proteins 
appear to be especially useful in glycoprotein synthesis, and the generality of this approach 
should be very useful for generating quantitatively modified structures for studying several 
outstanding questions in glycobiology. 
 
Direct incorporation approaches. Ribosomal synthesis of proteins containing 
appropriately designed ncAAs allows for the creation of some authentic, genetically 
encoded posttranslationally modified proteins and metabolically stable mimics of other 
modifications. Significant effort has been dedicated to the genetic incorporation of subtle 
posttranslational modifications into proteins. The Schultz laboratory has biosynthetically 
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incorporated sulfotyrosine (80) into proteins expressed in E. coli and used it in a number of 
contexts. In an initial report, they demonstrated the improved inhibition of thrombin by 
sulfo-hirudin versus desulfo-hirudin (266). They also solved the X-ray crystal structure of 
the sulfo-hirudin-thrombin complex using biosynthetically produced sulfo-hirudin (267). In 
this case, the genetic encoding of the modification enabled the generation of large protein 
samples quantitatively sulfated at a specific position, a feat difficult to achieve by any other 
protein production method. More recently, Schultz and coworkers have explored the utility 
of sulfated antibodies in the context of directed evolution (268, 269); these results will be 
discussed below in the “Evolution” subsection. 
 Lysine modifications are particularly important posttranslational modifications. For 
example, lysine acetylation, which results in the amino acid Nε-acetyllysine (81), impacts 
the function of many proteins. A report has described the biosynthesis of proteins 
containing this modification, including the naturally lysine-acetylated protein rat 
mitochondrial manganese superoxide dismutase (100). Chin and coworkers have recently 
applied this strategy to the study of histone acetylation (270). The preparation of histone 
H3 quantitatively acetylated at lysine 56 enabled the mechanistic study of a number of 
previously proposed effects of histone acetylation on histone properties. For example, 
FRET experiments indicated that reconstituted nucleosomes acetylated at lysine 56 of H3 
have DNA breathing increased by seven times over nonacetylated nucleosomes, explaining 
previously observed changes in gene expression from H3 mutants lacking lysine at position 
56. Suga and coworkers have also investigated the effects of lysine acetylation and 
methylation on heterochromatin protein 1 recognition of histone H3 N-terminal peptides by 
reprogramming the genetic code to combinatorially incorporate acetylated and methylated 
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lysine residues into genetically encoded peptides (271). Aside from histone acetylation, 
cyclophillin A (CypA), a protein with important roles in immunosuppression and viral 
infection, is also acetylated in human cells. Using an orthogonal acetyllysyl-tRNA 
synthetase/tRNACUA pair and amber suppression, Lammers et al. produced homogeneously 
and site-specifically acetylated recombinant CypA in E. coli (272). This approach enabled 
structural and biophysical analyses on acetylated CypA for the first time and revealed 
important roles of acetylation on CypA function. These roles include suppression of the 
protein’s catalytic activity, recognition of the HIV-1 capsid, cyclosporine binding, and 
calcineurin inhibition. 
 Xie et al. have genetically encoded a phosphotyrosine mimic in proteins (273). 
While phosphotyrosine is subject to hydrolytic and enzymatic cleavage, amino acid 82 is 
not due to the more stable linkages involved. The single negative charge on the amino acid 
is a reasonable substitute for the doubly charged phosphate group present in 
phosphorylated amino acids. DNA binding studies with a fragment of human signal 
transducer and activator of translation-1 (STAT1) containing amino acid 82 showed that it 
had an intermediate apparent affinity for DNA in between analogous phosphorylated 
STAT1 and unphosphorylated STAT1. These results indicate that the phosphotyrosine 
mimic may be used to study the effects of phosphorylation at specific protein sites, 
although the mimic is not a perfect analog of authentic phosphorylation. The amino acid 
3-nitrotyrosine (83), a residue commonly associated with disease and oxidative damage, 
has also been incorporated into proteins produced in E. coli (274). Studies on the catalytic 
activity of manganese superoxide dismutase (MnSOD) indicate that nitration of a particular 
tyrosine in the protein greatly impacts the catalytic activity of MnSOD, suggesting that 
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future studies of tyrosine nitration in proteins may shed additional light on the molecular 
and cellular effects of this modification. As stated above, protein modification by 
glycosylation is an area of widespread interest. However, biosynthetic incorporation of 
glycans into proteins has been a rather difficult task, and early reports on the subject (275, 
276) have since been retracted (277, 278). One report of the successful incorporation of a 
glycosylated amino acid into proteins using an in vitro translation system has appeared in 
the literature (279), suggesting that future efforts to directly incorporate glycosylated amino 
acids into proteins may yet prove fruitful. 
 More than half a dozen posttranslational modifications or mimics have been 
incorporated into proteins using biosynthetic approaches. These approaches to 
incorporating small posttranslational modifications and chemical approaches to 
incorporating modifications such as glycan structures into proteins appear to be relatively 
straightforward. The successful creation of uniformly modified proteins and elucidation of 
many of significantly altered functional properties of these proteins suggests that ncAAs 
will continue to provide researchers with powerful, specific tools for studying the effects of 
posttranslational modifications on biological processes. 
 
Immune modulation. Collaborative efforts at The Scripps Research Institute have recently 
raised the possibility of using ncAAs as aids in the development of vaccines. Many 
approaches to developing vaccines have previously been described that include the use of 
viruses, T-helper epitopes, and sophisticated adjuvants (280-282), but difficulties remain in 
developing robust immune responses against self-proteins. Grünewald et al. first presented 
the idea of incorporating immunogenic amino acids into self-proteins in 2008 (283). In this 
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work, researchers incorporated p-nitrophenylalanine (pNO2Phe, 84) into murine tumor 
necrosis factor-alpha (mTNF-α) based on previous reports of the highly immunogenic 
nature of nitroaryl groups. Immunization of mice with purified mTNF-α containing 84 
resulted in a very high level of mTNF-α-specific antibodies in the serum of the treated 
animals. In contrast, immunizations using wild-type mTNF-α or a variant containing a 
tyrosine to phenylalanine mutation did not result in significant antibody titers. The utility of 
the immunization procedure was tested using a mouse model of severe endotoxemia. 
Figure 1.9 depicts the results of challenging mice with bacterial lipopolysaccharides. While 
the presence of mTNF-α in the serum usually contributes to septic shock and death of the 
challenged mice, these data indicate that the presence of antibodies against mTNF-α can 
significantly improve the survival rate of the challenge. A follow-up report on this work 
expanded upon the above studies (284). In this work, the investigators found that the site of 
pNO2Phe within mTNF-α affected the strength of the immune response elicited in the 
mouse. They also note, somewhat surprisingly, that antibodies isolated from the serum of 
immunized mice do not necessarily recognize peptide epitopes containing the 
immunogenic amino acid, although further investigation will be necessary to examine this 
finding in more detail. Finally, the researchers incorporated pNO2Phe into murine retinol-
binding protein (mRBP4) and immunized mice with the resulting protein, again finding 
robust immune responses after administration of the proteins containing 84. In each of 
these papers, the authors stress that they have produced immunogenic materials based on 
precise molecular manipulations, an approach not possible with other immunization 
techniques. These results raise the tantalizing possibility that immunogenic ncAAs may 
lead to a general approach to developing therapies involving recognition of a self-protein or 
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other weakly immunogenic protein. While application to treatments for cancer or other 
diseases may still be quite distant, the initial experiments described here show a great deal 
of promise. 
 
Evolution. As far as scientific inquiries have been able to establish, the genetic code has 
remained more or less constant since its establishment in the so-called frozen accident 
(285). Therefore, evolution has operated with a single genetic code for more than one 
billion years (with some minor variations arising along the way (286)). However, there is 
no fundamental barrier to performing evolution experiments with alternative genetic codes. 
Using ncAAs, researchers have recently combined ncAAs and directed evolution to 
investigate new approaches to genetic code expansion and protein engineering. 
 
Evolution of organisms with altered genetic codes. Little is known about how the standard 
genetic code was established. Before becoming fixed, changes to the genetic code likely 
involved either introduction of a new amino acid into proteins or the substitution of one 
amino acid for another within proteins (286-288). These significant changes likely required 
substantial adaptations by the organism in order to accommodate the alterations. Two 
groups have investigated this adaptation process using laboratory evolution techniques. In 
1983, Wong grew tryptophan-auxotrophic Bacillus subtilis on solid media supplemented 
with 4-fluorotryptophan (13) in place of tryptophan (Trp) (289). After just two rounds of 
selection and two more of mutagenesis and selection, Wong isolated a mutant that grew 
logarithmically in a liquid culture supplemented with 13, but only linearly when the 
medium was supplemented with tryptophan. These impressive results demonstrated that it 
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is possible to change an organism’s amino acid preference from a canonical one contained 
in the genetic code to a noncanonical one. Bacher and Ellington performed similar 
selection experiments using E. coli auxotrophic in Trp production and then identified 
genetic mutations in the evolved strains (290). Three thousand hours of serial dilutions in 
liquid cultures containing increasing percentages of 13 in place of Trp resulted in strains 
showing improved growth rates in medium containing 99.97% 12, although these strains 
still showed a growth preference for Trp. Identification and characterization of mutations 
revealed that one mutation in the gene encoding tryptophanyl-tRNA synthetase enables 
improved discrimination against 13, but mutations in other genes conferred improved 
tolerance of the noncanonical substrate to the organism. Bacher et al. also subjected the 
phage Qβ to selection in media containing 95% 6-fluorotryptophan (15) (291). Two 
independent phage lines were subjected to twenty-five rounds of selection. Seven 
mutations became fixed in each of these lines, and, surprisingly, these mutations did not 
involve the alteration of any tryptophan codons. In the case of both E. coli and phage, the 
evolved organisms retained their abilities to grow on tryptophan while acquiring new 
growth capabilities. These results suggest that organisms can adapt to tolerate ambiguity 
within their genetic codes, implying that the “ambiguous intermediate” theory of genetic 
code expansion is plausible (288). Future studies of the ncAA accommodation process may 
shed additional light on the mechanisms by which changes to the genetic code are accepted 
in living creatures. 
 
Directed protein evolution. In the past two decades, scientists have developed a number of 
high-throughput selections and screens enabling the directed evolution of proteins (1, 292-
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295) and higher order protein-based systems (296). These efforts have enabled researchers 
to study the evolution of individual proteins and engineer proteins with new functions 
(297). Most work in this area has focused on exploring the sequence space defined by 
polypeptide chains containing the twenty canonical amino acids. However, two groups 
have employed ncAAs to explore alternative protein sequence spaces using directed 
evolution. The Tirrell laboratory has focused on the development of functional proteins 
fluorinated at leucine positions by substituting trifluoroleucine (44) for leucine. Global 
replacement of leucine in chloramphenicol acetyl transferase (CAT) resulted in a protein 
with greatly reduced half-life of inactivation at 60 °C (188). Two rounds of error-prone 
PCR and screening for mutants with increased activity after prolonged incubation at 60 °C 
yielded a mutant with substantially improved thermostability properties. Interestingly, the 
nonfluorinated mutant protein retained the thermostability of the parent CAT, indicating 
that mutations introduced during the course of evolution allowed the protein to improve its 
properties when fluorinated while retaining its original function. This trend is similar to the 
trend observed when an amino acid in the genetic code of an organism is replaced globally; 
both organisms and proteins appear to first adapt to accept an ambiguous genetic code 
before gaining a preference for the altered genetic code. In another set of evolution 
experiments, Yoo et al. evolved a GFP variant containing 44 in place of leucine using 
eleven rounds of random mutagenesis and screening using fluorescence-activated cell 
sorting (FACS) (189). A summary of the progress observed during the course of the 
directed evolution experiment is depicted in figure 1.10. The fluorescence of cells 
expressing various mutants in the presence of leucine or 44 indicates that nonfluorinated 
GFP mutants retain (and perhaps even slightly improve) their function, similar to the trend 
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observed in CAT evolution. The authors also found a marked improvement in the folding 
kinetics of the evolved GFPs in the absence of fluorination. Interestingly, several of the 
mutations observed in the final isolated mutant were also observed after screening for 
“folding-enhanced” GFP variants (298), suggesting that evolving proteins containing 
ncAAs may be a general method for improving the folding properties of proteins. 
 The Schultz laboratory has recently applied site-specific incorporation 
methodologies to directed evolution problems. Their work to date has focused on using 
ncAAs that are known to have affinities for particular molecules to engineer antibody 
fragments. In an initial report, they described the development of a phage display system 
that can be used in conjunction with an orthogonal aaRS-tRNA pair to encode for antibody 
fragments containing twenty-one amino acids (269). In this paper, they demonstrated the 
utility of encoding sulfotyrosine (80) in a saturation mutagenesis library. Despite an 
expression bias against antibody fragments containing 80, they were able to isolate variants 
from a naïve germline library containing sulfotyrosine after panning for binders against the 
HIV protein gp120. Perhaps these results were not too surprising since naturally occurring 
high-affinity antibodies against gp120 are known to be sulfated (299, 300), but the 
demonstration does prove that ncAAs can be used effectively in phage display applications. 
A follow-up report has shown that functional antibody variants can be isolated from 
saturation mutagenesis libraries of the tyrosine-sulfated 412d antibody fragment (268), 
although affinity maturation of the fragment proved challenging given the high affinity of 
the starting protein. Finally, this technique has also been applied to acyclic sugar binding 
(301). The amino acid p-boronophenylalanine (85) was encoded in a saturation 
mutagenesis library of phage-displayed antibody fragments, and the library was panned 
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against a glucamine resin. Many of the clones isolated after three rounds of panning were 
found to contain amino acid 85. Again, these results might have been expected based on the 
well-known propensity of boronates and diols to form boronate esters. However, these 
proof-of-principle experiments suggest that future libraries of antibody fragments 
containing ncAAs may yield high-affinity binders to antigens that are normally difficult to 
target. Taken as a whole, directed evolution experiments with proteins containing ncAAs 
appear to be promising for evolving proteins with properties that are difficult to introduce 
using only canonical amino acids, including particular molecular recognition and catalysis 
events. Furthermore, both protein and organism evolution experiments with ncAAs may 
provide insights into the kinds of adaptations necessary to maintain evolutionary fitness as 
amino acid compositions are changed or expanded. 
 
Proteomic studies. Labeling and identifying the proteins expressed in biological systems 
can provide great insights into the inner workings of these systems, including spatial and 
temporal information about the proteome (302, 303). Recent work with ncAAs has 
demonstrated that reactive amino acid analogs can function as effective tags for labeling 
and identifying newly synthesized proteins in a range of biological systems. The versatility 
of bioorthogonal chemistry enables the use of the same set of ncAAs for visualization and 
identification of newly synthesized proteins. 
 
Fluorescent labeling of newly synthesized proteins. Although a number of effective 
genetic, enzymatic, and chemical strategies for fluorescently labeling proteins have been 
developed (recently reviewed by Sletten and Bertozzi (249)), most of these approaches 
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have two major shortcomings: the identity of the protein to be labeled must be known in 
advance of the experiment, and the DNA encoding the protein of interest must be 
genetically modified in order to enable labeling. Metabolic incorporation of amino acids 
that can be tagged or visualized in some way provides an approach to labeling newly 
synthesized proteins without genetically modifying the system in question and without 
knowing the identities of the proteins to be labeled in advance. A longstanding strategy for 
labeling and visualization of newly synthesized proteins in living cells and organisms has 
been the use of [35S]methionine in conjunction with autoradiography (304). This method 
has enabled the study of a number of systems without genetic manipulations, but 
experiments involving [35S]methionine must be performed with care due to the inherent 
dangers of working with radioactivity. Recently described approaches to residue-
specifically incorporating reactive amino acids into proteins (for examples, see (46, 47, 
305, 306)) have enabled alternative chemical approaches to visualizing newly synthesized 
proteins in cellular systems. In 2005, Beatty et al. described the chemical modification of 
proteins produced in E. coli containing amino acids 2 (Homopropargylglycine, Hpg) or 86 
using a fluorogenic coumarin dye and copper-catalyzed azide-alkyne 1,3 dipolar 
cycloaddition (CuAAC) to generate fluorescently labeled proteins (307). The researchers 
found high, specific labeling of E. coli only after the cells had been incubated with ncAAs. 
Gel electrophoresis revealed that both an overexpressed recombinant protein and 
endogenously expressed E. coli proteins were labeled, suggesting that incorporation of 
ncAAs occurred in all newly synthesized proteins in the bacteria. 
 The concept of visualizing new protein synthesis proteome-wide using 
bioorthogonal chemistry has been extended to mammalian cells. Beatty, Liu, and 
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coworkers demonstrated that amino acid 2 could be used in mammalian cells as a chemical 
handle for labeling proteins expressed during a specified pulse time of the alkyne-
containing amino acid (35). Aided by the methionine auxotrophy of mammalian cells, the 
technique was applied in several different cell types and studied by microscopy and flow 
cytometry. Fluorescence quantification by flow cytometry revealed that labeling was 
selective for cells that had been exposed to the alkyne-containing amino acid by 
approximately one order of magnitude and that the extent of labeling could be varied by 
introducing small amounts of methionine along with 2. Visualization of the proteome has 
also been extended to labeling multiple populations of newly synthesized proteins using 
multiple pulses of ncAAs. In this work, proteins synthesized during specific time windows 
were distinguished by applying sequential pulses of 2 and 77 (Azidohomoalanine, Aha) to 
mammalian cells in culture. The researchers showed that after the completion of both 
pulses, proteins containing 2 could be labeled with an azide-containing fluorophore while 
proteins containing 77 could be labeled with an alkyne-containing fluorophore and 
visualized simultaneously within the same spatial area (308). 
 Monitoring the production of newly synthesized proteins within cells and 
organisms may shed light on a number of problems, including the localized synthesis of 
new protein populations. One area that has already been investigated using the visualization 
approaches described above is protein synthesis in neuronal dendrites, a poorly understood 
and somewhat controversial subject (309). Dieterich et al. designed fluorescent tags for 
visualization of azide or alkyne-containing newly synthesized neuronal proteins in situ 
(310). Their CuAAC tagging enabled detection of newly synthesized proteins after as little 
as 10 minutes of sample exposure to 2 or 77, and sequential pulses enabled tagging of 
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multiple time-defined populations of newly synthesized proteins. Furthermore, using strain-
promoted azide-alkyne ligation (249), the authors were able to study the diffusion of newly 
synthesized proteins by appending quantum dots to azide-containing neuronal proteins. The 
Flanagan laboratory has used ncAAs to aid their studies of the spatial regulation of protein 
synthesis in neuronal axons and dendrites. Use of 77 and an alkyne fluorophore helped 
confirm that the transmembrane receptor DCC, which regulates axon growth and guidance, 
colocalizes with newly synthesized proteins, revealing its previously undiscovered role in 
translation regulation (311). 
 Studies of protein S-acylation dynamics have also been aided by the visualization of 
newly synthesized proteins (312). Simultaneous monitoring of S-acylation and protein 
turnover in the protein H-RasG12V revealed a palmitate half-life of approximately fifty 
minutes on the protein. The authors note that these results are consistent with palmitate 
half-life values determined using radioactive compounds and suggest that their 
nonradioactive approach to monitoring turnover of this posttranslational modification could 
be applied generally to any cellular S-acylated protein. The successful application of 
ncAAs to study temporal and spatial aspects of protein synthesis and turnover in complex 
biological systems is a significant accomplishment. These promising results suggest that 
further employment of ncAAs to visualize the dynamics of the proteome will continue to 
yield information about where proteins are synthesized within cells and organisms and how 
these proteins are transported and degraded within these systems. 
 Future applications of proteome visualization may benefit greatly from recent 
methodological developments in chemical labeling methods and cell-selective 
incorporation of ncAAs into proteins. CuAAC ligations for the detection of proteins have 
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been quite successful in fixed cells, but their application to live cells may not be possible 
due to the toxic concentrations of copper needed to promote the chemistries involved. 
Strain-promoted azide-alkyne ligations provide a nontoxic alternative to labeling newly 
synthesized proteins, as the reaction of strained alkynes with azides does not require copper 
to promote the labeling chemistry (249, 313). Beatty et al. demonstrated the utility of such 
an approach by designing a set of membrane-permeant cyclooctynes functionalized with 
fluorophores and labeling of azide-tagged proteins in live mammalian cells (314). Multiple 
recent reports of CuAAC using short labeling times and newly developed ligand catalysts 
have demonstrated that glycans on the surface of live cells can be labeled without affecting 
cellular viability (315, 316). These results should also be applicable to the labeling of 
newly synthesized proteins appearing on the exteriors of live cells, but it is unclear whether 
these findings will enable labeling of proteins appearing in the interiors of cells without 
affecting cellular viability. The Lin laboratory has recently demonstrated an alternative 
chemistry for visualization of newly synthesized proteins (317). Use of the methionine 
analog homoallylglycine (87) and an ultraviolet light-promoted reaction with a fluorescent 
tag enables detection of proteins containing 87 within a precisely defined area. The method 
appears to be promising, although further application of the approach will likely require 
improved specificity, and the use of ultraviolet light may limit the method’s use to fixed 
cells. 
 The use of translationally active methionine analogs in the visualization of newly 
synthesized proteins enables researchers to study all newly synthesized proteins within a 
system simultaneously. However, in nature, interactions between different types of cells 
within the same organism or between the cells of multiple organisms may result in very 
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different cellular responses in the components of the interacting systems, leading to the 
problem of determining which cells express particular proteins at a given time. Ngo et al. 
have recently demonstrated an approach to selectively visualize the newly synthesized 
proteins from one cell type in a mixed cell population (318). The key component of this 
method is the use of a mutant methionyl-tRNA synthetase (MetRS) capable of efficiently 
and selectively charging 4 (Azidonorleucine, Anl) onto tRNAMet. When the mutant MetRS 
(termed NLL-MetRS) is expressed in a particular cell type, proteins expressed in the 
presence of 4 incorporate this azide-containing amino acid. In the absence of either the 
mutant synthetase or 4, cells remain unlabeled. Thus, only proteins synthesized in cells 
expressing the mutant synthetase will be tagged with azides upon introduction of 4 into the 
medium. Ngo and coworkers illustrated this concept using a mixed population of E. coli 
cells expressing two different recombinant proteins. Only proteins expressed in the strain 
containing NLL-MetRS were labeled during CuAAC as determined by Western blotting 
and microscopy. This technique was also found to be applicable in a mixed population of 
E. coli and mouse alveolar macrophages. Figure 1.11 depicts the results of labeling 
experiments following the infection of a macrophage culture with various strains of E. coli 
cells. Only E. coli cells expressing the NLL-MetRS were labeled with a TAMRA-alkyne 
probe after fixing the coculture. Macrophages in the same culture were unlabeled, and 
positive and negative controls further proved that both cellular populations were 
synthesizing proteins during the course of the infection and that the labeling in the system 
was very specific. Hang and coworkers have demonstrated the use of cell-selective labeling 
in cocultures of Salmonella typhimurium and mammalian cells (52). Use of Anl or the 
long-chain alkyne analog 2-aminooctynoic acid (AOA, 88) enabled selective labeling of S. 
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typhimurium cells with specificities similar to those observed by Ngo et al. These 
visualization experiments validate the idea of selectively labeling protein populations 
expressed in a cell type involved in interactions with other cells. The combined selectivity 
of ncAA incorporation and CuAAC-mediated fluorescence visualization ensures that a 
minority protein population can be examined in a vast background of other protein 
populations and should be applicable to a wide range of systems involving cell-cell 
interactions. 
 
Protein identification. The same concept of metabolically incorporating chemically 
reactive ncAAs into newly synthesized proteins or more specific protein populations can 
also be extended to protein identification techniques. Tagging newly synthesized proteins 
with affinity purification reagents enables selective separation and enrichment of proteins 
that have been synthesized in a defined temporal or spatial window or within a particular 
cellular population. The resulting samples can then be analyzed using mass spectrometry 
identification techniques. Dietrich et al. first described this technique in 2006, naming the 
resulting approach bioorthogonal noncanonical amino acid tagging (BONCAT) (319, 320). 
In this work, the researchers demonstrated several important principles in the development 
of this technique for use in mammalian cell culture. First, the azide-containing 
noncanonical amino acid azidohomoalanine (77) did not perturb cultured mammalian cells 
significantly. The visible phenotypes of cells remained the same whether or not 77 was 
added to cultures, and the protein populations present in cells incubated with methionine or 
77 were indistinguishable when examined with autoradiograms of one-dimensional gels. 
Second, as was found in fluorescence visualization studies, the tagging chemistry was very 
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specific for proteins that had been synthesized in the presence of 77. Finally, proteins 
tagged with an alkyne-FLAG tag could be enriched from the much larger overall protein 
population with a streptavidin column, digested into smaller peptides on the column, and 
identified using tandem mass spectrometry. Experiments performed in HEK293 cells 
identified proteins from a wide range of gene ontological categories, showing that a highly 
diverse set of proteins can be isolated using BONCAT. Numerous improvements to 
enriching azide- or alkyne-containing proteins have been reported in support of the 
BONCAT method. All of these approaches have aimed to replace the on-column 
trypsinization step of the original BONCAT procedure with separate column purification 
and digestion steps. For example, Kramer et al. reported selective cleavage of newly 
synthesized proteins containing 77 at the azide side chains of the proteins (321). Other 
approaches have involved the synthesis of purification tags designed to enable the use of 
click chemistry to conjugate affinity reagents to azide- or alkyne-containing proteins, and 
enrich tagged proteins under mild conditions using appropriate columns. Nessen et al. 
demonstrated the use of strain-promoted click chemistry for the selective enrichment of 
newly synthesized proteins from E. coli (322). In this work, the use of 77 and a cleavable 
cyclooctyne resin enabled the enrichment and identification of newly synthesized proteins 
from whole-cell lysates. Szychowski et al. designed and synthesized five biotin-azide 
probes that can be cleaved over a wide range of conditions including reducing, mild acidic 
conditions, and ultraviolet irradiation (323). Using a GFP model system, the authors 
showed that an acid-cleavable tag enables highly selective conjugation with alkyne-
containing proteins and leaves a small mass tag on labeled proteins after cleavage, an 
important consideration for proteomic studies. Hang and coworkers have developed several 
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tags that can be used for proteomic studies (52, 324). Application of these tags to labeling 
and mass spectrometric identification of newly synthesized proteins produced in S. 
typhimurium harboring MetRS-NLL in the presence of AOA (88) enabled identification of 
a large number of proteins from complex samples. Furthermore, samples from cocultures 
were enriched for proteins expressed in S. typhimurium, suggesting that the protein 
purification procedure successfully separated alkyne-containing proteins from unlabeled 
proteins. 
 BONCAT represents a potentially significant advance in the field of proteomics. 
The ability to selectively enrich a set of newly synthesized proteins from a larger proteomic 
sample may result in more sensitive detection method for protein subsets of interest. 
Furthermore, as demonstrated in the case of visualizing new protein synthesis, dynamic 
aspects of the proteome may be studied by varying the pulse time and duration of ncAAs or 
by pulsing sequentially with multiple ncAAs. The BONCAT technique may also be used to 
compare proteomes from two or more different cell samples by applying existing 
techniques such as SILAC (303) or by combining ncAA incorporation techniques with the 
use of ICAT (325) or iTRAQ (326) reagents. Finally, protein identification techniques 
appear to be compatible with the selective metabolic labeling strategy of Ngo et al. and 
Grammel et al. (52, 318). Proteomic studies with ncAAs take advantage of several aspects 
of ncAAs including global canonical amino acid replacement, bioorthogonal side chain 
chemistries, and varied aminoacyl-tRNA synthetase selectivities toward these noncanonical 
substrates. These several features enable the application of noncanonical amino acids in a 
broad range of proteomic applications, which should lead to new insights into a number of 
complex biological systems and processes. 
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Outlook 
 The future looks bright for applying noncanonical amino acids to problems in 
protein science and engineering. The question with ncAAs is no longer, “what kinds of 
noncanonical amino acids can be incorporated into proteins?” The range of chemical 
structures employed in experiments with ncAAs is quite impressive, ranging from single-
atom changes of canonical residues to ncAAs containing functional groups rarely, if ever, 
seen in nature. Instead, the question is now, “what types of problems can best be solved by 
incorporating noncanonical amino acids into proteins?” Recent research has hinted at the 
varied applications possible with ncAAs. Researchers have employed noncanonical amino 
acids to investigate problems ranging from atomic-level protein structural questions to 
organism-wide responses to proteins containing noncanonical amino acids, with time scales 
of individual experiments ranging over several orders of magnitude. The broad range of 
experiments performed using noncanonical amino acids suggests that these residues should 
be thought of as possible tools for studying many problems, and not necessarily as essential 
tools for studying any particular problem or class of problem. Generally speaking, good 
candidate problems are ones in which ncAAs offer a route to a substantial increase in the 
quality of information and/or desired protein properties that can be obtained from a 
particular set of experiments without drastically raising the level of difficulty of performing 
these experiments. The several application areas discussed in this review have already 
started to benefit from the use of noncanonical amino acids according to the criteria 
outlined above. These benefits are perhaps most apparent in the areas of X-ray 
crystallography and membrane protein studies, in which a very large amount of data has 
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been acquired using relatively simple approaches that are not possible without the use of 
noncanonical amino acids. 
 A few more questions come to mind regarding research with proteins containing 
noncanonical amino acids. First, aside from the areas discussed above, what additional 
problems might benefit from the use of ncAAs in the near future? Biophysical 
characterizations appear to be among the most accessible problems, especially in light of 
the number of successful uses of ncAAs in X-ray crystallography and NMR studies. 
Fluorescence spectroscopy can benefit from both the direct incorporation of fluorescent 
amino acids and the chemical conjugation of fluorescent labels to reactive chemical 
functionalities in proteins, and proof-of-principle experiments of both of these approaches 
already exist in the literature (for examples, see (104, 327-329); see Merkel et al. for a 
review on the subject of intrinsically blue fluorescent amino acids as tools for protein 
science (330)). Vibrational spectroscopy of proteins performed after the incorporation of 
bonds with unique infrared or Raman signatures should continue to grow in importance for 
protein characterizations. The work of Ye et al. on the membrane protein rhodopsin (212, 
213) is an early example of the effective exploitation of IR-active amino acids (discussed in 
the “Applications” section), and some work with IR-active amino acids in globular proteins 
also shows promise (331-333). Continued application of ncAAs to study the biological 
functions of proteins in living cells and organisms will also continue to grow in importance. 
Along with the visualization and identification of proteomic responses to biological stimuli, 
the precise control of protein function in biological settings is highly desirable. Proteins 
with activities or locations controlled by light have proven to be very powerful over the 
years for studying biological systems (334, 335), and some work suggests that using 
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ncAAs to achieve such photocontrolled systems may yield a number of new tools in this 
area (336-340). Given the large number of selective chemical conjugation strategies 
accessible with ncAAs (249, 251), protein therapeutics may also benefit from applications 
of ncAAs. Several simple strategies for modifying the pharmacochemical properties of 
proteins with ncAAs and selective chemistries have been reported in the scientific 
literature, including examples of protein PEGylation (313, 341-344) and viral surface 
modifications (345, 346). Commercial applications of these conjugation strategies may 
yield more drug-like bioconjugates for use as therapeutics. Furthermore, many more subtle 
changes to protein properties possible with ncAAs, such as those described in conjunction 
with protein stability, membrane proteins, and immune modulation, may facilitate further 
improvement of protein-based therapeutics. 
 What will be the role of in vitro protein synthesis in future work with noncanonical 
amino acids? The ribosomal production of genetically encoded polymers containing 
multiple ncAAs, ester linkages, N-methyl amino acids, and N-substituted glycine residues 
have all been reported in vitro (58-63). Cyclic peptides, which have many advantages over 
linear peptides as therapeutic entities, can be formed with the use of noncanonical amino 
acids in in vitro settings (347-349). These are intriguing molecules, but if the yields of such 
in vitro productions remain low, applications should be considered carefully and should 
provide a definite advantage over chemical peptide synthesis techniques. One proposed use 
of this production approach is as a platform for generating genetically encoded libraries of 
therapeutically relevant peptide drug candidates. These methodologies may complement or 
improve upon existing approaches to generating DNA-encoded chemical libraries (350). 
Genetically templated, highly unnatural molecules may also give researchers tools to 
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examine fundamental aspects of macromolecular folding and evolution. What kinds of 
three-dimensional structures can nonbiological polymers attain, how do they evolve, and 
what do these findings tell us about the functional and evolutionary properties of proteins? 
 Finally, will engineering additional components of the translational machinery 
make a large contribution to the ribosomal production of polymers containing noncanonical 
functionalities? Recent work on the ribosome (64, 65, 116, 117) and elongation factor-TU 
(351) raises the exciting possibility of expanding the translational capabilities of organisms 
or in vitro translation systems far beyond the capabilities of existing protein translation 
machinery. However, even the most promising recent experimental results suggest that 
engineering the translational machinery will require large numbers of incremental 
improvements to existing biological machinery. The limits to how far the ribosome and 
other translational components can be evolved away from their natural functions are still 
unclear, especially when this evolution is performing in living organisms. Performing 
evolution in vitro may be more appropriate for the creation of translational machinery with 
highly unnatural functions, but new in vitro protein expression systems and evolution 
techniques will likely have to be developed in order to enable this challenging type of 
translational apparatus engineering. Regardless of how the protein synthesis machinery is 
engineered, any resulting system should ideally be simple enough to use that it could be 
widely adopted by the scientific community and versatile enough to be employed for the 
generation of a wide variety of genetically encoded polymers. 
 In this review, we have highlighted the use of noncanonical amino acids as tools to 
study scientific problems. With careful experimental design, ncAAs can greatly augment 
scientists’ abilities to address an extremely broad range of questions; the ncAA toolkit is 
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very large and very effective. Research with noncanonical amino acids is poised to move 
beyond the methodological development efforts of a select few researchers to the 
collaborative exploitation of these methods across numerous scientific disciplines. 
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Scheme 1.1. Noncanonical amino acids, part 3. 1, selenomethionine. 2, 
homopropargylglycine. 3, hexafluoroleucine. 4, azidonorleucine. 5, norleucine. 6, 
p-fluorophenylalanine. 7, telluromethionine. 8, selenocysteine. 9, β-selenolo[3,2-b]pyrolyl-
alanine 10, [6,7]selenatryptophan. 11, p-iodophenylalanine. 12, 3-iodotyrosine. 13, 
4-fluorotryptophan. 14, 5-fluorotryptophan. 15, 6-fluorotryptophan. 16, m-fluorotyrosine. 
17, m-fluorophenylalanine. 18, o-fluorophenylalanine. 19, 2-fluorohistidine. 20, 
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4-fluorohistidine. 21, difluoromethionine. 22, p-trifluoromethylphenylalanine. 23, 
p-trifluoromethoxyphenylalanine. 24, p-methoxyphenylalanine (also called 
O-methyltyrosine). 25, O-nitrobenzyltyrosine. 26, amino-3-cyclopentylpropanoic acid. 27, 
O-methylserine. 28, tert-leucine. 29, 2-amino-4-methylhexanoic acid (homoisoleucine). 30, 
norvaline. 31, ethylglycine. 32, α-hydroxyalanine. 33, pipecolic acid. 34, N-methylalanine. 
35, cyclopropylglycine. 36, α-aminoisobutyric acid. 37, γ-nitroglutamate. 38, 
p-aminophenylalanine. 39, pentafluorophenylalanine. 40, α-hydroxyleucine. 41, 
α-hydroxyisoleucine. 42, p-fluorotyrosine. 43, tetrafluorotyrosine. 44, trifluoroleucine. 45, 
trifluoroisoleucine. 46, trifluorovaline. 47, 4R-fluoroproline. 48, 4S-fluoroproline. 49, 
methoxinine. 50, biocytin. 51, (2-nitrophenyl)glycine. 52, α-hydroxyvaline. 53, 
3-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-2,3-diaminopropionic acid (NBD-Dap). 54, 
p-azidophenylalanine. 55, dansylalanine. 56, p-bromophenylalanine. 57, 
p-cyanophenylalanine. 58, 3,5-difluorophenylalanine. 59, p-methylphenylalanine. 60, 
cyclohexylalanine, 61, allo-threonine. 62, allo-isoleucine. 63, allo-O-methylthreonine. 64, 
azetidine-2-carboxylic acid. 65, 5-tert-butylproline. 66, 5,5-dimethylproline. 67, 
3S-methylproline. 68, 5,7-difluorotryptophan. 69, 5,6,7-trifluorotryptophan. 70, 
4,5,6,7-tetrafluorotryptophan. 71, sulfated acetyllysine. 72, sulfated dimethyllysine. 73, 
sulfated trimethyllysine. 74 dehydroalanine. 75, dimethyllysine 76, 
N-tertbutyloxycarbonyllysine. 77, azidohomoalanine. 78, alkyne analog of pyrrolysine. 79, 
p-acetylphenylalanine. 80, sulfotyrosine. 81, Nε-acetyllysine. 82, 
p-carboxymethylphenylalanine. 83, nitrotyrosine. 84, p-nitrophenylalanine. 85, 
p-boronophenylalanine. 86, p-alkynylphenylalanine. 87, homoallylglycine. 88, 
2-aminooctynoic acid. 
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Figure 1.1. Overview of strategies for genetically incorporating noncanonical amino acids 
into proteins. (a) Residue-specific incorporation. A set of codons specifying one of the 
twenty canonical amino acids is “reprogrammed” to code for a ncAA. In this case, the six 
leucine (Leu) codons of the E. coli genetic code have been reassigned to the fluorinated 
leucine analog hexafluoroleucine (Hfl, 3). (b) Site-specific incorporation. A stop codon is 
converted into a sense codon. The depicted example shows the amber stop codon being 
reprogrammed to code for O-methyltyrosine (Omt, 24). 
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Figure 1.2. Methods for residue-specific incorporation of noncanonical amino acids into 
proteins. (a) Medium shift procedure to produce proteins containing the methionine (Met) 
analog homopropargylglycine (Hpg, 2). Methionine-auxotrophic E. coli cells are first 
grown in medium containing twenty canonical amino acids. After reaching a particular 
optical density, the culture is pelleted and washed two to three times in an isotonic salt 
solution to remove methionine from the cells. After the final wash, cells are pelleted and 
resuspended in medium containing nineteen canonical amino acids plus Hpg. If a particular 
protein of interest is to be overproduced, protein expression can be initiated by the addition 
of an inducer. (b–d) Additional modifications to expression hosts. Engineering auxotrophic 
E. coli strains enables the incorporation of additional ncAAs into proteins. The examples 
that follow are depicted for the case of overexpressed proteins, but can also be applied in 
the absence of a particular protein of interest for proteomic applications. 
(b) Overexpression of aminoacyl-tRNA synthetase (aaRS). Noncanonical amino acids that 
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are poor aaRS substrates do not support protein synthesis unless the E. coli strain employed 
has augmented aaRS activity. In the case shown here, overexpression of leucyl-tRNA 
synthetase (LeuRS) enables efficient global replacement of hexafluoroleucine (Hfl, 3) in 
place of leucine in a protein of interest (POI). (c) Overexpression of mutant aaRS. When no 
wild-type aaRS can activate a particular amino acid analog efficiently, mutant enzymes can 
be engineered and employed in E. coli expression hosts. Overexpression of a mutant 
methionyl-tRNA synthetase (MetRS) enables the global replacement of Met with 
azidonorleucine (Anl, 4). (d) Overexpression of editing-deficient mutant aaRS. Some 
amino acid analogs are kinetically competent aaRS substrates but are subjected to editing 
after activation or aminoacylation. Altering the editing activity of an aaRS can enable 
incorporation of amino acid analogs that are proofread by the wild-type aaRS. For example, 
overexpression of an editing-deficient LeuRS enables norleucine (Nrl, 5) to replace Leu in 
proteins. 
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Figure 1.3. Orthogonality requirements for adding tRNAs and aminoacyl-tRNA 
synthetases (aaRSs) to a translation system. (a) Transfer RNA orthogonality. The 
heterologous tRNA to be introduced should not be a substrate for any of the endogenous 
aminoacyl-tRNA synthetases in order to avoid the aminoacylation of the tRNA with 
canonical amino acids. (b) AaRS orthogonality. The heterologous aaRS should not 
aminoacylate the heterologous tRNA with canonical amino acids or aminoacylate 
endogenous tRNAs with ncAAs. (c) Noncanonical amino acid orthogonality. The amino 
acid to be “added” to the genetic code should not be a substrate for any of the endogenous 
aaRSs. (d) Orthogonal pair. A properly functioning orthogonal aaRS-tRNA pair performs 
its aminoacylation task efficiently and specifically in the context of the endogenous 
translational machinery. 
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Figure 1.4. Methods for site-specific incorporation of noncanonical amino acids into 
proteins. (a) Suppression of nonstandard codon for site-specific incorporation. An 
aminoacylated, orthogonal tRNA is introduced into a translation system to decode a 
nonsense or other nonstandard codon, resulting in a full-length protein containing a 
noncanonical amino acid at one specified position in the protein. (b–d) Systems for 
employing site-specific incorporation techniques. (b) In vitro translation. Chemically 
synthesized, orthogonal aminoacyl-tRNAs can be employed in conjunction with an in vitro 
translation system to effect site-specific ncAA incorporation. (c) Microinjection into 
Xenopus oocytes. Simultaneous injection of a gene containing a nonstandard codon to be 
suppressed and an aminoacylated, orthogonal tRNA allows for the synthesis of proteins 
containing a site-specifically incorporated noncanonical amino acid inside a living cell. 
Membrane proteins are commonly studied using this technique. (d) Use of an orthogonal 
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pair. E. coli cells outfitted with an additional aaRS-tRNA pair can synthesize proteins 
containing a site-specifically incorporated twentyfirst amino acid. In this case, the aaRS 
enzymatically aminoacylates the tRNA during the course of the experiment, requiring no 
chemical synthesis of aminoacyl-tRNAs. Omt, O-methyltyrosine (24). 
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Figure 1.5. NMR studies of ligand binding employing noncanonical amino acids as 
isotopically labeled probes. (a) Combined chemical shift data of tool compound 17 binding 
to the thioesterase domain of human fatty acid synthase (FAS-TE). Chemicals shift changes 
ΔCS have been scaled as described by Cellitti et al. in order to enable comparison between 
19F, 13C, and 15N NMR experiments (91). Conformational exchange prevented acquisition 
of chemical shift data on some o-nitrobenzyl-tyrosine (oNBTyr, 25) mutants. OMePhe, 
p-methoxyphenylalanine (24). OCF3Phe, p-trifluoromethoxylphenylalanine (23). (b) 
Structure of FAS-TE covalently modified with orlistat (2PX6.pdb) (352). The average 
chemical shift changes induced by the binding of 17 are calculated for each ncAA and 
color-coded for each position: ΔCS < 0.1 ppm, blue; 0.1-0.2 ppm, salmon; > 0.2 ppm, red. 
Disordered loops are indicated by dashed lines. The active site residues Ser-2308, Asp-
2338, and His-2481 are shown in magenta. Adapted from (91) with permission. © 2008 
American Chemical Society. 
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Figure 1.6. Secondary structure analysis and thermal denaturation of recombinant human 
prion protein (rhPrPC) containing methionine analogs. (a) Circular dichroism spectra of 
Met-rhPrPC and its norleucine (Nrl, 5) and methoxinine (Mox, 49) variants at 37 °C and 0.2 
mg/mL in 10 mM Mes buffer at pH 6.0. (b) Thermal denaturation monitored by the 
changes of dichroic intensities at 222 nm as a function of temperature. Note that both the 
secondary structural characteristics and denaturation behaviors are greatly influenced by 
the hydrophobicities of the amino acids incorporated at the Met positions. Adapted from 
(194) with permission. © 2009 National Academy of Sciences. 
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Figure 1.7. Unnatural amino acid mutagenesis on the 5-hydroxytryptamine type 3 receptor 
leads to a new model for receptor gating. (a) NcAAs used in study. These residues were 
incorporated in place of a key proline residue (Proline 8*) within the receptor. (b) The 
thermodynamics of the cis–trans isomerization propensities (ΔΔG(c-t)) of ncAAs and 
receptor activation by 5-hydroxytryptophan (ΔΔG(EC50)) are strongly correlated, 
suggesting that the isomerization properties of the residue at the position of interest are 
critical for forming functional channels. (c) Proposed model for receptor gating. 
Isomerization of the proline residue shown in blue (proline 8*) dictates M2-M3 loop 
conformation, which in turn controls ion flow through the channel. Adapted from (218) 
with permission. © 2005 Nature Publishing Group. 
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Figure 1.8. Use of noncanonical amino acids to investigate cation-π interactions in the 
muscle-type nicotinic acetylcholine receptor (nAChR) using patch-clamp experiments. 
(a) Receptor response to increasing doses of acetylcholine as measured by voltage-clamp 
current traces. The two experiments shown are from oocytes expressing tryptophan (Trp, 
Left) and 5,7-F2-Trp (Right, 68) at α149. Bars represent application of acetylcholine (µM). 
(b) Dose–response relations and fits to the Hill equation for (left to right): Trp; 5-F-Trp 
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(14); 5,7-F2-Trp (68); 5,6,7-F3-Trp (69); and 4,5,6,7-F4-Trp (70). (c) Plot of 
log[EC50/EC50(wild type)] versus quantum mechanically calculated cation–π binding 
ability at α149 for the same residues as in (b). The strong correlation observed confirms 
that residue α149 binds to acetylcholine through a cation-π interaction. Adapted from (231) 
with permission. © 1998 National Academies Press. 
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Figure 1.9. Use of ncAAs to breaking immunochemical self-tolerance. Immunization with 
p-nitrophenylalanine (84) at position 86 of murine tumor necrosis factor-α 
(pNO2Phe86mTNF-α) improves survival of mice in a TNF-α-dependent severe 
endotoxemia model. Kaplan–Meier survival plots of mice receiving active or passive 
immunizations are shown. (a) Mice (eight per group) immunized with 
pNO2Phe86mTNF-α or WT mTNF-α are compared with seven mice receiving sham 
immunizations. The survival advantage of mice immunized with pNO2Phe86mTNF-α (P < 
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0.01) versus WT is shown. (b–c) The survival advantage is preserved when antibodies (b) 
or pooled serum (c) from mice immunized with pNO2Phe86mTNF-α is transferred to other 
mice. Mice (eight per group) injected with 100 µg of purified IgG from 
pNO2Phe86mTNF-α or WT immunized mice were compared with controls receiving 
saline injection. Survival advantage of mice immunized with pNO2Phe86mTNF-α (P < 
0.01) versus WT is shown. (c) Mice (six per group) received 100 µL of pooled serum from 
mice immunized with pNO2Phe86mTNF-α or WT mTNF-α. Survival advantage of mice 
immunized with pNO2Phe86mTNF-α (P < 0.01) versus WT is shown. Adapted from (283) 
with permission. © 2008 National Academies Press. 
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Figure 1.10. Flow cytometric analysis of cells expressing green fluorescent protein (GFP) 
and GFP variants during the course of evolving fluorinated GFPs. Proteins were expressed 
in media depleted of Leu and supplemented with trifluoroleucine (Tfl, 44) (a) or in media 
containing all twenty canonical amino acids (b). Black line, GFPm (parent); blue line, 4.2.2 
(mutant isolated after sequential construction and enrichment of four libraries); gray line, 
8.3.3 (mutant isolated after enrichment of eight libraries); and red line, 11.3.3 (mutant 
isolated after enrichment of eleven libraries). The evolved, fluorinated variants have 
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regained fluorescence, likely through improved folding properties. Adapted from (189) 
with permission. © 2007 National Academies Press. 
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Figure 1.11. Cell-selective labeling in mixtures of bacterial and mammalian cells. 
(a) Fluorescence images of mixed cultures containing bacteria attached to or internalized 
by mouse alveolar macrophages. Infection was performed in medium containing 
azidonorleucine (4). Bacterial cells constitutively expressing the methionyl tRNA 
synthetase variant NLL-MetRS were labeled by TAMRA-alkyne (constitutive NLL), 
whereas cells lacking the NLL-MetRS (wild type) are visible only in the GFP channel (not 
shown). Macrophages were labeled with Mitotracker Deep Red (Invitrogen) and exhibited 
very low TAMRA background emission. In all cases, conjugation of TAMRA-alkyne was 
confined to bacterial cells expressing the NLL-MetRS. (b) Fluorescence images of 
macrophage infection with wild-type bacteria performed in the presence of 
azidohomoalanine. Protein synthesis by macrophages is indicated by strong TAMRA-
alkyne emission from both bacterial cells and macrophages. (c) Macrophages were infected 
with bacterial cells that express GFP under induction with IPTG and that constitutively 
express the NLL-MetRS. Infection was performed in medium containing IPTG and 
azidonorleucine to facilitate bacterial synthesis and labeling of GFP. Total cell lysate from 
the infection was subjected to conjugation with alkyne-functionalized biotin; labeled 
proteins were enriched with streptavidin avidity. Bacterially expressed GFP and 
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mammalian β-actin were followed by immunoblots. Analyses of the lysate (L), unbound 
flow-through (FT), washes (W1, W3, W5) and eluent (E) reveal a separation of bacterial 
and mammalian representative proteins. Bacterially expressed GFP was labeled with 
azidonorleucine and thus subject to conjugation to biotin and enrichment with streptavidin. 
Proteins originating from macrophages, including β-actin, were not labeled with 
azidonorleucine and therefore were not conjugated to alkyne-functionalized biotin. 
Adapted from (318) with permission. © 2009 Nature Publishing Group. 
 
 
 
 
CHAPTER 2 
Homoisoleucine: A Translationally Active Leucine 
Surrogate of Expanded Hydrophobic Surface Area 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter first appeared as a communication in ChemBioChem: James A. Van Deventer, 
John D. Fisk, and David A. Tirrell. ChemBioChem 2011, 12, 700-702. 
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Abstract  
 Homoisoleucine (Hil) serves as an effective surrogate for leucine with respect to 
protein translation in bacterial cells. Replacement of Leu by Hil stabilizes coiled-coil 
peptides, as shown by the elevation of the thermal denaturation temperature. The increase 
in denaturation temperature is larger than that observed previously for replacement of Leu 
by trifluoroleucine. 
 
Introduction  
 Noncanonical amino acids (ncAAs) provide useful tools for the investigation and 
control of protein behavior (1-4). Several laboratories have used ncAAs to explore the role 
of hydrophobic forces in stabilizing proteins, including prion proteins, T4 lysozyme, 
chloramphenicol acetyltransferase, green fluorescent protein, and coiled-coil and helix-
bundle proteins (5-12). Here we examine the consequences of introducing the leucine 
surrogate (2S,4S)-2-amino-4-methylhexanoic acid (homoisoleucine, Hil, 2; scheme 2.1) (5) 
into the coiled-coil peptide A1 (figure 2.1) (13). A1 contains six heptad repeats, designated 
(abcdefg), that mediate self-association of the peptide in aqueous solutions. Previous 
studies have shown that replacement of leucine by (2S,4R)-trifluoroleucine (Tfl, 3) or 
hexafluoroleucine (Hfl, 4) at the d positions of the heptad repeats leads to substantial 
stabilization of the coiled-coil structure of A1 (9, 10, 12), presumably through enhanced 
hydrophobic interactions between fluorinated peptide strands. Similar results have been 
obtained in other fluorinated coiled-coil and helix-bundle systems (14-16). 
 Whitesides and coworkers have pointed out that hydrocarbons and fluorocarbons 
exhibit equivalent “intrinsic” hydrophobicities when changes in molecular surface area are 
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taken into account (17). Marsh and coworkers have argued that the “efficient packing” of 
the bulkier fluorinated amino acids in helix bundle cores can be more important than 
fluorination per se (18). Because the molecular surface areas of Hil and Tfl are nearly 
identical (and larger than that of Leu by 14–19 Å2) (19), we imagined that replacement of 
Leu by Hil might stabilize coiled-coil peptides such as A1. 
 
Results and Discussion  
 We first focused our attention on the translational activity of Hil in bacterial cells. 
Schultz and coworkers reported incorporation of Hil into proteins via chemical 
misacylation of suppressor tRNA and in vitro translation (5), but we are unaware of 
previous studies of incorporation of Hil into cellular proteins. E. coli strain LAM1000 (a 
previously reported leucine auxotroph) was cotransformed with expression plasmid pA1EL 
and repressor plasmid pREP4 (10). pA1EL codes for both the protein A1 and a 
constitutively expressed copy of the E. coli leucyl-tRNA synthetase (LeuRS) gene. Protein 
expression was induced in minimal medium depleted of Leu and supplemented with Hil 
(see materials and methods for details). Electrophoretic analysis of whole-cell lysates 
indicated high-level protein expression in media containing as little as 0.25 mM L-Hil, a 
concentration comparable to the concentrations of canonical amino acids in minimal media. 
 ATP-PPi exchange assays confirmed that Hil is activated by the E. coli LeuRS, 
albeit at a rate substantially lower than that characteristic of the natural substrate (table 2.1). 
The reduced rate of activation of Hil is consistent with our observation that Hil supports 
high-level protein expression only when LeuRS is overexpressed in the bacterial host. 
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 A1 samples containing Leu and Hil were purified from 25 mL cultures in yields of 
15.9 ± 2.5 mg L−1 and 10.2 ± 1.1 mg L−1, respectively. Liter-scale expression and 
purification improved the yields of A1 sequence variants containing Hil two- to threefold. 
Liquid chromatography/mass spectrometry (LC/MS) indicated replacement of at least 97% 
of Leu by Hil (see “Determination of amino acid replacement levels” in materials and 
methods). 
 Figure 2.2A shows circular dichroism spectra of 10 µM solutions of the Leu- (Leu-
A1) and Hil- (Hil-A1) forms of A1. Strong minima at 208 and 222 nm confirm that both 
proteins assume α-helical structures; K2D2 (20) analysis indicates helical contents of 
60%–69%, consistent with the fact that the putative heptad repeats constitute 57% of the 
peptide sequence. A1 is expected to exist primarily as dimers under the conditions 
employed here (21). 
 Replacement of Leu by Hil increases the denaturation temperature of A1, as 
expected. Figure 2.2B shows the molar ellipticities at 222 nm of solutions of Leu-A1 and 
Hil-A1 as functions of temperature. Fitting the CD data to a model of a two-state transition 
between folded dimer and unfolded monomer states (22) yielded melting temperatures of 
58.7 ± 0.2 °C and 75.8 ± 0.1 °C for Leu-A1 and Hil-A1, respectively. 
 Table 2.2 compares the extent to which the thermal denaturation temperature of A1 
is elevated by replacement of Leu by bulkier hydrocarbon and fluorocarbon surrogates. 
Replacement of Leu by Hil raises Tm by 17 °C, as compared to 10 °C for replacement of 
Leu by (2S,4R)-Tfl and 22 °C for replacement by Hfl. Expansion of hydrophobic side chain 
volume at the d-position of the heptad repeat constitutes an effective strategy for 
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stabilization of coiled-coil peptides, irrespective of the hydrocarbon or fluorocarbon 
character of the side chain. 
 We do not mean to suggest similar molecular origins for the hydrophobic properties 
of hydrocarbons and fluorocarbons. Although Hil and Tfl behave similarly with respect to 
elevation of the melting temperature of A1, other experiments suggest important 
differences in the behavior of water adjacent to hydrocarbon and fluorocarbon side chains. 
Recent studies via ultrafast spectroscopy indicate a marked slowing of water motions upon 
replacement of Leu by Tfl at solvent-exposed sites (23). In contrast, replacement of Leu by 
Hil is accompanied by increased rates of solvent reorganization.  Much remains to be done 
to elucidate the origins of hydrophobic effects in proteins and other molecular systems. 
 In conclusion, we find that Hil serves as an effective surrogate for Leu with respect 
to protein translation in bacterial cells, and that replacement of Leu by Hil leads to 
substantial stabilization of recombinant coiled-coil peptides. The results reported here also 
highlight the value of amino acid replacement at multiple sites in peptides and proteins; 
replacement of a single Leu residue by Hil in T4 lysozyme has been reported to cause an 
increase of just 1.9 °C in the melting temperature of the protein (5). In contrast, 
replacement of six Leu residues in the putative coiled-coil domain of A1 raises Tm by 
17 °C. 
 
Materials and Methods  
Materials. All chemicals were purchased from Sigma-Aldrich and used as received unless 
otherwise noted. Dry solvents were obtained from commercial suppliers and used as 
received. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was purchased from Gold 
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Biotechnologies; Ni-NTA resin and spin columns were purchased from Qiagen. 
Sequencing grade modified trypsin was purchased from Promega; C18 Zip Tips, and 
Amicon Ultra-4 and Amicon Ultra-15 concentration devices were purchased from 
Millipore. A BCA assay kit was obtained from Pierce Protein Research Products. The E. 
coli expression strain LAM1000 outfitted with the plasmids pA1EL and pREP4 has been 
described previously (10). 
 
Protein expression. For 25 mL and 200 mL scale preparations of Hil-A1 and small-scale 
preparation of Leu-A1, a single colony of LAM1000 transformed with pA1EL and pREP4 
was used to inoculate an overnight culture of M9 minimal medium (M9 salts containing 
glucose (0.4% w/v), thiamine HCl (35 mg L−1), MgSO4 (1 mM), CaCl2 (0.1 mM), and 20 
amino acids (40 mg L−1)) supplemented with ampicillin (200 mg L−1), and kanamycin 
(35 mg L−1). Overnight cultures were diluted into fresh M9 medium containing all 20 
amino acids and allowed to grow with agitation at 37 °C until reaching an OD600 of 
approximately 0.9–1.0. Cells were pelleted at 6000 × g for 7 minutes at 4 °C, washed 3 
times in ice-cold sodium chloride solution (0.9% w/v) and resuspended in fresh M9 
minimal medium lacking leucine. Aliquots of the resuspended cultures were supplemented 
with Hil (0.5 mM) or Leu (0.3 mM), shaken at 37 °C for 15 minutes, and induced by 
addition of IPTG (1 mM final concentration). After 3 hours, cells were harvested by 
centrifugation at 6000 × g for 7 minutes. In the case of small-scale production, cells were 
frozen at −80 °C either before or after addition of Qiagen buffer B (8 M urea, pH 8.0, 
buffered with NaH2PO4 (100 mM) and Tris·Cl (10 mM)). For the case of large-scale 
production, cells were frozen at −80 °C before addition of Qiagen buffer B. 
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 For 200 mL scale production of Leu-A1, a single colony of LAM1000 transformed 
with pA1EL and pREP4 was used to inoculate an overnight culture of 2×YT medium 
supplemented with ampicillin (200 mg L−1) and kanamycin (35 mg L−1). The overnight 
culture was diluted 1:100 into fresh 2×YT supplemented with ampicillin and kanamycin 
and allowed to grow at 37 °C with shaking until reaching an OD600 of approximately 0.9–
1.1. The culture was induced by addition of IPTG to a final concentration of 1 mM. After 
3 hours, cells were harvested by centrifugation at 6000 × g for 7 minutes and frozen at 
−80 °C. 
 
Protein purification. At small scales, the cell pellets were thawed, Qiagen buffer B was 
added as necessary, and the resuspended pellets were incubated at room temperature with 
gentle agitation for at least 1 hour. The pellets were then subjected to 20–40 minutes of 
sonication in an immersion sonicator. In some cases, the pellets were frozen again at 
−80 °C and the above procedure was repeated. The sonicated pellets were then centrifuged 
for 20–30 minutes at 10000 × g, and the supernatants were saved. The clarified lysates 
were then subjected to purification using Qiagen Ni-NTA spin columns according to the 
manufacturer’s protocols (2000 Ni-NTA Spin Handbook) or using Ni-NTA agarose 
according to the manufacturer’s protocols with slight modifications. When Ni-NTA 
agarose was used, Qiagen buffer C was supplemented with 50 mM imidazole, and Qiagen 
buffer E was supplemented with 250 mM imidazole. 
 At large scales, the cell pellets were resuspended in Qiagen buffer B and subjected 
to sonication using a microtip on a Misonix Sonicator 3000. The total sonication process 
time was 10 minutes, with 5 second sonication pulses and 5 second wait periods. The 
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pellets were then frozen again at −80 °C and subjected to a second round of sonication. The 
lysates were clarified by centrifugation at approximately 75000 × g for 10 minutes at 
25 °C. The clarified lysate was then subjected to purification using Ni-NTA agarose with 
buffers as described above. 
 
Peptide mass spectrometry. Small (1–3 µL) samples of Leu-A1 and Hil-A1 eluents from 
the purifications were diluted 50- to 100-fold into sodium bicarbonate (50 mM, pH 7.8) and 
digested overnight by treatment with sequencing grade modified trypsin (5 µL) at 37 °C. 
Portions of these samples were desalted using C18 Zip Tips according to the 
manufacturer’s instructions with one slight modification. Prior to column equilibration in 
0.1% trifluoroacetic acid, columns were wetted with a 50/50 mixture of 0.1% 
trifluoroacetic acid and acetonitrile. The cleaned samples were then analyzed using matrix-
assisted laser desorption ionization (MALDI) mass spectrometry on an Applied Biosystems 
Voyager DE Pro instrument at the mass spectrometry facility of the Caltech Division of 
Chemistry and Chemical Engineering. All peptide masses were found to lie within the mass 
ranges of manufacturer-specified instrument tolerances. See figure 2.3 for typical results. 
 For quantitative analysis, the remainders of the trypsinized samples (not desalted) 
were submitted to the Protein and Peptide Mass Analytical Laboratory (PPMAL) of the 
Beckman Institute at Caltech for liquid chromatography tandem mass spectrometry 
(LC/MS/MS) analysis. The samples were separated on a 6 cm long, 100 µm diameter C18 
column using an Eksigent NanoLC-2D and then immediately injected into an Applied 
Biosystems QStar XL tandem mass spectrometer. Time-resolved data were analyzed using 
Analyst QS software provided by Applied Biosystems. Amino acid replacement levels 
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were determined by using information contained within extracted ion currents (XIC) of 
trypsin-digested protein samples. Peaks corresponding to peptides globally substituted with 
Hil were identified along with peaks corresponding to peptides substituted at only a 
fraction of the Leu positions. Assuming that substitution of Hil in place of Leu is a random 
event, the ratio of the peak areas yields the quantitative replacement level in a given 
sample. A full description of the method is provided below. Where possible, fragmentation 
of abundant peptide ions was used to confirm the sequences of substituted peptides. 
 
Determination of amino acid replacement levels. Liquid chromatography tandem mass 
spectrometry (LC/MS/MS) was used to quantitate the Hil replacement levels in purified A1 
protein samples. Figure 2.4 depicts results from a typical LC/MS/MS experiment. Figure 
2.4A shows the total ion currents (TIC) from the trypsinized Hil-A1, and figure 2.4B–E 
show the mass spectra and mass-filtered extracted ion currents (XIC) from the doubly 
substituted peptide SXEDEAAEXEQK (X = Hil) and the mixture of singly substituted 
peptides SLEDEAAEXEQK and SXEDEAAELEQK. The unsubstituted peptide 
SLEDEAAELEQK was not detected in this experiment. The areas of the XICs permit an 
estimation of the substitution rate. Assuming that replacement of leucine is a random event, 
the distribution of peak areas should follow the binomial distribution, 
 
€ 
A (1− p)2 + 2p(1− p) + p2[ ] , (2.1) 
 
where A is a multiplication factor equal to the sum of the areas of the unsubstituted, singly 
substituted, and doubly substituted peaks. The quantity p is the probability of substitution at 
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a given site, and the three terms in the polynomial represent non-, singly-, and doubly-
substituted peptides. The polynomial also has the property 
 
€ 
(1− p)2 + 2p(1− p) + p2 =1.  (2.2) 
 
The ratios of the areas of two substituted peaks are more relevant in this particular case 
because the total area A cannot be determined from the available experimental data. The 
experimentally accessible peak area ratio of singly to doubly substituted peaks is 
 
€ 
2p(1− p)
p2 , (2.3) 
 
which can be defined as X. Rearranging equation (2.2) yields the identity 
 
€ 
2p − 2p2
p2 =
2p(1− p)
p2 = X .  (2.4) 
 
Solving for p yields the two roots 
 
€ 
p = 0,  (2.5) 
or  
€ 
p = 2X + 2 .  (2.6) 
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Substituting the peak area ratio for X in the nonzero root yields the substitution rate. 
 The above analysis was used to determine the substitution of Hil in place of Leu in 
the peptides SLEDEAAELEQK and GSHHHHHHGSMASGDLENEVAQLER. A simpler 
calculation was also made to determine the incorporation of Hil based on the peptide 
AEIGDLNNTSGIR, which contains one leucine residue (The value p can be determined 
from the ratio of the XIC area of the substituted peptide to the sum of the substituted and 
unsubstituted peptide areas). When the XIC contained multiple peaks (often the case when 
searching for peptides of lower abundance), the areas of the clearly distinguishable peaks 
(generally having areas of 10 or more) were summed in order to ensure a conservative 
estimate of amino acid incorporation levels. The identities of the peptides in the 
SLEDEAAELEQK series were confirmed by tandem mass spectrometry. Two samples of 
Hil-A1 produced independently were analyzed to obtain the substitution levels summarized 
in table 2.3. 
 
Protein characterization. To determine protein yields, portions of Leu-A1 and Hil-A1 
produced at small scale and purified using Ni-NTA agarose resin were buffer exchanged 
into acetate buffer (100 mM NaCl, 10 mM sodium acetate, pH 4.0) using Amicon Ultra-4 
concentration devices with a 3000 Da molecular weight cutoff. The concentrations of the 
exchanged samples were determined with a BCA assay kit. 
 Circular dichroism samples were prepared by dialyzing protein samples in Qiagen 
buffer E (containing 250 mM imidazole) against phosphate-buffered saline, pH 7.4. 
Concentrations were again determined using the BCA assay, but prior to performing the 
assay, samples were heated to 42 °C for approximately 20 minutes in order to ensure that 
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samples were fully dissolved. Samples were adjusted to 10 µM by concentration with 
Amicon Ultra-15 concentration devices (molecular weight cutoff = 3000 Da) as necessary 
and dilution in fresh PBS. Circular dichroism spectroscopy was performed on an Aviv 
62DS spectropolarimeter in a 1 mm path length cell. All samples were heated to 42 °C and 
cooled on ice prior to measurement. Each experiment consisted of a wavelength scan 
performed at 1 °C followed by a temperature scan from 0 °C to 94.5 °C in 1.5 °C intervals 
with signal monitoring at 222 nm. During the temperature scans, the sample was allowed to 
equilibrate for one minute prior to performing readings at each temperature step. All data 
was referenced to background scans of PBS buffer acquired under identical conditions. 
Wavelength scans were analyzed using K2D2 (20), and temperature scans were analyzed 
using a Matlab implementation of a model for coiled-coil unfolding described previously 
(22). 
 
ATP-PPi exchange assays. E. coli LeuRS was expressed and purified as previously 
described and its concentration was determined from its absorbance at 280 nm under native 
conditions (24). Assays were run at room temperature in buffer containing HEPES 
(30 mM, pH 6.8), MgCl2 (10 mM), dithiothreitol (1 mM), ATP (2 mM), and [32P]-PPi 
(2 mM, 3 µCi in 200 µL rxn volume). Activation of leucine was performed in solutions 
containing LeuRS (75 nM) and varying Leu concentrations (1.6 to 50 µM), while 
activation of homoisoleucine was measured using a higher concentration of LeuRS 
(300 nM) and varying Hil concentrations (16 to 500 µM). Aliquots (30 µL) were taken 
every 2 (Leu) or 6 (Hil) minutes and quenched in a suspension of activated charcoal 
(3% w/v) containing HClO4 (7% w/v) and inorganic pyrophosphate (200 mM). The 
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charcoal was washed twice in a solution of HClO4 (0.5% w/v) and inorganic pyrophosphate 
(10 mM), and added to 20 mL scintillation vials. Scintillation fluid (5 mL) was added to 
each vial and samples were counted using a Beckman Coulter liquid scintillation counter. 
Data were fitted with nonlinear regression using the program Igor. 
 
Synthesis of homoisoleucine (2-amino-4-methylhexanoic acid, CAS # 3570-21-6). Silica 
chromatography was performed using 230-400 mesh silica gel 60 (EMD). TLC was run on 
Baker-flex silica gel IB-F plates, Rfs are reported under the same solvent conditions as 
columns unless otherwise noted. TLC was examined under UV light for fluorescent 
compounds or alternatively stained with KMnO4, ceric ammonium molybdenate or 
p-anisaldehyde. NMR spectra were recorded on Varian spectrometers (300 MHz for 1H) 
and processed with NUTS NMR software. NMR spectra were referenced to internal 
standards; proton spectra were referenced to tetramethylsilane and carbon spectra were 
referenced to solvent peaks. FAB mass spectrometry was performed at the Caltech 
Division of Chemistry and Chemical Engineering Mass Spectrometry Facility. 
 The following procedure was adapted from O'Donnell and Eckrich (25): 
aminoacetonitrile benzophenone imine (1.21 g, 5.5 mmol), benzyltriethylammonium 
chloride (0.1 g, 0.4 mmol), 50% aq NaOH (0.75 mL, 14 mmol) and toluene (1 mL) were 
combined in a 10 mL round bottom flask which contained a magnetic stir bar. The flask 
was chilled in an ice-water bath and stirred vigorously (~1200 rpm). (S)-2-methyl 
bromobutane (1.15 g, 0.94 mL, 7.6 mmol, 1.4 eq) was added portion-wise via syringe over 
1 hour to the stirred solution. The reaction mixture was stirred for an additional 2 hours at 
0 °C and then allowed to come to room temperature. Stirring was continued at room 
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temperature for 96 hours. The reaction mixture was transferred to a separatory funnel and 
diluted with H2O (20 mL) and CH2Cl2 (40 mL). The aqueous layer was washed 3 times 
with CH2Cl2 (10 mL × 3) and the combined organic layers were washed 3 times with H2O 
(10 mL × 3) and once with saturated NaCl (10 mL). The organic layers were dried over 
Na2SO4 and filtered, and the solvent was removed to yield a yellow oil (1.80 g). 
Purification by silica chromatography (eluting with 6% ethyl acetate in hexanes; Rf 0.18 in 
10% ethyl acetate/hexanes) gave a yellow oil (1.40g, 88%); a mixture of diastereomers. 1H 
NMR (300 MHz, CDCl3) δ 0.73 (dd, 3H J = 4.5, 6.5 Hz), 0.82 (dd, 3H J = 7.5, 14.0 Hz), 
1.00-1.37(m, 2H), 1.41-1.81(m, 2H), 1.82-2.14 (m, 1H), 4.27 (dd, 0.5H, J = 6.3, 8.0 Hz), 
4.31 (dd, 0.5H, J = 6.3, 8.1 Hz), 7.15-7.26 (m, 2H), 7.27-7.37 (m, 2H), 7.37-7.58 (m, 4H), 
7.58-7.82 (m, 2H) 13C NMR (75 MHz, CDCl3) δ 10.724, 10.891, 18.416, 18.699, 28.865, 
28.923, 30.680, 31.086, 41.266, 41.347, 51.037, 51.606, 119.747, 119.899, 127.108, 
127.238, 128.039, 128.789, 129.205, 130.933, 135.007, 135.051, 138.243, 138.294, 
172.259, 172.582. FAB MS calculated for C20H22N2 (M+) 290.1783, observed 290.1787. 
 The following procedure was adapted from Dorizon et al. (26): HCl (1 M, 14 mL) 
was added dropwise to a solution of alkylated aminoacetonitrile benzophenone imine (290 
mg, 1.00 mmol) in diethyl ether (7 mL). The mixture was stirred vigorously at room 
temperature for 24 hours. The aqueous phase was extracted twice with diethyl ether and 
evaporated to give 1-amino-1-cyano-3-methylpentane hydrochloride (180 mg, ~100%). 
This material was dissolved in 6 M HCl (3 mL) and heated to reflux for 72 h. The solution 
was evaporated under reduced pressure to give an off-white solid (168 mg, 93%). 1H NMR 
(300 MHz, CD3OD) δ 0.929 (t, 3 H J = 7.5 Hz), 0.936 (t, 3 H J = 7.5 Hz), 0.979 (d, 3 H 
J = 3.6), 0.999 (d, 3 H J = 3.4), 1.148-1.548 (m, 2 H), 1.554-2.010 (m, 3 H), 3.979 (m, 1H); 
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13C NMR (75 MHz, CD3OD) δ 10.036, 10.265, 17.665, 18.004, 28.846, 29.254, 30.649, 
30.659, 37.601, 37.656, 51.117, 51.133, 171.117, 171.244; FAB MS calculated for 
C7H16NO2 (M+H) 146.1176, observed 146.1205. 
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Scheme 2.1. Amino acids used in study. 1, leucine (Leu). 2, (2S,4S)-2-amino-4-
methylhexanoic acid (homoisoleucine, Hil). 3, (2S,4R)-trifluoroleucine (Tfl). 4, 
hexafluoroleucine (Hfl). 
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Figure 2.1. A1 peptide sequence and helical wheel representation of A1 homodimers. The 
amino acids that comprise the putative heptad repeats are highlighted in gray, with 
additional emphasis on the leucine residues at the d positions. 
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Figure 2.2. Circular dichroism spectra of Leu-A1 and Hil-A1. A) Wavelength scans 
performed at 1 °C. B) Ellipticity at 222 nm as a function of temperature. All experiments 
were performed with 10 µM peptide in PBS, pH 7.4. 
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Figure 2.3. MALDI spectra of tryptic fragments of A) Leu-A1 and B) Hil-A1. The portions 
of the spectra shown encompass the m/z region in which the peptide 
LKNEIEDLKAEIGDLNNTSGIR appears with or without Hil substitution. In the Leu-A1 
sample, the major peak appears at 2441.43 Da (calculated mass: 2442.28 Da). In the Hil-
A1 sample, the largest peak appears at 2483.43 Da (calculated mass: 2484.32 Da), 42 mass 
units away from the unsubstituted peak, corresponding to complete replacement of Leu by 
Hil. A smaller peak at 2469.44 Da (calculated mass: 2470.31 Da) indicates the presence of 
some peptides that contain only two out of three Hil substitutions. 
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Figure 2.4. LC/MS results obtained on trypsinized sample of Hil-A1 (Sample A in table 
2.3). A) Total ion current (TIC) of sample. B) Mass spectrum at time = 24.382 min, 
revealing a doubly charged ion having the mass corresponding to the masses of the singly 
substituted peptides SXEDEAAELEQK and SLEDEAAEXEQK (X = Hil). Calculated 
doubly charged ion 688.33 Da, observed 688.37 Da. C) Extracted ion current (XIC) of 
masses ranging from 688 to 690 amu. The mass filtering reveals a single, well-defined peak 
of integrated area 1.0 × 104 arbitrary units. D) Mass spectrum at time = 25.845 min, 
revealing a doubly charged peak having a mass corresponding to the mass of the doubly 
substituted peptide SXEDEAAEXEQK. Calculated doubly charged ion 695.34 Da, 
observed 695.36 Da. E) XIC of masses ranging from 695 to 697 amu. Again, a single, well-
defined peak is observed and has an integrated area of 4.4 × 105 arbitrary units. The 
sequences of these peptides were confirmed with LC/MS/MS fragmentation. 
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Table 2.1. Kinetic parameters for activation of Leu and Hil by LeuRS 
Substrate[a] kcat [s−1] Km [µM] kcat/Km [rel] 
Leu[b] 15.1 ± 2.2 3.7 ± 1.9 1 
Hil 0.4 ± 0.1 77 ± 65 1/690 
[a] Leu was used as the L-isomer; Hil as a mixture of the D- and L- isomers. The concentrations of 
Hil reported here are those of the L-isomer. Kinetic parameters are reported as averages determined 
from three independent experiments with errors reported as averages of the 95% confidence 
intervals. [b] Parameters determined for activation of Leu are consistent with previous reports; the 
value of kcat measured in this work is within the range of reported values, while the value of Km 
reported here is lower than literature values by a factor of 2–10 (10, 12, 24, 27). 
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Table 2.2. Stabilization of A1 by replacement of Leu with noncanonical amino acids 
Amino acid at d position Leu (2S,4R)-Tfl Hil Hfl[b] 
ΔTm[a] 0 10 (ref 12) 17 22 (ref 10) 
[a] Increase in melting temperature (as compared to Leu-A1) determined from CD spectroscopy of 10 
µM solutions of peptide in PBS, pH 7.4. [b] 74% replacement of Leu. 
 
 154 
Table 2.3. Incorporation levels of Hil in A1 samples determined from multiple series of 
substituted peptides 
Peptide series Sample A Sample B 
SLEDEAAELEQK 98.9% 97.1% 
GSHHHHHHGSMASGDLENEVAQLER 99.5% 99.0% 
AEIGDLNNTSGIR 98.5% ND[a] 
[a] Not determined due to insufficient signal of unsubstituted ion. 
 
CHAPTER 3 
Hydration Dynamics at Fluorinated Protein Surfaces 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter first appeared as an article in Proceedings of the National Academy of 
Sciences, USA: Oh-Hoon Kwon, Tae Hyeon Yoo, Christina M. Othon, James A. Van 
Deventer, David A. Tirrell, and Ahmed H. Zewail. Proc. Natl. Acad. Sci. USA 2010, 107, 
(40) 17101-17106. 
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Abstract  
 Water-protein interactions dictate many processes crucial to protein function 
including folding, dynamics, interactions with other biomolecules, and enzymatic catalysis. 
Here we examine the effect of surface fluorination on water-protein interactions. 
Modification of designed coiled-coil proteins by incorporation of 5,5,5-trifluoroleucine or 
(4S)-2-amino-4-methylhexanoic acid enables systematic examination of the effects of side-
chain volume and fluorination on solvation dynamics. Using ultrafast fluorescence 
spectroscopy, we find that fluorinated side chains exert electrostatic drag on neighboring 
water molecules, slowing water motion at the protein surface. 
 
Introduction  
 The past decade has witnessed substantial expansion in the number and diversity of 
noncanonical amino acids that can be incorporated into recombinant proteins expressed 
in bacterial cells (1-3). Fluorinated amino acids have drawn special attention (4-16) 
because of the unusual solubility properties of fluorinated hydrocarbons. Several 
independent studies have shown that fluorination of coiled-coil and helix-bundle proteins 
leads to enhanced stability with respect to thermal or chemical denaturation (6-12), an 
effect attributed to the hyperhydrophobic and fluorophilic character of fluorinated amino 
acid side chains. 
 Although both classes of compounds are hydrophobic, hydrocarbons and 
fluorocarbons differ in important ways (17-22). The high electronegativity of fluorine 
renders the C-F bond both strongly polar and weakly polarizable (17, 21, 22). The dipole 
associated with the C-F bond exerts strong inductive effects on neighboring bonds (23) 
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and can form reasonably strong electrostatic interactions with ionic or polar groups when 
the two moieties are appropriately positioned. The hydrophobic character of fluorinated 
compounds has been described as “polar hydrophobicity (17),” and is believed to play 
important roles in organic and medicinal chemistry. Furthermore, the C-F bond is 
significantly longer than the C-H bond, and the calculated volume of the trifluoromethyl 
group is about twice that of a methyl group (20). The studies described here constitute an 
attempt to understand more fully the interaction of water with fluorinated molecular 
surfaces, and to provide a sound basis for the use of fluorinated amino acids in the 
engineering of proteins with unique and useful physical properties. 
 The hydration layer adjacent to protein surfaces exhibits properties different from 
those of bulk water; the more rigid and denser structure of the hydration layer plays a 
crucial role in protein structure, folding, dynamics, and function (24-26). Elucidation of 
the dynamic features of this region, on the timescales of atomic and molecular motion, is 
essential in understanding protein hydration. In the past decade, the knowledge of 
hydration on protein surfaces has been extensively expanded by studying the dynamic 
properties of biological water for various proteins containing tryptophan (Trp) or 
synthetic fluorescent amino acids as local probes; the results have revealed 
multicomponent relaxation dynamics spanning a wide range of timescales (25, 27-29). 
The nature of the protein hydration layer can be affected not only by the topographic and 
electrostatic properties of the protein surface (24), but also by the physical and chemical 
properties of individual surface-exposed residues (27, 30). In view of the unique 
properties of the C-F bond and of fluorocarbon–water interfaces (23, 31), we anticipated 
that fluorinated amino acid side chains might exhibit unusual hydration behavior. Here 
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we report studies of local hydration dynamics at fluorinated protein surfaces by 
monitoring the time-dependent fluorescence Stokes shifts of surface-exposed Trp 
residues in coiled-coil proteins with 5,5,5-trifluoroleucine (Tfl, 1; scheme 3.1) residues 
adjacent to the probe. The results are compared to the hydration dynamics at 
hydrogenated protein surfaces with Leu (2) or (4S)-2-amino-4-methylhexanoic acid 
(homoisoleucine, Hil, 3) adjacent to the Trp probe. Hil has approximately the same 
volume as Tfl (20, 21), and although the shapes of the residues differ, the nearly identical 
side-chain volumes of Tfl and Hil allow us to differentiate changes due to fluorination 
from those that result from the increase in side-chain volume that accompanies 
replacement of Leu (scheme 3.1). 
 
Results  
Coiled-coil protein system. The coiled-coil protein A1 (figure 3.1 A and B) was used as a 
model system to examine the effects of fluorinated amino acids on local hydration 
dynamics. The primary structure of A1 contains six copies of a heptad repeat (abcdefg)n, 
where positions a and d are occupied by hydrophobic amino acids. Self-association of the 
peptide juxtaposes the a and d positions and results in the formation of a hydrophobic core. 
Fluorinated Leu analogues have previously been incorporated into the d positions of A1; 
the resulting proteins exhibited improved resistance to thermal and chemical denaturation 
with minimal differences in secondary structure (9, 11, 12). In this work, the surface-
exposed Asp residue at the f position of the third heptad (position 34) was replaced by Trp, 
which serves as a fluorescence probe (figure 3.1C). The Trp variant of A1 was designated 
A1m. In order to examine the effects of fluorinated analogues on the local hydration 
 159 
dynamics, a Leu codon was introduced at one of two positions within A1m. Mutation of a 
serine residue at the c position of the third heptad (position 31) yielded a variant of A1 
designated S31L (figure 3.1D), while replacement of an alanine residue at position b of the 
fourth heptad (position 37) gave the A1 variant A37L (figure 3.1E). Each protein was 
expressed in Tfl, Leu, and Hil form, yielding a total of nine different proteins that were 
examined in detail (see (32) for nomenclature). 
 
Characterization of global structure. Analysis of each protein showed that the overall 
structural properties of the molecules were generally insensitive to genetic mutations and 
incorporation of noncanonical amino acids. Circular dichroism spectroscopy indicated 
that all nine proteins were helical, as determined from the molar ellipticity at 222 
nanometers (figure 3.2) (33); an analysis with K2D2 software showed that the helicities 
of individual proteins range between approximately 40% and 48% (34). These results are 
consistent with the design of the A1 protein (35), in which approximately half of the 
amino acids are located within the heptad repeats expected to form α-helical secondary 
structure. The oligomerization states of the protein samples were determined by 
sedimentation velocity analysis (figure 3.3). Although A1 forms dimers and tetramers at 
neutral pH (11), the variants examined in this study form trimers or hexamers under 
mildly acidic conditions (pH 4). We suggest that protonation of Glu side chains at the e 
and g positions (figure 3.1A) of the proteins decreases the density of negative charges 
adjacent to the hydrophobic core and promotes formation of larger helical aggregates at 
pH 4. A1m, in which the single Trp residue occupies a surface-exposed position, is 
predominantly trimeric in Leu-, Tfl-, and Hil-forms, with a small fraction of hexamers 
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(see figure 3.3). The majority of the S31L samples are present as hexamers, while the 
A37L samples appear to contain mixtures of trimers and hexamers. 
 
Characterization of local structure. The steady-state fluorescence emission spectrum of 
Trp depends on the extent of exposure of the Trp side chain to water (36). All nine 
protein samples showed emission maxima between 349 and 352 nm, close to that of free 
Trp at 353 nm (table 3.1 and figure 3.4). These observations indicate that the Trp residues 
are exposed to the aqueous environment (consistent with the original design), and not 
involved in oligomerization of the proteins. In addition, the steady-state UV-visible 
absorption and steady-state fluorescence emission spectra of each mutant containing Leu 
were nearly identical to the spectra of the corresponding mutant when it contained Tfl or 
Hil (figure 3.4), further confirming that perturbation of the protein structure upon 
replacement of Leu by Tfl or Hil was minimal. 
 The mobility of the probe residue was explored in each protein by measuring fs-
resolved depolarization dynamics (figure 3.5). The anisotropic dynamics were found to 
consist of three components: ultrafast (≤ 500 fs), intermediate (20–80 ps), and slow (≥2 
ns) decays. The ultrafast decays are attributed to fast internal conversion between the first 
two excited singlet states (1La and 1Lb) of Trp, the intermediate decays to local wobbling 
motions of Trp, and the slow decays to tumbling motions of the proteins (28, 37). Similar 
values for the wobbling motions (φTrp) and their cone semiangles (θ) were observed for 
each series of S31L and A37L proteins (table 3.1); see material and methods for details. 
 Both mutation of residues around Trp and fluorination of the protein hydrophobic 
core can affect the environment of the probe and change the protein structure and/or the 
 161 
dynamic properties of the hydration layer. In many cases these properties are related to 
one another. The minimal change in the steady-state fluorescence spectrum caused by 
replacement of Leu by Tfl or Hil suggests similar features of the hydration region probed 
by Trp (e.g., the effective number of water molecules in the hydration shell). In addition, 
the similarity of the Trp wobbling angle of the Leu-, Tfl-, and Hil-forms of the proteins 
suggests similar organization and flexibility of neighboring residues around the probe 
(28). All these features make it possible to compare the dynamic properties of protein 
hydration for most of the proteins in the A1m, S31L, and A37L proteins containing Leu, 
Tfl, and Hil. For A1m-H, we note that the wobbling angle of Trp was found to be 33°, 
which is significantly higher than the 17°–21° wobbling angles determined for all of the 
other proteins. This result indicates that the organization of local residues or the 
flexibility of the local Trp environment in A1m-H differs from that in the other proteins, 
despite the lack of global structural changes observed by circular dichroism or 
sedimentation velocity measurements. The abnormal behavior of the A1m-H variant is 
also observed in the fluorescence lifetime measurements. Every protein except A1m-H 
displayed a short-lifetime component of a few hundred picoseconds, present at all 
wavelengths. These types of quenching processes have been attributed to Trp interactions 
with nearby charged residues (38-40), and the absence of such a feature in A1m-H again 
indicates that this protein has a local structure different from those of the other eight 
proteins. The perturbation of local structure and, thus, local solvent exposure can result in 
different hydration dynamics, making it unreliable to compare the dynamics of A1m-H to 
those of the other A1m proteins. Accordingly, the dynamics obtained for A1m-H were 
not used in the analysis that follows. Small shifts in the fluorescence emission maximum 
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and Trp wobbling angle were observed for A37L-L as compared to A37L-T and A37L-H 
(see table 3.1 and figure 3.4). These differences may be significant enough to alter the 
local environment surrounding the Trp probe, potentially complicating assignment of 
changes observed in the hydration dynamics to a particular effect (e.g., changes in an 
amino acid close to Trp). Despite these concerns, the dynamics results for A37L-L 
remain consistent with the conclusions of the paper (see below). 
 Our stringent standards for comparison of hydration dynamics between modified 
proteins require that there be (i) no global change in protein structure as measured by 
circular dichroism spectroscopy and sedimentation velocity measurements; (ii) no change 
in solvent exposure as measured by steady-state fluorescence maximum (± 1 nm); and 
(iii) no change in local protein structure or flexibility as measured by fluorescence 
anisotropy (± 1°). Seven of the nine proteins prepared in this study met all of these 
criteria, and an additional protein, A37L-L, displayed changes just outside the margin of 
error. Only one protein, A1m-H, showed changes significant enough to require us to 
disregard the hydration measurements observed. Given the subtle effects of the chemical 
environment on hydration dynamics, we will compare hydration results only within 
protein families. Thus, our strongest conclusions will be drawn from observations made 
on the S31L protein variants, and the data for A1m and A37L will be used as 
corroborating evidence. 
 
Ultrafast hydration dynamics. To investigate hydration dynamics at the protein 
surfaces, we utilized a methodology developed by Zhong and coworkers for the 
reconstruction of femtosecond-resolved fluorescence spectra (28, 41). As an example, 
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figure 3.6A shows several representative femtosecond-resolved fluorescence transients 
recorded for A1m-T. The overall decay dynamics is retarded compared to that of free Trp 
in buffer solution. Details of the results for all the protein samples are presented in table 
3.1. The hydration dynamics of the proteins were well represented by triple-exponential 
decays with distinctive timescales of 0.2–0.8, 1.4–6.1, and 10–61 picoseconds. 
Relaxation occurring on a time scale of a few hundred femtoseconds to several 
picoseconds is attributed to fast librational/rotational motions of bulk-type and local 
water molecules around Trp. Observation of the fs component suggests that the Trp probe 
in the test proteins is neither crowded by neighboring residues nor protected from 
exposure to water (27, 28, 42). The slowest phase of hydration dynamics (on the 
timescale of tens of picoseconds) is collective water network rearrangement coupled to 
protein fluctuation dynamics (27, 42-44). 
 Several key features of the results (figure 3.7 and table 3.1) are summarized as 
follows. First, S31L-T and A37L-T, in which Tfl lies close to Trp as well as in the 
hydrophobic core, showed slower hydration dynamics than their Hil and Leu 
counterparts, indicating that the fluorinated surface of the protein slows down the 
hydration dynamics. For S31L-T, the timescales of local and collective water motions (τ2 
and τ3, respectively) are increased by 2–5 times (3.0 and 48 ps) from those of S31L-H 
(1.4 and 10 ps). The overall solvation of S31L-T is slower than that of S31L-L as well. 
However, this difference is manifested as an increase in the contribution of the τ3 
component to the overall solvation of Trp. The 70% increase of the relaxation energy 
(333 cm−1) of the slowest component (E3) compared to that of the nonfluorinated S31L-L 
(194 cm−1) is an indication of the dramatic slowing of hydration dynamics near the 
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fluorinated surface. For A37L-T, τ2 and τ3 are also retarded to a greater extent (3–5 times 
slower) than those for A37L-H. These results suggest that replacement of Leu by Tfl 
increases the residence time of water molecules near the Trp probe and/or the number of 
water molecules influenced by the amino acid side chain. 
 Second, S31L-H and A37L-H showed similar or even faster hydration than their 
Leu counterparts. This result indicates that in the comparison between hydrocarbon 
residues, increasing the hydrophobic surface area results in faster motion of water 
molecules around the residue. It should be noted that, for the S31L series, hydration is 
greatly accelerated when Leu is replaced with Hil. This pronounced hydrophobic effect 
(due to the increase in the size of the residue) on the hydration is counteracted by 
fluorination of leucine, resulting in slowing dynamics for S31L-T. On the other hand, for 
A37L, increasing the size of the hydrophobic surface does not appear to affect the 
hydration dynamics as greatly. Therefore, the retardation of the dynamics upon 
fluorination is much more pronounced for A37L-T than for the corresponding 
fluorination of S31L. Finally, A1m-L and A1m-T, which differ from one another only in 
the nature of their hydrophobic cores, exhibited almost identical hydration dynamics. 
Fluorination of the hydrophobic core of a helix-bundle protein can affect protein 
dynamics (45). However, the nearly identical hydration dynamics for A1m-L and A1m-T 
spanning a few hundred picoseconds indicates that modification of the hydrophobic core 
of A1m does not affect protein motions that are coupled to local hydration dynamics at 
the surface of the protein on the timescales examined here (46). 
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Discussion 
 Protein surfaces are heterogeneous, consisting of polar, hydrophilic, and 
hydrophobic residues, and it is intriguing to consider how the heterogeneous surface 
chemistry affects the behavior of water molecules in the protein hydration layer. Head-
Gordon and coworkers have reported heterogeneous water dynamics in the first hydration 
shell of model peptides (N-acetyl-leucinemethylamide and N-acetyl-glycinemethylamide), 
with faster water motions near the hydrophobic side chains than near the hydrophilic 
backbone (47, 48). Similar results have been reported for molecular dynamics simulation 
studies of a folded β-hairpin peptide (30). In addition, Qiu et al. showed that mutation of 
charged or polar residues of the enzyme staphylococcal nuclease into more hydrophobic 
residues (Ala), resulted in faster hydration dynamics; this result was attributed to the lack of 
strong interaction between the charges (or dipoles) of the mutated protein and the 
surrounding water (27). This observation can be understood in that the elimination of 
specific interactions between hydrophobic residues and water molecules causes a lower 
number of hydrogen bonds between water and a hydrophobic surface compared to those 
near a hydrophilic surface, thus allowing water molecules to reorient more freely. 
Computational studies have suggested that water layers adjacent to extended hydrophobic 
surfaces of low curvature are of lower density than those around hydrophilic and small 
hydrophobic molecules, and are dynamic rather than static (49-56). X-ray reflectivity 
experiments indicate submonolayer water depletion at hydrocarbon and fluorocarbon 
surfaces (57). Our observation of accelerated hydration dynamics around larger Hil 
residues as compared to the smaller Leu is consistent with these experimental and 
computational results, supporting the idea that water molecules neighboring hydrophobic 
 166 
side chains in the hydration layer of proteins are more dynamic than those around polar or 
hydrophilic residues. 
 Even though a simple comparison suggests that Tfl should be more hydrophobic 
than Leu by virtue of its larger surface area, introduction of a Tfl residue adjacent to the 
Trp probe caused retardation of the local hydration dynamics, in contrast to the results 
obtained when Leu was replaced with Hil (figure 3.7). These results suggest that hydration 
dynamics around fluorinated amino acid side chains cannot be explained exclusively by the 
increase in residue size. The C-F bond is assumed not to be involved in hydrogen bonding 
with liquid water, largely because of its low polarizability (17). However, replacement of 
Leu by Tfl introduces a strong dipole at the fluorinated protein surface. Lee and coworkers 
have shown that introduction of CF3 groups reduces the contact angle of water on self-
assembled alkanethiol monolayers (23), an effect that they attribute to dipolar interactions. 
Our results suggest that such dipolar interactions can also slow water motions at fluorinated 
molecular surfaces. 
 Fluorinated compounds are more hydrophobic than hydrogenated compounds of 
equal carbon number (4, 5, 17-21), and the increase in hydrophobic character of 
fluorocarbons has been ascribed to their increased molecular size (18, 58). This 
interpretation appears to be consistent with the observation that the melting temperature of 
A1-Tfl is 13 °C higher than that of A1-Leu (11), while Tm for A1-Hil is increased by 17 °C 
in comparison to A1-Leu. However, the results reported here clearly indicate that the 
chemical nature of the protein surface dictates the dynamics of solvent-protein interactions, 
and that size effects alone cannot explain the altered solvation dynamics observed at 
fluorinated protein surfaces. 
 167 
Conclusions 
 The results reported here show that fluorinated amino acids influence hydration 
dynamics at protein surfaces in a manner quite different from their hydrogenated 
counterparts. In general, water-protein interactions dictate many processes crucial to 
protein function including folding, dynamic motions, interactions with other biomolecules, 
and enzymatic catalysis (26). The slower timescales of hydration dynamics observed near 
fluorinated residues in proteins suggest that some of the water-mediated processes 
processes listed above may be changed upon fluorination. Tailoring the dynamics of 
protein-water interactions by the introduction of fluorinated residues may yield proteins 
with functional properties, such as binding, molecular recognition, or catalytic activities, 
that cannot be achieved with the canonical amino acids. Understanding hydration dynamics 
at fluorinated molecular surfaces is a critical step toward exploiting the properties of 
fluorine in biological systems. 
 
Materials and Methods  
Summary of protein expression and characterization. A1 variants A1m, S31L, and 
A37L were expressed in 2×YT medium (which contains Leu) to yield proteins A1m-L, 
S31L-L, and A37L-L, respectively, in Leu-free M9 minimal medium (12.8 g/L 
Na2HPO4·7H2O, 3 g/L KH2PO4, 0.5 g/L NaCl, 1 g/L NH4Cl) supplemented with 19 
canonical amino acids plus Tfl to give A1m-T, S31L-T, and A37L-T, and in Leu-free M9 
medium supplemented with 19 canonical amino acids plus Hil to give A1m-H, S31L-H, 
and A37L-H. The proteins were purified under denaturing conditions and dialyzed against 
10 mM acetate (pH 4)/100 mM NaCl. The extent of replacement of Leu by Tfl in A1m-T, 
 168 
S31L-T, and A37L-T, was determined by amino acid analysis to be 90%–91%. Leu 
replacement by Hil in A1m-H, S31L-H, and A37L-H was analyzed by liquid 
chromatography tandem mass spectrometry and determined to be at least 90% (figure 3.8). 
See below for further details of expression, purification, and incorporation analysis. 
 
Summary of steady-state measurements. Circular dichroism spectra were recorded on an 
Aviv 62DS spectropolarimeter (Lakewood, NJ). Absorption spectra were collected using a 
Cary 500 UV-Vis spectrophotometer and a 0.05 mm path length cuvette. Steady-state 
fluorescence emission spectra were measured using a FluoroMax-2 fluorimeter (ISA-
Spex). 
 
Summary of time-resolved fluorescence measurements. The experimental apparatus for 
time-resolved measurements are detailed below. All fluorescence spectra and transients 
were obtained by the excitation of samples (~550 µM) at 295 nanometers. The lifetime 
components were obtained by global analysis of fluorescence transients collected using a 
time-correlated single photon counting spectrometer. All transients show additional 
multiple-exponential decay (at the blue side) and rise (at the red side) with time constants 
spanning from a few hundred femtoseconds to several tens of picoseconds. In order to 
extract hydration dynamics precisely, we reconstructed apparent and lifetime-associated 
time-resolved fluorescence spectra with eight or nine transients at different wavelengths 
covering the blue and the red sides (figure 3.6B). By fitting these spectra to lognormal 
functions, we traced the time-dependent apparent emission maxima (νs) and lifetime-
associated emission maxima (νl) as plotted in figure 3.6C. Using Δν(t) = νs(t) − νl(t), we 
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correlated the extracted time-dependent spectral shift, Δν(t), to the hydration energy 
relaxation, ΔEs (figure 3.7). 
 
Materials. All restriction enzymes were purchased from New England Biolabs (Beverly, 
MA). D,L-5,5,5-trifluoroleucine (Tfl) was purchased from Oakwood Products (West 
Columbia, SC). DNA oligomers were synthesized at Qiagen (Valencia, CA) or Integrated 
DNA Technologies (Coralville, IA). (4S)-2-amino-4-methylhexanoic acid 
(homoisoleucine, Hil) was prepared according to the methods of O’Donnell and Eckrich 
(59) and Dorizon and coworkers (60). 
 
Plasmid construction. An EcoRI/HindIII fragment of pQEA1 (11) containing the A1 
coding sequence was ligated into EcoRI/HindIII-digested pQE-80L (Qiagen) to yield pQE-
80L/A1. The Asp residue at position 34 of A1 was mutated to Trp by site-directed 
mutagenesis. The resulting plasmid was designated pQE-80L/A1m. A Leu codon was 
introduced into either position 31 or position 37, yielding pQE-80L/S31L and pQE-
80L/A37L, respectively. Plasmid pA1EL (12), which encodes both the protein A1 and a 
constitutively expressed leucyl-tRNA synthetase (LeuRS), was mutated using similar site-
directed mutagenesis techniques. A Trp codon was introduced first at position 34 of A1, 
yielding pA1mEL. Introduction of leucine codons into either position 31 or position 37 
resulted in the plasmids pS31LEL and pA37LEL, respectively. 
 
Expression of fluorinated proteins. M9 medium supplemented with 0.4% glucose, 
3.5 mg⁄L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 20 amino acids (40 mg⁄L), and 200 mg⁄L 
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ampicillin was inoculated 1:50 with an overnight culture (M9) of Escherichia coli strain 
DH10B transformed with pQE-80L/A1m, pQE-80L/ S31L, or pQE-80L/A37L and grown 
at 37 °C with shaking. After each culture reached OD600 = 0.9–1.0, the cells were harvested 
by centrifugation (6000 × g, 4 °C, 6 min) and washed twice with cold 0.9% NaCl. The cell 
pellets were resuspended in M9 medium containing 19 amino acids (no Leu) and 1 mM 
Tfl. Protein expression was induced 10 min after the medium shift by addition of IPTG to a 
final concentration of 1 mM. After 3 h, the cells were harvested by centrifugation (6000 × 
g, 4 °C, 10 min), and the cells were stored at −20 °C at least 12 h before purification. In the 
case of the protein S31L-T, one sample was made using the procedure for the production of 
proteins containing Hil described below. 
 
Expression of proteins containing homoisoleucine. M9 medium supplemented with 
0.4% glucose, 35 mg⁄L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 20 amino acids (40 mg⁄L), 
200 mg⁄L ampicillin, and 35 mg⁄L kanamycin was inoculated 1:50 with an overnight 
culture (M9) of E. coli strain LAM1000 transformed with pREP4 and pA1mEL, pS31LEL, 
or pA37LEL at 37 °C with shaking. After each culture reached OD600 = 0.9–1.1, the cells 
were harvested by centrifugation (5000 × g, 4 °C, 15 min) and washed three times with 
cold 0.9% NaCl. The cell pellets were resuspended in M9 medium containing 19 amino 
acids (no Leu) and 0.5 mM Hil. Protein expression was induced 15 min after the medium 
shift by the addition of IPTG to a final concentration of 1 mM. Cells were harvested by 
centrifugation (5000 × g, 4 °C, 15 min), resuspended in Qiagen buffer B (8M urea, 
100 mM NaH2PO4, 10 mM TrisCl, pH 8.0) and sonicated for 10 min total process time 
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with a pulse duration of 5 s and a wait duration of 5 s. The sonicated lysates were frozen at 
−80 °C for at least 12 h before proceeding with purification. 
 
Expression of hydrogenated proteins. Rich (2×YT) medium was used instead of 
supplemented M9 medium. When the culture reached OD600 = 0.9–1.0, IPTG was added to 
a final concentration of 1 mM. After 3 h, the cells were harvested by centrifugation (6000 × 
g, 4 °C, 10 min), and the cells were stored at −20 °C at least 12 h before purification. In the 
case of S31L-L, one sample was expressed using the cell strain LAM1000 containing 
pREP4 and pS31LEL and harvested using the procedure used for the production of proteins 
containing Hil. 
 
Protein purification. N-terminally histidine-tagged A1 variants were purified under 
denaturing conditions by affinity chromatography using Ni-NTA resin (Qiagen, 
Chatsworth, CA) according to the manufacturer’s instructions. For proteins containing Hil 
and for one batch each of S31L-L and S31L-T, the lysates in Qiagen buffer B were thawed, 
sonicated, and then clarified using centrifugation (~75,000 × g, 25 °C, 10 min). Imidazole 
was added to Qiagen buffer C (50 mM) and Qiagen buffer E (250 mM) in order to improve 
purification efficiency. The purified protein solutions were dialyzed against 10 mM sodium 
acetate (pH 4)⁄100 mM NaCl, and were concentrated by ultrafiltration (Amicon Ultra-15 
devices, mwco: 10,000 or 3000, Millipore, Billerica, MA). The protein concentration was 
determined as measured by the absorbance at 280 nanometers of solutions, assuming 
extinction coefficients of 5500 M−1 cm−1 (61). 
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Amino acid analysis and sedimentation velocity analysis. Amino acid analysis of 
fluorinated proteins was performed at the W. M. Keck Facility at Yale University (New 
Haven, CT) on a Hitachi L-8900 amino acid analyzer (San Jose, CA) after hydrolysis at 
115 °C in 70% formic acid. Sedimentation velocity analysis was performed at the National 
Analytical Ultracentrifugation Facility at the University of Connecticut (Storrs, CT) by 
using a Beckman XL-I Analytical Ultracentrifuge at 20 °C. The rotor was accelerated to 
55,000 rpm, and interference scans were acquired at 1 min intervals for 7 h. The data were 
analyzed by using the program Sedfit (62) to obtain normalized c(s) versus sedimentation 
coefficient plots (figure 3.3). 
 
Mass spectrometry. Liquid chromatography tandem mass spectrometry (LC/MS/MS) of 
proteins containing Hil or Tfl was performed at the Caltech Protein and Peptide Mass 
Analytical Laboratory. Trypsinized samples were subjected to liquid chromatography on an 
Eksigent (Dublin, CA) NanoLC-2D using a 6 cm long, 100 µm diameter C18 column, 
followed by MS/MS on an Applied Biosystems (Foster City, CA) QStar XL instrument. 
Data were analyzed using Analyst QS software provided by Applied Biosystems. Hil or Tfl 
incorporation levels were estimated using information contained within extracting ion 
currents (XIC) of trypsin-digested protein samples. For a given sample, a peak 
corresponding to a peptide globally substituted with the noncanonical amino acid and 
coding for multiple leucines was identified, and the related peak corresponding to 
replacement at a fraction of the leucine positions was also identified. Determination of the 
ratio of the partially substituted to globally substituted peak areas allowed for the 
estimation of amino acid incorporation levels assuming that leucines in the fragment were 
 173 
replaced statistically. An example calculation is shown in the subsection “LC/MS/MS 
amino acid incorporation estimates,” which can be found below. 
 
Time-correlated single-photon counting (TCSPC). The protein samples were prepared at 
55 µM concentration in 10 mM acetate (pH 4)⁄100 mM NaCl solution. The TCSPC 
measurements were performed by using femtosecond pulses (<100 fs) from a Ti-sapphire 
oscillator (Spectra-Physics, Mai Tai HP). Laser output, of which the repetition rate was 
attenuated from 80 to 8 MHz utilizing a pulse picker (Spectra-Physics, Model 3980-5), was 
tuned to 885 nanometers and frequency-tripled to 295 nanometers using a time-plate tripler 
(Minioptic Technology, TP-2000B) for selective excitation of Trp. The UV beam, 
vertically polarized using a half waveplate, was introduced to a sample chamber and 
focused onto the sample cell. The residual frequency-doubled beam from the tripler was 
directed to a photodiode to trigger a TCSPC system (PicoQuant GmbH, FluoTime 200). 
Typically, the energy of the excitation pulse (attenuated) at the sample was ~10 picojoules. 
In a right-angle geometry, the emitted fluorescence was collected at a magic angle (54.7°) 
with respect to the vertically polarized excitation beam and focused into a MCP-PMT 
(Hamamatsu, R3809U), which is attached to a double monochromator. The photomultiplier 
tube signal was routed to a time-to-amplitude converter as a start signal followed by a 
constant fractional discriminator (PicoQuant GmbH, SPC 630). To avoid possible 
photobleaching and photodegradation, samples were kept stirring using a micro magnetic 
stirrer. In this configuration, the instrument response has a full width at half maximum of 
~30 ps. Multiexponential decays convoluted with instrumental response functions were 
analyzed using the FluoFit software package (PicoQuant).  
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Femtosecond fluorescence upconversion. The protein samples were prepared at 550 µM 
concentration in 10 mM acetate (pH 4)⁄100 mM NaCl solution. An amplified Ti-sapphire 
laser system (Spectra-Physics, Hurricane X) was used, which produces ~110 fs pulses 
centered at 805 nanometers (fundamental), with a 1 kHz repetition rate and a 0.8 millijoule 
energy. The output beam was split into equal parts to generate the pump and the gate pulse 
trains. For the pump, the fundamental light was used to pump an optical parametric 
amplifier (Spectra-Physics, OPA-800C), the infrared idler output of which was sum-
frequency mixed with the residual fundamental in a 0.5 mm thick β-barium borate (BBO) 
crystal (type I), recompressed with a prism pair, and frequency-doubled to provide the 295-
nanometers pulses in a 1.0 mm thick BBO crystal. The pump pulses were focused, with a 
24 cm focal length lens, on the rotating circular cell (1 mm thickness) containing the 
sample. Typically, the energy of the pump pulse (attenuated) at the sample was ~200 nJ. At 
these energies, the fluorescence signals from samples were linearly dependent on the pump 
energy. To check for sample degradation during experiments, fluorescence spectra were 
periodically measured right after the rotating cell by using a fiber-optic-coupled 
spectrometer (Acton Research, SpectraPro-300i) coupled to a charge-coupled device 
(Princeton Instruments, SpectruMM-256HB) before and after the collection of averaged 
transients for each sample. No difference between the spectra was observed.  
 The forward-scattered fluorescence from excited samples was collected and 
focused by two off-axis parabolic mirrors into a 0.5 mm thick BBO crystal. Cutoff filters 
were placed between the mirrors to reject scattered laser light and pass the desired 
fluorescence wavelengths. The gate pulses, attenuated to 23 µJ⁄pulse, passed through a 
computer-controlled optical delay line and were noncollinearly overlapped with the 
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fluorescence in the BBO crystal. After the crystal, the upconverted signal was separated 
from the gate beam and the fluorescence by using an iris, and was focused on the entrance 
slit of a 0.25 m double-grating monochromator (Jobin Yvon, DH10) equipped with a 
photomultiplier tube at the exit slit. Upconversion efficiency was maximized by angle-
tuning of the BBO crystal. The upconverted fluorescence transients were taken at the magic 
angle (54.7°) of the pump polarization relative to the gate polarization, parallel to the 
acceptance axis of the upconversion crystal, in order to eliminate the influence of induced 
sample anisotropy on the signal. The photomultiplier output was amplified (Stanford 
Research Systems (SRS), SR445) and processed by a gated integrator (SRS, SR250). The 
temporal response of the instrument was typically 350–450 fs. The observed fluorescence 
transients were fit to theoretical functions, using a Scientist nonlinear least-squares fitting 
program (Micromath), for the convolution of the Gaussian instrument response function 
with a sum of exponentials. All experiments were carried out at an ambient temperature of 
~24 °C, and all fluorescence transients were obtained by the excitation of samples at 
295 nanometers. 
 For fluorescence anisotropy measurements, the pump-beam polarization was 
rotated either parallel or perpendicular to the acceptance axis of the upconversion crystal to 
collect the parallel (I||) and perpendicular (I⊥) signals, respectively. These transients were 
used to construct time-resolved anisotropy: r(t) = (I|| – I⊥)/(I|| + 2I⊥). The results of the time-
resolved anisotropy are shown in figure 3.5. The ultrafast depolarization time constant, φI, 
attributed to fast internal conversion between the first two excited singlet states (1La and 
1Lb) of Trp, varies dramatically with the time resolution. This process has a timescale of 
~100 fs (63, 64). The limited resolution of our current apparatus (350–450 fs) does not 
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allow us to fully resolve these dynamics and gives rise to a large uncertainty in the value of 
φI. The variability of φI will impact the fit of φTrp. The uncertainty in the amplitude of the 
anisotropy, rTrp and r∞, is not however affected by the limited time resolution of our data. 
Therefore we use the wobbling cone angle to reveal details about the local crowding near 
Trp. The wobbling cone angle is given by 1 – rTrp /(rTrp + r∞) = [(3cos2q – 1)/2]2 (37), and 
only depends upon the amplitude of the tryptophan wobbling motion and the anisotropy 
due to the rotation of the molecule. 
 
LC/MS/MS amino acid incorporation estimates. LC/MS/MS was used to estimate the 
replacement levels of leucine in some protein samples. Figure 3.8 depicts the total ion 
currents (TIC, figure 3.8A) and three extracted ion currents (XICs, figure 3.8B–D) from a 
digested A1m-H sample. The large peak in figure 3.8B corresponds to a peptide in which 
all of the Leu residues are replaced by Hil, the smaller peak in figure 3.8C corresponds to a 
mixture of two peptides containing one Leu and one Hil residue, and the very small peak in 
figure 3.8D corresponds to a peptide containing only Leu residues. The areas in the three 
XICs allow determination of the extent of incorporation of noncanonical amino acids in 
place of leucine. Assuming that there is a probability p of homoisoleucine substitution in 
place of leucine, the distribution of peak areas should correspond to the binomial 
distribution, 
 
€ 
A (1− p)2 + 2(1− p)p + p2[ ],  (3.1) 
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where A is a multiplication factor equal to the total area of the three peaks and the three 
terms of the polynomial correspond to nonsubstituted, singly substituted, and doubly 
substituted peptides, respectively (the term for singly substituted peaks takes into account 
both positional isomers of singly substituted peptides). Because these three terms represent 
the only combinations of substitutions possible in the peptide, the relationship 
 
  (3.2) 
 
also holds. The ratio between two peaks in a peptide series depends only on the probability 
of incorporation and not on the value of A. Therefore, the ratio of two peaks from 
experimental data can be used in order to get an estimate of p. The ratio of the peak areas of 
singly substituted to doubly substituted peptides is  
 
.  (3.3) 
 
Rearranging the above expression, 
 
,  (3.4) 
 
where X is the experimentally observable ratio of singly substituted to doubly substituted 
peptides. Solving for p gives  
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,  (3.5) 
or 
,  (3.6) 
 
with the root of interest being the nonzero root. Substituting for the ratio of peak areas 
gives an estimate of the incorporation level p. 
 In some cases, peaks corresponding to peptides containing three leucine or leucine 
analogs were observed and used to quantify incorporation levels. In these cases, the peak 
area distribution is represented by 
 
,  (3.7) 
 
with 
 
.  (3.8). 
 
Defining the ratio of doubly substituted to triply substituted peak area as X, substituting X 
into equation (3.8), and solving for p yields the nonzero root 
 
,  (3.9) 
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again enabling an estimation of the incorporation level of noncanonical amino acids in 
place of leucine. In some cases, the tandem mass spectrometry did not enable positive 
identification of all possible positional isomers of a peptide. For example, in some cases, 
only two out of three of the possible doubly substituted positional isomers containing three 
possible substitution locations were identified in the tandem mass spectrometry data. In 
these cases, X was multiplied by an appropriate factor to account for peptides that were not 
observed (again invoking the assumption of completely random incorporation). Using the 
above example, when only two out of three doubly substituted peptides could be identified, 
X was multiplied by a factor of 1.5 in order to estimate what the peak area ratio would have 
been with all three peaks present in equal weights. Using this methodology, the 
homoisoleucine-containing proteins used were found to have 90% or greater Hil in place of 
Leu, and the sample of S31L-T that was analyzed in this fashion contained approximately 
99% Tfl in place of Leu. These results were obtained by examining three separate series of 
peptides from each protein sample. These peptides had the following sequences: 
AEIGDLNNTSGIR, GSHHHHHHGSMASGDLENEVAQLER, and SLEWEAAELEQK 
(A1m), LLEWEAAELEQK (S31L), or SLEWEALELEQK (A37L). 
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H2N COOH H2N COOHH2N COOH
CF3
1 2 3  
Scheme 3.1. Amino acids used in study. 1, 5,5,5-trifluoroleucine (Tfl). 2, leucine (Leu). 3, 
(4S)-2-amino-4-methylhexanoic acid (homoisoleucine, Hil). 
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Figure 3.1. Protein sequence and structure. A) Helical wheel diagram and B) amino acid 
sequence of the A1 protein. The Asp residue at the f position of the third heptad (position 
34) was replaced by Trp to yield a variant of A1 designated Alm. A Leu codon was 
introduced at the c position of the third heptad (position 31, dark blue) or at the b position 
of the fourth heptad (position 37, dark blue) to yield S31L and A37L, respectively. Side 
views of C) A1m, D) S31L, and E) A37L. 
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Figure 3.2. Circular dichroism. Wavelength scans of A1m and variant proteins at 25 ºC. 
The protein samples were prepared at 20 µM concentration in 10 mM acetate (pH 4)/100 
mM NaCl solutions. 
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Figure 3.3. Normalized plots from the Sedfit c(s) analysis for A) A1m-L, B) S31L-L, 
C) A37L-L, D) A1m-T, E) S31L-T, F) A37L-T, G) A1m-H, H) S31L-H, and I) A37L-H. 
The protein samples were prepared at 550 µM concentration in 10 mM acetate 
(pH 4)⁄100 mM NaCl solution. The broad, single peak of the A37L-L trace may be the 
result of an equilibrium mixture between trimeric and higher-order species. It seems likely 
that the breadth of the traces derived from sedimentation velocity analysis of A1m-T, 
S31L-T, and A37L-T is a consequence of incomplete replacement of Leu with Tfl. 
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Figure 3.4. Steady-state UV-visible absorption (red) and fluorescence emission spectra 
(black) of proteins excited at 295 nanometers. The protein samples were prepared at 
550 µM concentration in 10 mM acetate (pH 4)⁄100 mM NaCl solution. 
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Figure 3.5. Time-resolved anisotropy, r(t), of the proteins. All anisotropy decays were 
fitted to r(t) = rI exp(–t/fI) + rTrp exp(–t/fTrp) + r∞, where rI is the initial ultrafast anisotropy, 
rTrp is the Trp motion-related anisotropy (value given in parentheses in each panel), r∞ is 
the offset anisotropy, fI is the initial ultrafast internal-conversion time constant of Trp (≤1 
ps), and fTrp is the Trp-rotational correlation time constant. 
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Figure 3.6. Hydration dynamics. Experimental determination of local hydration dynamics 
at the surface of A1m-T, excited at 295 nm. A) Representative femtosecond-resolved 
fluorescence up-conversion transients. B) Normalized time-resolved fluorescence spectra at 
different time delays. The steady-state emission spectrum is also depicted (dotted line). C) 
Time-dependent spectral shift of the apparent emission maxima (νs) and the lifetime-
associated (population) emission maxima (νl). Inset: entire evolution of νs and νl. 
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Figure 3.7. Hydration energy relaxation. Comparison of the hydration-correlated energy 
relaxation, ΔEs(t), probed by Trp emission. Top panel: The solvation-energy relaxation data 
for A1m proteins. Data for free Trp in the same buffer is also depicted for comparison. 
Middle panel: Solvation energy relaxation data for S31L analogs. Bottom panel: solvation 
energy relaxation data for A37L analogs. Insets: enlargement of the early-time hydration 
behavior. 
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Figure 3.8. LC/MS/MS of trypsinized A1m-H. A) TIC of digested protein sample. B)–D) 
XICs of peptides containing B) two, C) one, or D) no leucine to homoisoleucine 
substitutions in the peptide SLEWEAAELEQK. The ratios of the peak areas obtained in 
the XICs can be used to estimate the extent of leucine replacement in the protein sample. 
Peptide masses: SXEWEAAEXEQK: 2+ ion: 730.86 Da observed, 730.87 Da expected. 
SLEWEAAEXEQK, SXEWEAAEXEQK: 2+ ion: 723.88 Da observed, 723.86 Da 
expected. SLEWEAAELEQK 2+ ion: 716.87 Da observed, 716.85 expected. 
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Table 3.1. Fluorescence emission maxima (λmax), hydration-correlated energy 
relaxation [ΔEs(t)], and depolarization dynamics [r(t)] 
ΔEs(t)* r(t) † 
Sample λmax, nm 
τ1, ps τ2, ps τ3, ps E1, cm−1 E2, cm−1 E3, cm−1 rTrp θ, ° 
Trp 353 0.30 1.5 13 883 682 18 0.196  
A1m-L 352 0.30 2.1 31 610 646 171 0.056 21 
A1m-T 352 0.28 2.5 31 877 568 161 0.049 20 
A1m-H 352  1.9 34 0 2138 500 0.058 33 
S31L-L 349 0.53 3.6 40 580 450 194 0.030 18 
S31L-T 349 0.79 3.0 48 607 375 333 0.044 19 
S31L-H 349 0.21 1.4 10 308 492 344 0.023 18 
A37L-L 352 0.31 1.7 13 685 522 157 0.055 20 
A37L-T 350 0.56 6.1 61 685 324 108 0.030 17 
A37L-H 349 0.34 2.2 21 443 625 128 0.034 17 
* All hydration-correlated energy relaxation dynamics were fitted to ΔEs(t) = E1exp(−t/τ1) 
+ E2exp(−t/τ2) + E3exp(−t/τ3). 
† Refer to materials and methods for anisotropy analysis detail. 
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Abstract  
 Noncanonical amino acids (ncAAs) can be used to modulate the physical and 
chemical properties of proteins. In this work, we examine how ncAAs can be used to 
engineer the binding properties and chemical reactivity of a model anti-digoxin antibody 
fragment in its single chain variable fragment (scFv) form. Experiments with scFvs 
displayed on the surface of Escherichia coli cells revealed that replacement of the 
methionine (Met) residues of the scFv with an analog containing an alkyne side chain 
reduced the fluorescence levels of cells treated with a fluorescently labeled antigen to 
background levels, indicating loss of binding function. Replacement of Met with analogs 
containing aliphatic and azide side chains left the fluorescence of cells unchanged and 
reduced by a factor of 0.6, respectively. Fluorescence-activated cell sorting of libraries of 
cell surface-displayed scFvs enabled the isolation of clones functional in multiple amino 
acid contexts. Cells displaying variants containing alkyne, azide, and aliphatic analogs and 
treated with fluorescently labeled antigen were more fluorescent than cells displaying the 
Met form of the parent scFv by factors of roughly 1.7, 3.5, and 1.3, respectively. 
Furthermore, the amino acid context used during high-throughput screening experiments 
appears to affect the frequencies of mutations occurring at various positions within the scFv 
construct. High-throughput sequencing revealed that populations isolated in different 
amino acid contexts exhibit mutational rates differing by greater than twenty percent at 
some residues in the protein.  
 Characterization of soluble scFvs indicated that each ncAA used in this study 
modulates the binding kinetics of scFvs in a distinct fashion. Perhaps most interestingly, 
scFvs containing the azide-containing analog azidohomoalanine (Aha) exhibit improved 
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binding kinetics relative to their methionine-containing counterparts. Replacement of Met 
by Aha in several variants lowers the dissociation constant of the fragment by up to a factor 
of two. Chemical conjugation of azide-containing scFvs to fluorescent dyes and biotin 
proved facile with strain-promoted cycloaddition reactions. Quantifications of the extent of 
reaction using fluorescent dyes revealed that approximately 0.4 dyes had been conjugated 
per protein, and the resulting conjugates were found to retain their binding function in 
kinetic and Western blotting assays. Experiments in which Aha-containing fragments were 
displayed on the surface of Escherichia coli cells and subjected to strain-promoted 
cycloadditions demonstrated that the extent of chemical modification and antigen binding 
can be monitored simultaneously and used to isolate cells displaying functional, modified 
proteins. These experiments demonstrate how ncAAs can be used to modulate multiple 
properties of antibody fragments and illustrate the feasibility of developing and screening 
libraries of chemically modified proteins. Evolved, functional bioconjugates may be 
applicable to a variety of outstanding diagnostic and therapeutic problems. 
 
Introduction  
 The vastness of protein sequence space provides scientists with ample possibilities 
for mutating and engineering proteins in order to improve their existing functions or 
properties and to impart them with nonnatural characteristics (1-3). Biosynthetic 
incorporation of noncanonical amino acids (ncAAs) into proteins is a powerful approach to 
augmenting or altering the functions of full-length proteins (4-7). Residue-specific 
incorporation of ncAAs into proteins by the global replacement of one or more of the 
twenty canonical amino acids can facilitate large changes in protein properties, either by 
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introducing new chemical functionalities into proteins or by employing subtle side chain 
structures that change the stability, aggregation, or solvation characteristics of proteins (8-
12). Site-specific incorporation approaches also afford opportunities for changing local 
protein properties by making atomic-level changes to amino acid side chains or polypeptide 
backbones (6, 7, 13, 14). However, property changes that result from ncAA incorporation 
are not always readily predictable, and can lead to insignificant or even deleterious changes 
to proteins of interest. 
 The techniques of directed evolution provide a powerful set of tools for engineering 
proteins with more desirable properties. Our laboratory and others have demonstrated that 
directed evolution can be combined with ncAAs to enable the creation of ncAA-containing 
proteins with user-defined characteristics. Using high-throughput screening approaches, 
our laboratory has previously evolved fluorinated proteins to have biophysical properties 
comparable to the properties of conventional proteins. These efforts resulted in the isolation 
of a thermostable fluorinated enzyme and a fluorinated green fluorescent protein with 
folding kinetics comparable to the parent protein (15, 16). The Schultz laboratory has 
combined the use of phage display and antibody fragments containing site-specifically 
incorporated ncAAs to target specific antigens. They were able to create libraries of 
antibody fragments containing the ncAAs sulfotyrosine and p-boronophenylalanine and 
successfully screen these libraries for binders against the HIV protein gp120 (17, 18) and 
the acyclic sugar glucosamine (19), respectively. The results of directed evolution 
experiments performed with libraries of ncAA-containing proteins illustrate the feasibility 
and power of using high-throughput screening techniques to explore unnatural sequence 
spaces in search of molecules with properties of interest (i.e., fluorinated, functional 
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molecules or high-affinity binders against a particular target). The ability to tailor the 
properties of molecules containing ncAAs via directed evolution may be particularly useful 
in the context of protein therapeutics, where candidate molecules must have many 
favorable properties. The chemical reactivity of protein therapeutics is especially critical, 
often simultaneously requiring selective conjugation of proteins to other molecules while 
preserving the original molecule through the reduction or elimination of all undesirable 
reactions with native side chains (20-23). Some recent studies have demonstrated how 
unique chemical handles can be introduced into proteins in the form of ncAAs and 
exploited through selective chemistries (24). However, little work has been done to 
understand how the functional properties of these proteins change after incorporation of 
ncAAs or how directed evolution can be used to manipulate these proteins. 
 In this work, we focus on changing the chemistries of antibody fragments through 
the global replacement of methionine (Met, 1, scheme 4.1) with homopropargylglycine 
(Hpg, 2), azidohomoalanine (Aha, 3), or norleucine (Nrl, 4). Substituting Hpg or Aha for 
Met introduces residues useful for performing bioorthogonal chemical reactions (scheme 
4.2) including copper-catalyzed azide-alkyne cycloaddition (CuAAC) chemistry (Hpg, 
Aha) and copper-free, strain-promoted cycloadditions (Aha) (25). While replacement of 
Met by Nrl does not introduce any new chemical functionality, it eliminates the thioether 
moiety of Met, an oxidizable group that can pose problems for long-term protein storage 
(26-28). 
 We investigate the directed evolution of antibody fragments containing ncAAs and 
the effects of ncAA incorporation on the binding and chemical properties of these 
therapeutically relevant proteins. Replacing Met with ncAAs changes the genetic code, 
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which can be thought of as changes to the amino acid context or sequence space in which a 
protein exists. We have adapted a previously reported E. coli cell surface display anchor for 
use with ncAAs and used it to engineer ncAA-containing anti-digoxin single chain variable 
fragments (scFvs). This platform enabled us to perform screens of antibody fragment 
libraries using fluorescence-activated cell sorting (FACS) in a number of amino acid 
contexts and study how different ncAA side chains distinctly affect the course of directed 
evolution experiments. Production and characterization of several soluble scFv variants 
containing the different Met analogs highlighted the effects of each analog on antigen 
binding kinetics. Furthermore, examination of the chemical reactivities of scFvs showed 
that azide-containing fragments can be used to create functional conjugates via strain-
promoted click chemistry. Finally, we demonstrate the feasibility of using E. coli cell 
surface display for screening libraries of proteins for functional, chemically modified 
protein variants via flow cytometry. Our findings illustrate how ncAAs can be used to 
manipulate the antigen binding and chemical reactivity of antibody fragments 
simultaneously and suggest new methods for developing functional bioconjugates. 
 
Results and Discussion 
Cell surface display and flow cytometry. The Lpp-OmpA’ E. coli cell surface display 
system was adapted to be compatible with engineering antibody fragments containing 
ncAAs. This system has previously been used to screen libraries of anti-digoxin single 
chain variable fragments (scFvs) using flow cytometry (29-31). We placed the display 
construct under the control of the isopropyl-β-D-1-thiogalactopyranoside (IPTG)-inducible 
T5 promoter in order to avoid potential incompatibilities with residue-specific ncAA 
 203 
incorporation techniques (31). Tight repression was maintained by cotransforming cells 
with two plasmids containing constitutively expressed lacI: derivatives of pQE-80L 
containing display constructs and the repressor plasmid pREP4. 
 Flow cytometry experiments were used to investigate the function of the scFv form 
of a variant of the high affinity murine 26-10 anti-digoxin antibody (32) in multiple amino 
acid contexts. Display of functional copies of the scFv (referred to here as the base 
construct or Base) on E. coli cells after IPTG induction was confirmed by probing induced 
cells with BODIPY FL digoxigenin 5 and measuring fluorescence levels on a flow 
cytometer (figure 4.1A) (33, 34). In contrast, replacement of Met by Hpg resulted in cells 
with near-background levels of fluorescence (figure 4.1B), suggesting that the substitution 
of the alkyne amino acid for Met greatly reduced or eliminated the binding function of the 
displayed scFv. This apparent loss of binding activity served as a starting point for 
investigating whether anti-digoxin scFv variants that function in the Hpg context could be 
identified using directed evolution. 
 
Screening for Hpg-tolerant scFv variants. We used flow cytometry to investigate 
whether Hpg-tolerant variants of Base could be isolated from a library of scFvs. Error-
prone PCR was employed to introduce mutations throughout the majority of the Lpp-
OmpA’-scFv gene (excluding only the N-terminal Lpp portion and C-terminal histidine tag 
of the gene), and the resulting genetic mutants were used to construct a library (Lib1_1a) 
consisting of approximately 5.3 × 105 transformants. Introducing mutations throughout the 
construct allowed us to simultaneously explore the possibilities that either i) display of the 
scFv is impaired by replacing Met with Hpg in the display anchor, or ii) the binding 
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function of the scFv is impaired upon substitution of Met by Hpg. The display anchor 
contains four Met residues (including the initiator Met), and Base codes for four additional 
Met residues. Although few functional binders appeared to be present in the naïve library 
when Met was replaced by Hpg (figure 4.2), screening the library under expression 
conditions in which 20 µM Met was added to the Hpg expression medium (16) enabled 
isolation of a population of mutants tolerant of at least some level of Hpg substitution. Two 
more rounds of sorting for cells able to bind to 5, in which the population to be screened 
was expressed under conditions of near-complete replacement of Met by Hpg, resulted in 
the isolation of a population of cells able to bind to substantial amounts of labeled antigen 
in the Hpg context (figure 4.2). 
 Individual clones were isolated, tested for their ability to bind antigen in the Hpg 
context when displayed on cells using flow cytometry, and sequenced. All ten clones 
randomly selected from the population were functional when Met was replaced with Hpg, 
and every clone contained at least one mutation in the scFv portion of the protein (table 
4.1). The majority of observed mutations involve either the elimination or addition of a Met 
codon within the scFv, and the mutation of the Met at position 80 of the scFv heavy chain 
(H80, Kabat numbering) to leucine appears in every fragment sequenced. Another striking 
result is the frequent isolation of clones containing the same set of three mutations 
involving Met (M(H20)I, M(H80)L, and L(H82C)M); these five clones were found to be 
identical at the genetic level and will be referred to as Mut2. While the majority of 
sequenced clones contained at least one amino acid mutation in the display anchor portion 
of the construct, all isolated clones bound to comparable amounts of digoxigenin probe 
regardless of whether the mutants contained amino acid mutations in their display anchors. 
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A complete list of every amino acid mutation observed in sequenced clones can be found in 
table 4.2. 
 After three rounds of sorting, the isolated population (referred to here as Lib1_1a 
Hpg3x; see (35) for additional nomenclature) retained binding function in the Met context 
while gaining the ability to bind to antigen in a new amino acid context. These results 
suggested that perhaps isolated clones would retain their binding activity after replacement 
of Met with other ncAAs in addition to Hpg. In order to examine this possibility, we 
studied Mut2’s ability to bind to digoxigenin after replacement of Met with Hpg, Aha, and 
Nrl. Flow cytometry revealed that cells displaying Mut2 consistently exhibit higher levels 
of fluorescence than Base in all of the amino acid contexts investigated (figure 4.1), 
confirming the improved function of this clone in ncAA contexts, particularly in the Hpg 
and Aha contexts. Because Mut2 was isolated in the Hpg context in screens aiming only to 
maximize the fluorescence of cells displaying scFvs, we suspected that further 
improvement of the kinetic properties of clones in multiple amino acid contexts might be 
possible with the generation and screening of an additional library of scFv variants. 
 
Screening in multiple ncAA contexts for variants with improved binding function. 
Lib1_1a Hpg3x was amplified using additional error-prone PCR and then used to construct 
a library consisting of 5.6 million transformants, Lib2 (see materials and methods). Lib2 
was subjected to screening after replacement of Met with Hpg, Aha, or Nrl. The use of 
multiple ncAAs during screening allowed us to investigate how different analogs affect 
scFv properties, and whether these effects would be large enough to result in context-
dependent mutations. Four rounds of FACS were performed under increasingly stringent 
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conditions (table 4.3) after library expression in each amino acid context, including the use 
of a kinetic competition procedure in the last two rounds of screening (29) in an attempt to 
isolate clones with the most favorable kinetic properties. After one round of sorting, the 
majority of clones in the sorted populations exhibited high levels of fluorescence, and the 
mean fluorescence of the sorted populations remained high after each round of sorting 
(figure 4.3). Individual clones were picked randomly after three (Hpg and Aha contexts) 
and four (Hpg, Aha, and Nrl contexts) rounds of enrichment, sequenced, and assessed for 
digoxigenin binding function using a method to estimate dissociation constants with cells 
displaying scFvs (29). The majority of clones isolated appeared to have on-cell dissociation 
rates comparable to or lower than that of Mut2 in the same amino acid context (table 4.4), 
and these clones exhibit numerous mutations that add or eliminate Met (ncAA) residues, 
convert small, aliphatic residues to aromatic residues, or convert aromatic residues to small, 
aliphatic residues (table 4.5). Although the mutations observed were similar regardless of 
the amino acid context used during screening, the frequencies with which these mutations 
occurred appeared to be context dependent. 
 
High-throughput sequencing of sorted populations. Differences in the sequences of 
isolated clones prompted us to more fully investigate whole populations of sorted clones. 
We used high-throughput sequencing to characterize samples of Lib1_1a Hpg3x, Lib2 
Hpg4x, Lib2 Aha4x, and Lib2 Nrl4x. Alignment of the sequencing output from each 
sample using the DNA sequence of Base as a reference enabled the calculation of 
frequencies of mutation at each position of the gene. Many positions within the populations 
were mutated at a frequency greater than five percent in at least one sample (table 4.6), and 
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a number of these nucleotide changes result in amino acid mutations within the scFv 
portion of the display construct such as Met additions and eliminations and conversions 
between small aliphatic and large aromatic residues (figure 4.4 and table 4.6). 
 Certain positions within the fragment appear to show ncAA context-dependent 
mutational frequencies in the sorted Lib2 populations (figure 4.4). For example, the 
observed frequencies of M(H20)I, M(H80)L, and L(H82C)M mutations increase from 
Lib1_1a Hpg Sort 3 to the Lib2 Hpg4x and Lib2 Aha4x populations, while these mutations 
are found to have similar or decreased frequencies in the Lib2 Nrl4x population. Mutations 
at position H24, which do not involve the Met codon, are found in over half of the reads 
covering this position in Lib2 Aha4x and Lib2 Nrl4x, while they occur at a much lower rate 
of twenty to thirty percent in Lib2 Hpg4x. We should note that the FACS procedure of 
isolating bright cells from a population does not ensure that all cells displaying scFvs with 
favorable binding properties will be isolated during the course of screening, nor does it 
ensure that bright cells will be isolated with a frequency proportional to their function. 
However, within our ability to limit these factors by oversampling populations to be sorted 
by at least tenfold, we observe amino acid–dependent changes in mutational frequencies. 
These results suggest that the mutations observed here affect scFv function in an amino 
acid context dependent fashion. 
 
Frequent amino acid mutations. Investigation of previously reported crystal structures of 
the Fab form of the 26-10 anti-digoxin antibody (32) revealed that most of the mutations 
identified in this work are located in regions far from the binding pocket of the protein 
(figure 4.4B). These results are consistent with the high affinity of the parent fragment for 
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digoxin and the surface complementarity observed between the binding pocket and the 
steroid portion of the antigen (32). Some of the mutations observed in this study are 
striking because of the frequent addition or elimination of Met (ncAA) residues within the 
scFv. Mutations M(H20)I and M(H80)L have been observed in previous engineering 
experiments with the 26-10 scFv (in the Met context only) (29), albeit only in one out of 
several sequence variants reported. Examinations of VH protein sequences from mouse 
germlines indicate the frequent presence of Met, Leu, and Ile at position H20, and 
predominantly Met and Leu residues at position H80 (36, 37). Perhaps mutations to convert 
Met to other commonly occurring residues at these framework positions become more 
favorable in ncAA contexts due to differences in Met and ncAA side chain properties. In 
particular, the differences between Met and Hpg side chains are quite striking because the 
Hpg side chain has one less rotatable bond than Met, Aha, and Nrl due to the presence of 
the terminal alkyne. The restriction of side chain conformation experienced upon 
replacement of Met by Hpg may partially explain why the clone Mut2 was isolated so 
frequently from Lib1_1a. The Hpg side chain has far fewer possible conformations than the 
Met side chain and may prevent adequate packing of the hydrophobic core upon 
substitution at positions H20 and H80. The mutation of Leu to Met (Hpg) at position H82C 
is more surprising given the structural differences between the side chains of Leu and Hpg 
and the lack of murine germline sequences possessing this mutation (36, 37). Perhaps the 
unique side chain character of Hpg or the position of this residue within a complementarity 
determining region (CDR) makes its insertion at position H82C more favorable or 
tolerable. However, we cannot rule out the possibility that this mutation is not 
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advantageous given its frequent occurrence in parallel with Met elimination mutations that 
appear to be much more beneficial to the scFv. 
 Mutations at positions H20, H80, and H82C seem to be accommodated quite well 
in the Aha and Nrl contexts. However, their slight deenrichment in the Nrl4x population 
suggests that these mutations may not be as favorable with the aliphatic side chain 
compared to their occurrence with other amino acid side chains. The infrequent 
eliminations of Met observed in sorted populations at positions H34 and H100B show that 
not all Met positions within the scFv are intolerant of ncAA side chains. In fact, 
Met(H100B) directly contacts the antigen in the crystal structure of the Fab-digoxin 
complex (32), suggesting that the substituted ncAAs also directly contact the antigen upon 
incorporation. This direct contact with the antigen may be responsible for some of the 
changes in binding behavior observed in soluble scFvs (see below). Mutations at positions 
H24, H27, H29, and H30 are within a region known as the upper core of the scFv (38) that 
is disordered within the uncomplexed 26-10 Fab crystal structure (32). Mutations in this 
region have previously been observed to occur frequently in evolution experiments with the 
26-10 scFv (29). Given the importance of residues within this region for packing the upper 
core, ensuring a stable scFv framework, and ensuring proper orientation of the framework 
relative to complementarity determining regions (CDRs) (38), it seems plausible that the 
mutations observed here have beneficial effects on scFv stability or folding. Destabilization 
or poor protein folding oftentimes accompany ncAA substitutions (15, 16, 39) and may 
make mutations within the upper core very favorable in the amino acid contexts 
investigated here. 
 
 210 
Kinetic characterization of scFvs produced in soluble form. We further studied the 
functional characteristics of scFvs containing ncAAs by expressing and purifying a number 
of mutants in soluble form (figure 4.5, table 4.7). Mutants for further characterization were 
chosen based on their on-cell dissociation kinetics (table 4.4): we selected the two to three 
mutants with the best koff values measured on-cell and one mutant exhibiting kinetics within 
the central range of koff values observed on-cell. Expression and purification resulted in the 
production of approximately 0.5–5 mg/L pure, monomeric protein for all scFvs produced 
(table 4.8). Each scFv variant isolated from Lib2 was produced in the ncAA context in 
which it was isolated and in its Met form, and Mut2 was produced in all four amino acid 
contexts of interest. Base was also expressed in all four amino acid contexts, but could only 
be purified in Met and Nrl forms. The extent of replacement of Met by ncAAs was 
estimated by MALDI mass spectrometry on trypsinized fragments of scFvs and found to be 
approximately 80%–90% in all samples analyzed (see materials and methods, figure 4.6, 
and table 4.8). 
 Systematic characterization of the kinetic properties of soluble scFvs using surface 
plasmon resonance revealed that the isolated fragments possess a modest range of kinetic 
characteristics that are influenced by amino acid context and amino acid mutations (table 
4.8, table 4.9). These differences manifest themselves almost entirely in the dissociation 
constants of the fragments. The sensitivity of the kinetics to replacement of Met is evident 
in the dissociation constant of Mut2. Incorporation of Hpg in Mut2 increases the 
dissociation rate constant by a factor of four, substitution of Aha lowers (improves) the 
dissociation constant by a factor of two, and incorporation of Nrl leaves the dissociation 
constant essentially unchanged. Interestingly, the dissociation constant of Mut2 in the Met 
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context is the same as that of Base, confirming that screening for scFv mutants functional 
in the Hpg context led to the isolation of clones retaining function in the methionine 
context while adapting to this new amino acid. Variants isolated from Lib2 were found to 
exhibit improved kinetics, with the koff values of the best variants isolated in Hpg and Nrl 
contexts reduced by twofold. Interestingly, the dissociation rate constants of these clones 
were also improved in the Met context compared to Mut2 and Base (also by twofold), 
suggesting that the mutations introduced into these clones are beneficial in multiple amino 
acid contexts; this trend is also borne out in the kinetic properties of other scFvs 
characterized in soluble form (table 4.8). The Aha forms of clones isolated in the Aha 
context had dissociation constants comparable to the koff values of Mut2 containing Aha, 
and in the case of Aha4x4, the Met form was found to have superior kinetic properties to 
the Met forms of Mut2 and Base. The lack of observed affinity maturation in the Aha 
context may be a result of the high affinity of Mut2 and other parent proteins in Aha form. 
 These kinetic characterizations reveal general trends in the effects of substituting 
ncAAs for Met in scFvs: i) compared to Met, Hpg is somewhat detrimental to the binding 
properties of all sequence variants characterized, ii) Aha improves binding affinity 
modestly, and iii) Nrl leaves the binding properties of scFvs unchanged. In all three ncAA 
contexts, we were successful in isolating sequence variants with favorable binding 
properties, demonstrating that sequence spaces containing ncAA analogs of Met still 
include numerous functional proteins. These results also suggest that affinity maturation 
experiments in multiple amino acid contexts can result in the isolation of clones with 
improved functional properties, as demonstrated by our ability to isolate Hpg- and Nrl-
containing fragments with lowered dissociation rates. 
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Chemical modification of scFvs. We attempted to exploit the chemical reactivities of 
Hpg- and Aha-containing scFvs using copper-catalyzed and copper-free click chemistries. 
An initial assessment of the surface accessibility (40) of all potential modification sites 
indicated that many appear to be buried in the interior of the protein (Figure 4.7). In our 
hands, copper-catalyzed azide-alkyne cycloadditions (CuAAC) of ncAA-containing 
proteins with fluorescent dyes appear to be inefficient (figure 4.8, table 4.10), with CuAAC 
on scFvs proceeding in lower yields than CuAAC with control proteins containing Aha or 
Hpg. These results are in line with previous reports suggesting that surface accessibility is 
critical for such reactions (41). However, strain-promoted click modification of azide-
containing proteins with dibenzocyclooctyne-functionalized Alexa Fluor 488 (DIBO 488, 
6) (42, 43) was more successful (Figure 4.9). Quantification of the extent of modification 
with the Aha forms of Aha3x2, Aha4x4, and Aha4x5 showed that roughly 0.4 dyes had 
reacted per protein in the case of Aha3x2 and Aha4x5 (table 4.11). The lack of labeling in 
the case of Aha4x4 may be explained by the absence of a potential modification site at 
position H34; this residue has been mutated from Met to isoleucine in Aha4x4. MALDI 
characterizations of intact and trypsinized protein samples before and after click chemistry 
confirmed labeling and enabled identification of position H34 as a frequent site of 
modification (figure 4.9, figure 4.10). The high number of proteins having multiple 
modifications may result from enhanced reactivity after a single protein site is modified. 
 Multiple experiments confirmed that proteins modified with 6 retain binding 
function. Kinetic characterizations revealed no substantial changes to the kinetic properties 
of chemically modified proteins (table 4.12). Western blotting with the clicked scFvs 
verified that these conjugates can detect the presence of digoxigenin-labeled proteins 
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(figure 4.11, figure 4.12). Probing nitrocellulose membranes with the Aha form of 6-
labeled Aha4x5 enabled fluorescence detection of the BSA-Dig samples down to 
approximately 5 nanograms. Interestingly, when the presence of BSA-Dig was detected 
through the hexahistidine tag of the Aha and Met forms of Aha4x5, the Aha form enabled 
fluorescence detection down to 5 nanograms BSA-Dig, while the Met form was only able 
to detect quantities of 50 nanograms BSA-Dig or greater. The higher sensitivity of the Aha 
form is consistent with the improved kinetic properties of scFvs containing Aha in place of 
Met. 
 
Simultaneous detection of scFv function and modification. The successful modification 
of Aha-containing scFvs with 6 prompted us to investigate the feasibility of using flow 
cytometry to detect function and modification of cell surface-displayed scFvs. Cells 
displaying Aha4x5 in Met and Aha forms were subjected to click reactions with biotin 
cyclooctyne 7 (44) and probed for binding with 5 and modification with streptavidin-
phycoerythrin (SA-PE). Control experiments allowed us to establish that i) many copies of 
the displayed scFvs remain functional after click chemistry, ii) whole-cell labeling with 7 is 
selective for cells displaying Aha-containing fragments, iii) the majority of signal 
associated with SA-PE detection of 7 is due to the display of Aha-bearing scFvs and not 
other cellular proteins, and iv) treating cells with unlabeled digoxin prior to treatment with 
5 blocks binding of the fluorescent probe to the scFvs (figure 4.13). Having shown that 
binding and modification can be simultaneously assessed on whole cells, we used a subset 
of samples to demonstrate separation of various cellular populations via FACS (figure 
4.14). Four-way sorting of a mixture of cells resulted in the isolation of populations of cells 
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binding antigen and possessing modifications, cells binding antigen without possessing 
modifications, cells possessing modifications without binding labeled antigen, and cells 
possessing neither modifications nor binding antigen. These results illustrate the feasibility 
of using FACS to screen libraries of chemically modified proteins. 
 
Conclusions 
 The combined use of ncAAs and E. coli cell surface display provides a powerful 
platform for engineering antibody fragments. Our results demonstrate that highly functional 
scFvs tolerant of ncAA side chains can be isolated from large protein libraries. These 
proteins appear to have gained functionality after ncAA incorporation while retaining their 
original functionality and can be thought of as amino acid “generalists,” in analogy to how 
enzymes tend to retain their activity toward an established substrate while evolving new 
substrate recognition capabilities (45, 46). Previous work has attributed the property of 
ncAA tolerance to robust folding properties (16, 39). In this work, the frequent mutation of 
amino acids located far away from the antigen binding pocket and within flexible regions 
of the protein chain suggests that the protein variants we have isolated may be favored for 
similar reasons. 
 We find that the binding properties of scFvs can be affected by the replacement of 
Met with ncAAs. The side chain properties of Hpg are apparently distinct enough from 
those of Met that two rounds of directed evolution were insufficient to isolate mutants that 
function equally well in Met and Hpg contexts. All of the Nrl-containing scFvs investigated 
here exhibit kinetic properties almost identical to their Met counterparts, suggesting that 
creating and evolving Nrl-containing proteins may provide an alternative route to 
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oxidation-resistant proteins for use in therapeutic settings (26-28). The functional 
consequences of replacing of Met with Aha in anti-digoxin scFvs are striking in that the 
kinetic properties of the scFvs examined here appear to be improved in their Aha forms. 
The Met residue that directly contacts the antigen in the Fab-digoxin complex, M(H100B) 
(32), is conserved in all of the sequence variants characterized in this work. This 
conservation suggests the incorporation of the azide functionality into the binding pocket 
may be responsible for the improvements in the kinetic properties we have observed. This 
view is further supported by the fact that removal of each of the commonly occurring Mets 
(ncAAs) from two other structural locations (H34, H82C), in the scFv variants Aha4x4 and 
Aha4x5 does not appear to eliminate the kinetic improvement accompanying substitution 
of Aha for Met. Employing ncAAs in library designs aimed toward heavily patterning the 
binding pockets of proteins with combinations of a few amino acids (47) may reveal that 
unnatural side chains such as that of Aha have unique molecular recognition capabilities. 
Site-specific incorporation of ncAAs into antibody fragments is known to endow these 
binding proteins with advantages in recognizing targets where specific molecular 
interactions are known to be favorable (17-19), but a more expansive exploration of 
chemical space in binding pockets may yield new classes of binding reagents or general 
insights into how molecular recognition events are mediated. 
 The chemical reactivity of scFvs containing ncAAs provides mild routes to the 
preparation of functional bioconjugates. We achieved reasonably efficient labeling of 
azide-containing scFvs with strained alkynes even in the absence of azide groups predicted 
to be surface accessible, and soluble proteins modified in this fashion retain their function. 
The cell surface display platform utilized to isolate functional sequence variants also 
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provides a means for monitoring the chemical modification state of scFvs. Our FACS data 
suggests that libraries of proteins should be able to be screened for proteins that are both 
functional and amenable to chemical conjugation. The ability to improve protein function 
and chemistry simultaneously in a high-throughput manner may provide an efficient means 
to develop protein-small molecule (20, 21) and protein-polymer conjugates (22, 23) with 
properties useful for biopharmaceutical applications. This approach may be particularly 
useful for systematically studying how the number and location of modification sites within 
a protein impact protein function. Genetically encoding and screening libraries of 
chemically modified proteins may also be applicable to areas including the chemical 
construction of bi- or multivalent protein structures (48), switchable sensors (49, 50), or 
cyclized peptides (51, 52). 
 
Materials and Methods  
Materials.  The plasmids pB18D and pB30D, which encode for the cell surface-displayed 
anti-digoxin single chain variable fragment (scFv) in pBAD18 and pBAD30 vector 
backbones, were generous gifts from Professor George Georgiou (31). The plasmid 
pAK400, which is a standard periplasmic expression vector used with scFvs, was a 
generous gift from Professor Andreas Plückthun (53). The plasmids pQE-80L and pREP4 
were obtained from Qiagen (Valencia, CA). All DNA oligomers were purchased from 
Integrated DNA technologies (IDT, Coralville, Iowa), and all restriction enzymes were 
obtained from New England Biolabs (Ipswich, MA). DNA polymerases for cloning and for 
error prone PCR (Mutazyme II) were obtained from Stratagene/Agilent (Santa Clara, CA), 
and deoxynucleoside triphosphates were obtained from either Stratagene or Roche 
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(Indianapolis, IN). The E. coli cell strains XL-1 Blue and DH10B were obtained from 
Qiagen and Invitrogen (Carlsbad, CA), respectively. The methionine auxotrophic E. coli 
strain TYJV2 was made in-house using the red recombinase gene knockout method of 
Datsenko and Wanner to eliminate the gene metE from the E. coli strain DH10B (54, 55). 
Chemical reagents were purchased from Sigma-Aldrich (Madison, WI) unless otherwise 
noted. Canonical amino acids and L-norleucine (Nrl, 4) were obtained from Sigma-Aldrich.  
L-Homopropargylglycine (Hpg, 2) was purchased from Chiralix (Nijmegen, Netherlands). 
L-Azidohomoalanine (Aha, 3) was synthesized using the method of Link et al. (56) with 
minor modifications. BODIPY FL Digoxigenin 5 used during flow cytometry experiments 
was a generous gift of Professor Patrick Daugherty (originally purchased from Invitrogen), 
and propidium iodide for viability staining was from Invitrogen. Streptavidin-
phycoerythrin (SA-PE) was purchased from EBioSciences. Isopropyl-β-D-thiogalactoside 
(IPTG) was obtained from Gold Biosciences. DIBO 488 6 and TAMRA-Alkyne were from 
Invitrogen. Synthesis of the lissamine-rhodamine azide (57) and biotin cyclooctyne 7 (44) 
have been described previously. Tris(3-hydroxypropyltriazolylmethyl)amine (THPTA) and 
3-azidopropanol were gifts from Dr. Janek Szychowski. THPTA was synthesized as 
described previously (58), and 3-azidopropanol was prepared by azide displacement of 
bromine in 3-bromopropanol. GFPrm_AM (55) in alkyne and azide forms were provided 
by Alborz Mahdavi. The amine-reactive version of digoxigenin, 
3-amino-3-deoxydigoxigenin hemisuccinamide, succinimidyl ester, was purchased from 
Invitrogen. Bovine serum albumin was from Equitech Bio. (Kerrville, TX) or Pierce 
(Rockford, IL). Columns used in protein purification and reagents used in Biacore assays 
were obtained from GE Healthcare Life Sciences (Picataway, NJ). Nickel-nitrilotriacetic 
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acid (Ni-NTA) resin was purchased from Qiagen. Dialysis membranes were from 
Spectrum Labs (Rancho Dominguez, CA). Nitrocellulose membrane was from GE 
Healthcare Life Sciences. Alexa Fluor 647-labeled anti-penta His antibodies were 
purchased from Qiagen. Sequencing grade porcine trypsin was purchased from Promega 
(Madison, WI). Desalting columns for purifying mass spectrometry samples were 
purchased from Millipore (Billerica, MA). Zeba spin desalting columns for small-scale 
buffer exchanges were from Pierce, and PD-10 desalting columns for intermediate volume 
buffer exchanges were from GE Healthcare Life Sciences. 
 
Cloning and library construction. The plasmid pQE-80L-antidig-HisGS-Base was 
constructed in several steps. An EcoRI site in pB30D was eliminated via site-directed 
mutagenesis using the primer EcoRIElimFwd (sequence given in table 4.13) and its reverse 
complement EcoRIElimRev. This resulted in the generation of plasmid pJAV2, which was 
sequence verified. The Lpp-OmpA-scFv fusion was then amplified in two steps from 
pB18D. In the first step, an internal HindIII site was eliminated by performing two PCRs. 
The 5’ fragment was amplified using primers Lpp-OmpA-antidigFwd and HindIIIElimRev, 
and the 3’ fragment was amplified using HindIIIElimFwd and Lpp-OmpA-antidigRev1. 
After gel purification, a second amplification with the 5’- and 3’-fragments and primers 
Lpp-OmpA-antidigFwd and Lpp-OmpA-antidigRev2 was undertaken. The purified PCR 
product and pJAV2 were doubly digested using XmaI and HindIII and ligated. After 
transformation of electrocompetent XL-1 Blue cells and selection on plates containing 
chlorampenicol, sequences of clones containing the correctly sized insert were verified with 
DNA sequencing at Laragen (Culver City, CA). The resulting plasmid was designated 
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pJAV2-antidig-RGSHis. This plasmid was used as a template for additional PCR 
amplification of the fusion with Lpp-OmpA-antidigFwd and LppHisRescue. Double 
digestion of pQE-80L and the resulting PCR product, purification, and ligation resulted in 
the construction of the sequence-verified plasmid pQE-80L-antidig-HisGS. Introduction of 
restriction sites into the Lpp-OmpA-scFv fusion gene at locations suitable for library 
construction was accomplished through assembly PCR. Four PCRs were performed in 
which pQE-80L-antidig-HisGS was amplified with the following pairs of primers: 
80LLibFwd and PstIAddRev; PstIAddFwd and PstIElimRev; PstIElimFwd and 
BglIIAddRev; BglIIAddFwd and 80LLibRev. The resulting four PCR products were gel 
purified, mixed, and amplified using the primers 80LLibFwd and 80LLibRev. This PCR 
product was gel purified and doubly digested along with pQE-80L, both with the enzymes 
HindIII and XmaI. The two digest products were gel purified, ligated, transformed into 
electrocompetent E. coli XL-1 Blue cells, and plated on ampicillin plates. Colonies were 
tested for the proper insert size and sequence verified for the desired restriction site 
modifications (PstI and BglII), resulting in plasmid pQE-80L-antidig-HisGS-Base. The 
introduction of these restriction sites shortly after the Lpp portion of the construct and after 
the scFv sequence did not appear to affect the function of the display construct when 
compared to pQE-80L-antidig-HisGS or pB18D. 
 Libraries were constructed using pQE-80L-antidig-HisGS-Base (Lib1_1a) or the 
sorted population Lib1_1a Hpg3x (Lib2) as a template for error-prone PCR. The 
polymerase Mutazyme II from the Stratagene GeneMorph II kit was used to introduce 
errors throughout the length of the Lpp-OmpA-scFv gene at targeted error rates of roughly 
two to five mutations per gene (Lpp and histidine tags excluded from mutagenesis). After 
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an initial error-prone PCR step, additional amplification of DNA was performed using a 
higher fidelity polymerase. The insert and base construct were doubly digested using PstI 
and BglII. After gel purification and ligation, the resulting DNA was used to transform 
~200 µL of electrocompetent E. coli TYJV2 cells containing pREP4. These cells were 
rescued for one hour in 20–25 mL super optimized broth with catabolic repression (SOC), 
followed by inoculation into a large amount (0.25–1.0 L) of 2×YT medium containing 
ampicillin (200 mg/L) and kanamycin (34 mg/L) (2×YT KA). Before growing cells, small 
amounts (~0.5–50 µL) of the broth were distributed on agar plates containing ampicillin 
and kanamycin in order to estimate the total number of transformants in the library. The 
libraries were grown at 37 °C until surpassing an OD600 of 1.0, and plates were incubated at 
37 °C until colonies were large enough to count. Plasmid DNA was isolated from large 
amounts of culture volume (~200 mL) using a Qiagen Maxiprep kit. Aliquots of cells 
containing the library were stored at a 1:1 ratio with cell stock buffer (65% glycerol 
(vol/vol), 25 mM Tris, 100 mM MgSO4, pH 8.0) and frozen at −80 °C. In the construction 
of the first library (Lib1_1a), two separate transformations were performed (1 and 1a), 
aliquoted, and maxiprepped. Colony counts indicated that transformation 1 yielded about 
4.5 × 105 transformants, while transformation 1a yielded roughly 7.7 × 104 transformants. 
Random picking of ten clones revealed nine with the proper insert. Sequencing of these 
transformants using the primer 80LLibFwd revealed an approximate error rate of 
2.7 mutations per kilobase, or 3.0 per gene. Construction of Lib2 resulted in approximately 
5.6 × 106 independent transformants. Restriction fragment analysis of twelve clones 
showed that all twelve transformants selected had the proper inserts. Sequencing of ten 
clones using 80LLibRev revealed an approximate error rate of 4.2 mutations per kilobase, 
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or 4.7 per gene, in Lib2 relative to Base (this includes mutations acquired during the first 
round of screening). 
 Miniprepped plasmid DNA isolated from sorted libraries was transformed into 
fresh TYJV2 cells and grown on plates containing ampicillin and kanamycin. Individual 
colonies were randomly picked from plates, subjected to medium shifts and flow cytometry 
experiments to determine binding function on-cell (see below), miniprepped, and 
sequenced. The scFv portions of DNA from the variants to be studied in soluble form were 
PCR amplified using primers AntidigpAK400Fwd and AntidigpAK400Rev with the 
exception of clone Nrl4x3, which contained a mutation within the priming region of 
AntidigpAK400Fwd and was therefore amplified in the forward direction with the primer 
AntidigpAK400FwdNrl4x3. After PCR amplification, all PCR products and the vector 
pAK400 were digested with SfiI. Ligation of scFv genes and vector were performed using 
the New England Biolabs Quick Ligation Kit and transformed into electrocompetent 
DH10B cells. These cells were grown on agar plates at 30 °C containing chloramphenicol 
(35 mg/L) and one percent glucose. Resistant colonies were grown at 30 °C in liquid 
culture containing chloramphenicol and glucose, miniprepped, tested for the desired inserts, 
and verified by sequencing. 
 
Expression of cell surface display constructs. Protein expression of all cell surface-
displayed sequence variants and library populations to be studied via flow cytometry was 
performed using a standard medium shift procedure suitable for cell surface display (59). 
On the day of expression, cells harboring the sequence variants or populations of interest 
were grown at 37 °C in M9 minimal medium (M9 salts containing glucose (0.4% w/v), 
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thiamine hydrochloride (35 mg/L), MgSO4 (1 mM), CaCl2 (0.1 mM), and 20 amino acids 
(40 mg/L)) supplemented with ampicillin (200 mg/L), and kanamycin (35 mg/L) (M9 KA 
Glucose 20AA). Upon reaching an OD600 of roughly 0.5–1.0, cells were pelleted (6000 × g 
for 7 minutes in a fixed angle rotor or 3000–4000 × g for 10 minutes in a variable angle 
rotor) and resuspended in minimal medium lacking Met and allowed to grow at 37 °C for 
ten minutes. Cells were again pelleted and resuspended in minimal medium lacking Met 
and supplemented with Met or ncAAs as suitable for the given experiments. These cells 
were induced with 1 mM IPTG and allowed to grow at 25 °C for six hours. At the end of 
this time period, cells were pelleted and prepared for flow cytometry according to 
procedures described below. 
 
Flow cytometry, Lib1_1a. A single colony bearing plasmids 
pQE-80L-antidig-HisGS-Base (Base) and pREP4 was used to inoculate an overnight 
culture of minimal medium (2 mL) containing the twenty canonical amino acids, 
kanamycin, ampicillin, and glucose (M9 KA Glucose 20AA) and then grown at 37 °C. This 
culture was then diluted 1:100 into fresh M9 KA Glucose 20AA (~10 mL) the next 
morning. In the initial round of screening, equal volumes of transformations 1 and 1a were 
mixed, diluted 1:30 into 60 mL M9 KA Glucose 20AA, and grown at 37 °C. After reaching 
suitable OD600s (0.7–0.8) cells were shifted into new medium as described above. Cells 
bearing the plasmid coding for Base were aliquoted (3–4 mL/aliquot) and induced with 
1 mM IPTG in M9 KA Glucose containing 20 amino acids or 19 amino acids (−Met) 
supplemented with 2.5 mM Hpg. Cells bearing Lib1_1a were aliquoted into several small 
samples and induced in medium containing twenty canonical amino acids or 19 amino 
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acids (−Met) with 2.5 mM Hpg supplemented with 0, 10, 20, or 30 µM Met. Upon 
completion of the expression (6 hours), all cells were pelleted, washed once in phosphate-
buffered saline (PBS, pH 7.4: 8.00 g/L NaCl, 0.20 g/L KCl, 1.15 g/L Na2HPO4H2O, 
0.20 g/L KH2PO4), and resuspended in PBS to an OD600 of 1.0. Cells were then treated 
with 200 nM 5 in 0.25–1.0 mL aliquots for at least 45 minutes with gentle agitation at room 
temperature, diluted 1:20 into PBS, and filtered using 25 mm filters containing 5 µm 
Acrodisc Supor membranes (Pall Life Sciences, Ann Arbor, Michigan). 
 A MoFlo flow cytometer (Beckman Coulter, Miami, FL) was used for all scanning 
and library sorting. Control experiments confirmed that expression of Base in Met resulted 
cells exhibiting high fluorescence after exposure to 5, while cells expressed in 2.5 mM Hpg 
exhibited low fluorescence levels after exposure to 5, confirming that the medium shift was 
successful. Lib1_1a expressed in 2.5 mM Hpg and 20 µM Met was judged to have a 
sufficient number of positive events to make it suitable for sorting. A gate was set to collect 
the brightest ~0.1 % of the events, and sorting was allowed to proceed for a total of 
35 million events in the sort mode Single 1. Approximately 36,000 events satisfied the 
gating criteria and were deposited directly into a tube of SOC medium on ice. Upon 
completion of the sort, cells were rescued for 1 h at 37 °C in 2.5 mL SOC, diluted with 
10.5 mL 2×YT medium containing ampicillin and kanamycin, and allowed to grow 
overnight at 37 °C. The next day, aliquots of the sorted population were mixed 1:1 with cell 
stock buffer and frozen at −80 °C. The remainder of the rescued cells was miniprepped in 
order to isolate the plasmid DNA from the sort. Subsequent rounds of expression, scanning, 
and Lib1_1a sorting were performed as described above, with a frozen aliquot from the 
previous round of sorting used as the input for the next round of expression and cell 
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sorting. In rounds 2 and 3, the population to be sorted was expressed in M9 KA Glucose 
containing nineteen amino acids plus 2.5 mM Hpg (no Met). Sorting was performed with 
comparable stringencies and event totals as in round 1. 
 Miniprepped DNA from the third round of sorting was used to transform 
electrocompetent TYJV2 cells containing pREP4. Cells were rescued for one hour with 
SOC and plated on agar containing ampicillin and kanamycin. Ten colonies were chosen 
randomly for sequencing and characterization. Following inoculation into overnight 
cultures of M9 KA Glucose 20AA grown at 37 °C, cells were diluted 1:100 into fresh M9 
KA Glucose 20AA and 1:200 into fresh 2×YT supplemented with kanamycin and 
ampicillin (2×YT KA). Cells in minimal media were then subjected to medium shifts, 
induced with 1 mM IPTG in 2.5 mM Hpg for six hours, and harvested. Cells were treated 
with 200 nM 5 and subjected to flow cytometry to assess binding in the Hpg amino acid 
context. Cells grown in 2×YT KA were miniprepped for plasmid DNA and submitted for 
sequencing with the primers 80LLibFwd and 80LLibRev. 
 
Flow cytometry, Lib2. Rounds one and two of Lib2 sorting in various amino acid contexts 
were performed essentially as described for sorting Lib1_1a. Aliquots of the library were 
thawed and diluted 1:30 into fresh M9 KA Glucose 20AA, grown, shifted into fresh 
medium, and subjected to six-hour induction of protein expression in medium containing 
either 0.27 mM Met, 2.5 mM Hpg, 0.28 mM Aha, or 0.30 mM Nrl. In round 1, cells were 
sorted in Purify 1 mode after treatment with 200 nM 5, dilution, and filtering. A total set of 
events greater than ten times the library size was screened in each amino acid context, with 
0.2%–0.5% of the most fluorescent events retained and rescued as described above. In 
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round 2, the populations were treated with 100 nM 5 prior to screening, and 0.1%–0.2% of 
the most fluorescent events were retained and rescued. 
 Beginning with the third round of sorting, significant changes were made to the 
expression and sorting protocol. Frozen aliquots of library fractions were thawed and 
diluted 1:100 into fresh M9 KA Glucose 20AA and allowed to grow to saturation overnight 
at 37 °C, then diluted 1:50 the next morning into fresh M9 KA Glucose 20AA and grown, 
medium shifted, and induced as before. After completion of the induction period, cells 
were washed once in PBS, and library fractions of cells induced in the presence of ncAAs 
were resuspended at an OD600 of 0.2. The library fraction Hpg2x expressed in Hpg was 
sorted on the same day it was expressed. The library fraction was treated with 100 nM 5, 
with control samples (i.e., library fractions expressed in Met and Base in Met and Hpg) 
resuspended and treated with 100 nM 5 at an OD600 of 1.0. All other populations to be 
sorted (i.e., Aha2x, Aha3x, Hpg3x, Nrl2x, and Nrl3x) were incubated with gentle agitation 
overnight at 4 °C in PBS along with control samples (at the OD600s listed above). 
 Washing, viability staining, and kinetic competitions were used with all samples to 
be sorted in rounds three and four of sorting in an attempt to enrich sorted populations for 
clones with improved kinetic properties and exclude dead cells from isolation. Samples to 
be sorted were treated with 100 nM 5 for at least 45 minutes before being washed twice in 
PBS, diluted, filtered, and scanned. Cells were also treated with 5 µM propidium iodide 
(PI) at least five minutes before being scanned on the flow cytometer. Prior to sorting 
library fractions, the kinetic competition method of Daugherty et al. was employed (29). 
Two kinetic competitions were run in parallel: cells to be monitored as a function of time 
were washed twice after treatment with 5, diluted to an OD600 of 0.05, filtered, and exposed 
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to PI prior to competition. The population to be sorted was washed twice after treatment 
with 5 and diluted to an OD600 of 0.5 without exposure to PI prior to competition. The cells 
diluted to OD600 = 0.05 were scanned on the flow cytometer, and then competition was 
initiated in both samples by adding unlabeled digoxin to a final concentration of 2 µM. 
Total competition duration was determined empirically by monitoring the competition 
progress with scans of the more dilute cells every five minutes. When the mean 
fluorescence of the scanned population had been reduced by roughly 40%–60%, the 
competition of the cells at OD600 = 0.5 was stopped by washing the cells twice in ice-cold 
PBS. Cells were then diluted to an OD600 of 0.05, filtered, treated with PI, and sorted on the 
MoFlo using sort mode Single 1. Approximately 0.1%–1% of events were retained in each 
sort, which was gated to isolate cells exhibiting high levels of fluorescence after kinetic 
competition while excluding dead cells, doublets, and other aberrant events. Again, events 
totaling at least ten times the size of the sorted population (≤ 30,000 distinct clones, based 
on the number of events retained in previous sorts) were scanned in the course of a sort. 
Cells were retained and rescued as above. 
 
On-cell estimates of dissociation constants. Individual clones from sorted library 
populations were obtained by transforming electrocompetent TYJV2 cells containing 
pREP4 with plasmid DNA samples from sorted populations Hpg3x, Aha3x, Hpg4x, 
Aha4x, and Nrl4x. These transformed cells were then allowed to grow on agar plates 
supplemented with ampicillin and kanamycin. Individual colonies were picked and used to 
inoculate overnight liquid cultures in M9 KA Glucose 20AA and grown at 37 °C. The next 
morning, samples were diluted 1:50 into fresh M9 KA Glucose 20AA and grown at 37 °C 
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in preparation for medium shifts. During the medium shifts performed on cells bearing 
individual mutants, a portion of each culture was diluted into fresh 2×YT KA and allowed 
to grow to saturation. Plasmid DNA from the 2×YT cultures was extracted and 
subsequently sequenced to determine the mutations present in each clone. Another portion 
of cells was shifted into fresh medium, and protein expression was induced in the ncAA 
context in which the clones were isolated. After expression, all cells were washed once and 
resuspended in PBS at an OD600 of 1.0 and kept at 4 °C overnight with gentle agitation. The 
next day, samples were treated with 100 nM 5 for at least 45 min at an OD600 of 0.2 and 
stored on ice. While on ice, all samples to be used in kinetic dissociation experiments (30) 
were treated with PI. Prior to scanning, samples that had been induced in the presence of 
Met, Hpg, or Aha were washed twice and then resuspended in PBS, again containing PI. 
For samples induced in the presence of Nrl, cells were pelleted, but not washed, prior to 
resuspension in PBS containing PI due to rapid loss of fluorescence in these samples. An 
initial scan of each clonal population was obtained prior to initiation of competition. 
Samples were then treated with 1 µM unlabeled digoxin competitor, mixed, and scanned 
every 60 seconds over a period of ten minutes. 
 Data from timed scans was analyzed using FlowJo (Tree Star, Ashland, OR) and 
Excel (Microsoft, Redmond, WA) using a previously described approach (30). All sample 
scans were gated to exclude PI-positive cells from the analysis. The mean fluorescence of 
all PI-negative cells was then calculated. To eliminate background fluorescence from all 
samples, the mean fluorescence of a sample of Base induced in the presence of Hpg 
(obtained on the same day as all data for kinetic dissociation experiments and gated to 
eliminate PI-positive cells) was subtracted from the fluorescence of all other samples. The 
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background-corrected data for an entire competition were then normalized based on the 
brightness of the sample of cells involved in the competition at t = 0 min. The resulting 
background-corrected, normalized data were fit to a first-order exponential equation of the 
form 
€ 
F = e−koff t ,  (4.1) 
where F is the relative fluorescence of the sample compared to the sample at time t = 0 min 
and koff is the dissociation rate of the antibody fragment. Results reported for all clones 
discussed here were performed once and served as a means for identifying individual 
clones to study in more detail. On each day these experiments were performed, the rate 
constant of either Base induced in Met or the protein product of pQE-80L-Antidig-HisGS 
containing Met was estimated as a control for day-to-day consistency of technique. Data 
are reported in groups of samples that were all assayed at the same time. All data was 
analyzed using the program Igor (Wavemetrics, Lake Oswego, OR), and the errors reported 
are the 95% confidence intervals of the fits to equation (4.1). 
 
Flow cytometry, simultaneous investigation of binding and chemical modification. 
TYJV2 cells containing a plasmid encoding cell surface-displayed Aha4x5 and the plasmid 
pREP4 and TYJV2 cells lacking plasmids were grown in M9 KA Glucose 20AA as 
described above and induced with 1 mM IPTG after using the standard cell surface display 
medium shift procedure, with induction performed in medium containing either 0.27 mM 
Met or 1 mM Aha. Samples left uninduced (TYJV2 cells with or without plasmids) were 
also subjected to medium shifts and expression conditions, without the addition of IPTG. 
After the six-hour expressions, cells were washed twice in ice-cold PBS and resuspended to 
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an OD600 of 1.0. Samples of cells were treated with 100 µM biotin cyclooctyne 7 and 
incubated at 37 °C for 16 hours (60). Additional portions of cultures were also incubated 
for 16 hours at 37 °C without exposure to 7. All samples were pelleted and resuspended, 
with cells treated with 7 washed twice in PBS prior to resuspension. Fluorescent probes 
were then added to probe the binding and modification states of cellular populations. All 
samples were treated with 100 nM 5, a 1:100 dilution of 0.2 mg/mL streptavidin-
phycoerythrin (SA-PE), or both dyes simultaneously for a period of 45 minutes or longer. 
Cells displaying the Aha form of Aha4x5 were also treated with 10 µM digoxin prior to 
exposure to 5 and SA-PE. After dye exposure, all samples were washed twice in PBS, 
diluted by at least tenfold, and filtered. 
 Samples were scanned using a MoFlo XDP flow cytometer (Beckman Coulter) 
upgraded from MoFlo to MoFlo XDP status by Propel Labs (Fort Collins, CO). Manual 
compensation was performed to enable simultaneous detection of BODIPY and 
phycoerythrin fluorescence without cross talk between fluorescence channels. Antigen 
binding and chemical modification were examined with scans of many different samples 
(see Figure 4.13). Once the ability to simultaneously monitor antigen binding and chemical 
modification was established, a model sort was set up by combining four populations of 
cells bearing the plasmid coding for Aha4x5 that were all reacted with 7 and exposed to 5 
and SA-PE: uninduced cells grown in Aha, induced cells expressed in Met, induced cells 
expressed in Aha blocked with unlabeled digoxin, and induced cells expressed in Aha. 
Elliptical regions were established in the two-dimensional dot plot of BODIPY versus 
phycoerythrin fluorescence intending to capture populations of cells with interesting 
combinations of fluorescence properties. A four-way sort performed in Purify mode 
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enabled isolation of cells with all possible combinations of high and low BODIPY and 
phycoerythrin fluorescence. The fluorescence properties of the isolated populations were 
examined by running each population on the flow cytometer immediately after completion 
of the sort. 
 
Expression and purification of soluble scFvs. TYJV2 cells bearing individual scFv 
sequence variants in the pAK400 backbone were inoculated into 2 mL M9 minimal 
medium containing twenty amino acids and 0.4% glucose supplemented with 
chloramphenicol (M9 Chlor Glucose 20AA). Cells were allowed to grow at 30 °C for four 
or more hours, followed by 1:20 dilution into 20–40 mL fresh M9 Chlor Glucose 20AA 
and growth at 30 °C overnight. Saturated cultures were then diluted 1:20 into 0.25–1.0 L 
M9 Chlor Glucose 20AA and grown at 30 °C until reaching an OD600 of approximately       
0.9–1.0. At this time, the cells were pelleted (15 min at 5000 × g, 4 °C), washed three times 
in ice-cold 0.9% NaCl, and resuspended in fresh M9 medium containing 19 amino acids 
(minus Met), 0.4% glycerol, and chloramphenicol (M9 Chlor Glycerol 19AA). Aliquots 
were supplemented with Met (0.27 mM), Hpg (1 mM), Aha (1 mM), or Nrl (2.3 mM) and 
grown at 25 °C for thirty minutes. Cultures were then induced with 1 mM IPTG and 
allowed to grow for four hours at 25 °C. 
 At completion of expression, cells were pelleted (15 min at 5000 × g, 4 °C) and 
resuspended vigorously in 32 mL per liter culture volume of ice-cold 0.75 M sucrose, 
0.1 M Tris, pH 8.0 (Tris/sucrose buffer). All subsequent scFv purification steps were 
performed at 4 °C or on ice unless otherwise noted. An adaptation of a previously 
described osmotic shock procedure (61) was used to isolate the periplasmic fractions of 
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cells, which contain the expressed scFvs. After resuspension, the Tris/sucrose buffer 
containing cells was supplemented with 3.2 mL per liter culture volume 10 mg/mL ice-cold 
lysozyme in Tris/sucrose buffer. Pellets were rotated at 140 RPM on ice during dropwise 
addition of 64 mL per liter culture volume of 1 mM ethylenediaminetetraacetic acid 
(EDTA). After a ten-minute incubation (still with rotation), 3 mL per liter culture volume 
0.5 M magnesium chloride was added dropwise to the cell suspension. After another ten-
minute incubation period, the samples were pelleted (10,000 × g, 20 minutes, 4 °C). The 
supernatants were dialyzed overnight against a solution of Ni-NTA start buffer (0.3 M 
NaCl, 0.05 M NaH2PO4, 0.01 M imidazole, pH 8.0) at 4 °C using 12–14 kilodalton 
molecular weight cutoff (MWCO) dialysis tubing. Dialyzed samples were filtered using 
25 mm Acrodisc Supor filters with 5 µm pores and incubated for multiple hours with Ni-
NTA agarose prewashed with Ni-NTA start buffer (4.0 mL per liter culture volume 
resuspended slurry) at 4 °C. The Ni-NTA slurries were added to columns and the 
flowthrough was collected. After two washes using 20 mL per liter culture volume Ni-NTA 
wash buffer (0.3 M NaCl, 0.05 M NaH2PO4, 0.02 M imidazole, pH 8.0), samples were 
eluted using 4 × 4.0 mL per liter culture volume Ni-NTA elution buffer (0.3 M NaCl, 0.05 
M NaH2PO4, 0.25 M imidazole, pH 8.0). The presence of protein in the eluent was 
confirmed by spotting small portions of each elution fraction onto filter paper, staining the 
paper with coomassie blue stain (2.5 g/L coomassie blue and 2.5 g/L cupric sulfate in a 
solution of 5:4:1 water:ethanol:acetic acid) and destaining using 5:4:1 water:ethanol:acetic 
acid. Fractions found to contain large amounts of protein were pooled and dialyzed against 
ion exchange start buffer (125 mM NaCl, 20 mM Tris, pH 8.0), saving aside small amounts 
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of eluent for sodium docedecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis. 
 Ion exchange and size exclusion chromatography were performed on dialyzed 
eluents from Ni-NTA purification using an AktaPrime Plus fast performance liquid 
chromatography (FPLC, GE Healthcare) system refrigerated at 4 °C. A 1.0 mL HiTrapQ 
XL ion exchange column was used according to the manufacturer’s instructions with ion 
exchange start buffer and ion exchange high salt buffer (1 M NaCl, 20 mM Tris pH 8.0). 
The majority of scFv protein samples eluted during initial injection onto the column, while 
impurities tended to bind to the column until the salt concentration on the column was 
increased. The column flow-through containing scFv was collected, pooled, and 
concentrated to approximately 1.0–1.5 mL using Amicon Ultra-15 10 kilodalton MWCO 
concentration devices primed with HBS +EDTA (150 mM NaCl, 10 mM HEPES, 3 mM 
EDTA, pH 7.4). Size exclusion chromatography was performed using a HiPrep 16/60 
Sephacryl S-100 HR using HBS +EDTA at a flow rate of 1 mL/min. This column allowed 
resolution of dimer and monomer scFv peaks. Fractions of monomeric protein were 
collected, pooled, and concentrated using Amicon Ultra-15 concentrators. 
 
Protein characterization. All purification processes were assessed by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. After Ni-NTA, ion 
exchange, and size exclusion chromatography, all samples were found to be greater than 
ninety percent pure as judged by quantification of band intensities after colloidal blue 
staining (Invitrogen). Gels were imaged on a Typhoon Trio (GE Healthcare, Piscataway, 
NJ) imager, and the resulting images were processed using ImageQuant software (GE 
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Healthcare). Concentrations of protein samples were determined using bicinchoninic acid 
(BCA) assay kits from Pierce. Proteins were stored in HBS +EDTA buffer at 4 °C long 
term. Size exclusion chromatography on monomeric fractions of select proteins after 
storage for multiple months revealed no evidence of dimerization or aggregation. 
 Matrix-assisted laser desorption ionization (MALDI) mass spectrometry was 
performed on trypsinized samples in order to assess amino acid replacement levels. All 
samples to be examined were buffer exchanged into denaturing buffer (8 M urea, 0.1 M 
Tris, pH 8.0) using Amicon Ultra-0.5 mL concentration devices. 20–40 µL of sample was 
reduced by adding tris(2-carboxyethyl)phosphine (TCEP) to a final concentration of 
3.75 mM and incubating the sample at room temperature for 15 minutes. In the case of 
azide-containing samples, dithiothreitol (DTT) was used to reduce some samples by adding 
the reducing agent to a final concentration of 2.5 mM and incubating samples at 55−60 °C 
for 15 minutes. All reduced samples were then alkylated by adding iodoacetamide to a final 
concentration of 12.5 mM and incubation at room temperature in the dark for 15 minutes. 
Following alkylation, 10 volumes of 50 mM ammonium bicarbonate, pH 7.8, were added 
to each solution along with 2.5–5 µL of trypsin (Promega, 0.1 µg/µL), and cleavage was 
allowed to proceed overnight at 37 °C. Trifluoroacetic acid (TFA) was added to a final 
concentration of 0.1% to each cleaved sample, and C18 Zip Tips (Millipore) were used to 
desalt peptide samples according to the manufacturer’s protocol with one slight 
modification. In between wetting and equilibrating the columns, a 50/50 acetonitrile/0.1% 
TFA solution was used to wash the columns. All samples were then complexed with 
α-cyano-4-hydroxycinnamic acid, dried on a MALDI target, and assayed using a Voyager 
DE Pro (Applied Biosystems, Carlsbad, CA) at the Caltech Division of Chemistry and 
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Chemical Engineering Mass Spectrometry Facility. All observed peptide masses fell within 
instrument tolerances of mass accuracies. Azide-containing peptides were observed to 
frequently lose dinitrogen and gain two hydrogen atoms during acquisition of MALDI 
mass spectra (62). 
 Incorporation levels of ncAAs were determined using processed MALDI mass 
spectra. All spectra were baselined and deisotoped using Data Explorer software (Applied 
Biosystems). The fraction of peptides bearing the ncAA substitution was calculated based 
on the counts of peaks corresponding to substituted and unsubstituted peptides. In most 
cases, the deisotoping procedure resulted in the presence of single peaks at the substituted 
and unsubstituted mass positions. In cases where the deisotoping still resulted in multiple 
peaks, the counts of all peaks corresponding to unsubstituted and substituted peptides were 
summed prior to calculating the fraction of substituted peaks. 
 MALDI mass spectrometry was also used on trypsinized and whole-protein 
samples in order to determine modification sites after click chemistry (see below). 
Trypsinized samples of modified proteins were prepared as described above. Whole-
protein samples were also buffer exchanged into a solution of 8 M Urea, 0.1 M Tris, 
pH 8.0. To each solution was added ten volumes of 50 mM ammonium bicarbonate, 
pH 7.8, followed by adjustment of the sample to 0.1% TFA. Protein samples were then 
desalted using C4 Zip Tips and further prepared for MALDI as described above. 
 
Protein modification. All strain-promoted click chemistry on soluble scFvs was 
performed using Alexa Fluor 488 dibenzocyclooctyne (DIBO) (6, Invitrogen). Compound 
6 was added to a final concentration of 10 µM to 1.75 µM solutions of Aha- or Met-
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containing scFvs in HBS +EDTA buffer. Solutions were vortexed briefly, and reaction was 
allowed to proceed for one hour at room temperature. Reactions were quenched by adding 
3-azidopropanol to a final concentration of 10–20 mM and vortexing. Copper-catalyzed 
azide-alkyne cycloadditions (CuAAC) were performed with reference to the conditions 
outlined by Hong et al. (58). All reactions were performed on protein solutions in PBS, pH 
7.4, having concentrations of roughly 1.0 to 1.75 µM protein. scFv protein samples were 
buffer exchanged into PBS prior to reaction using one or two Zeba Spin desalting columns 
(7000 Dalton MWCO) from Pierce. Modification of alkyne-containing proteins was 
performed using a lissamine rhodamine azide dye described previously (57), and 
modification of azide-containing proteins was performed with TAMRA-alkyne 
(Invitrogen). Final reaction mixtures contained 100 µM cupric sulfate, 500 µM THPTA, 
5 mM aminoguanidine, and 5 mM sodium ascorbate (added last). Fluorescent dyes were 
preincubated with cupric sulfate and THPTA and added to the reactions at final 
concentrations of 20–200 µM (azide-containing proteins) or 20 µM (alkyne-containing 
proteins). Reaction mixtures were capped, vortexed briefly, and incubated for one hour at 
room temperature. All reactions were quenched with 10 mM 3-azidopropanol. GFPrm_AM 
(55) in azide and alkyne forms was used as a positive control. 
 All dye-labeled proteins were run on denaturing SDS-PAGE gels in order to assess 
dye labeling. After electrophoretic separation, gels were destained in a solution of 50% 
methanol, 40% water, and 10% acetic acidic and rinsed in water. The Typhoon Trio was 
used to detect the presence of fluorescent bands on the gels. Gels were then stained 
overnight in colloidal blue staining solution, washed with water, and imaged again on the 
Typhoon Trio. Gels images were processed using ImageQuant software to assess the 
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relative amounts of fluorescent dyes attached to protein samples of various types. 
Quantification of the extent of reaction between azide-containing proteins and compound 6 
was performed by using Alexa Fluor 488-labeled streptavidin as an in-gel fluorescence 
standard. Absorbance measurements on a Cary 50 ultraviolet-visible spectrophotometer 
(Agilent) were used to obtain protein concentrations and the extent of labeling of the 
concentrated fluorescent streptavidin standard. Known concentrations of standard and 
known protein quantities of labeled samples were run on SDS-PAGE gels and imaged as 
above. Establishment of a standard curve enabled estimation of the quantity of fluorescent 
dye present in the bands of each experimental sample, and knowledge of the protein 
concentration enabled the number of dye molecules per protein to be calculated. Results 
reported here are the averages of three triplicate experiments. In the case of the Aha form 
of Aha4x5, protein expressed and purified in two separate batches was used to estimate the 
extent of dye labeling. All other proteins assessed for extent of modification were from a 
single batch of purified proteins. 
 
Western blotting. Digoxigenin-labeled bovine serum albumin (BSA) was prepared by 
conjugating amine-reactive 3-amino-3-deoxydigoxigenin hemisuccinamide, succinimidyl 
ester (Invitrogen) to BSA using reaction conditions described by the manufacturer. Briefly, 
approximately 10.2 mg of BSA was dissolved in 1 mL 0.1 M NaH2CO3, pH 9.0 and stirred 
in a scintillation vial. A small amount (≤ 1 mg) of 3-amino-3-deoxydigoxigenin 
hemisuccinamide, succinimidyl ester dissolved in 150 µL N,N-dimethylformamide was 
added dropwise to the BSA solution. The mixture was stirred at room temperature for five 
minutes, diluted to 2.5 mL using PBS, pH 7.4, and run on a preequilibrated PD-10 
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desalting column in order to isolate the BSA from the unreacted labeling agent and to 
perform a buffer exchange into PBS, pH 7.4. 
 Detection of the presence of digoxigenin-labeled BSA (BSA-Dig) in protein 
samples was achieved using standard Western blotting procedures. Samples of BSA and 
BSA-Dig mixed with E. coli lysates (~5.5 µg/lane) were run on SDS-PAGE gels and 
transferred onto nitrocellulose membranes. Membranes were blocked for at least one hour 
in PBS, pH 7.4, containing 0.1% TWEEN-20 and either 3% (w/v) BSA or 5% (w/v) 
powdered milk solution (Nestle, Glendale, CA). Membranes were washed in PBS, pH 7.4 
containing 0.1% TWEEN-20 (PBS-TWEEN) before exposure to labeled scFvs. 100–
250 µL of 1.75 µM antibody fragment samples reacted with compound 6 as described 
above were diluted into approximately 10 mL of PBS-TWEEN containing either 3% BSA 
or 5% powdered milk and exposed to membranes for approximately 1 hour. Membranes 
were washed with multiple changes of PBS-TWEEN and imaged using the Typhoon Trio. 
In some cases, membranes were placed back into PBS-TWEEN containing 5% milk and 
exposed to Alexa Fluor 647-labeled anti-penta-his antibodies added to solution at a 
1:10,000 dilution for one hour, washed, and imaged. These experiments enabled secondary 
detection of digoxigenin using the histidine tag of the scFvs and served to probe the 
binding function of scFvs regardless of whether the antibody fragments in question 
appeared to be labeled with fluorescent dye. 
 
Kinetic characterizations of soluble scFvs. A Biacore T100 instrument was used to 
determine the binding kinetics of scFvs using surface plasmon resonance. All assays were 
performed on CM5 chips to which BSA and BSA-Dig were immobilized using standard 
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amine coupling procedures for the T100 processing unit. Flow cells to which BSA was 
immobilized served as a means to double reference all data obtained on flow cells 
containing immobilized BSA-Dig. Two separate CM5 chips containing immobilized BSA 
and BSA-Dig were prepared and used to assay the binding kinetics of scFvs. One chip 
contained 92.9 response units of BSA immobilized to one flow cell and 12.7 response units 
of BSA-Dig immobilized to a second flow cell. The other chip used to assay kinetics 
contained one flow to which 39.7 response units of BSA was bound and three flow cells to 
which BSA-Dig was bound at response unit levels of 10.6, 5.4, and 45.9. Standard 
multicycle kinetics assays were performed at 25 °C on all scFvs of interest, including dye-
labeled samples, using HBS EP+ (HBS +EDTA with 0.005 % surfactant P20) as a running 
buffer at a 90 µL/min flow rate. Surface regeneration was achieved by exposing the chip to 
10 mM glycine-HCl, pH 2.0, for 60 seconds (90 µL/min flow rate). scFv samples were 
injected onto the chip in concentrations ranging from 0.3125 to 40 nM in twofold 
increments (i.e., 0.3125, 0.625, 1.25, 2.5, 5, 10, 20, and 40 nM concentrations). Blank 
samples (no scFv) were also run, and each sample/blank was run twice during the course of 
an assay. Injection and dissociation times depended on the amino acids present in the scFv 
sample in question. scFvs containing Hpg were injected for a period of 180 seconds, while 
scFvs containing all other amino acids were injected for 120 seconds. The dissociation of 
scFvs containing Aha from the chip surface was monitored for 650 seconds, while all other 
scFv dissociations were monitored for 450 seconds. All scFv samples (including those 
samples reacted with 6) were diluted to the final concentrations need for kinetic assays 
using HBS EP+, without dialysis or other buffer exchange into the Biacore running buffer. 
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Before assaying experimental samples, and in between different scFv samples, the chip 
used in assays was reconditioned using at least five startup cycles. 
 Kinetic constants for all scFvs were determined using Biacore T100 Evaluation 
software. All binding curves were subjected to software-provided double referencing 
procedures before performing data fits using the standard 1:1 binding kinetic transport 
model provided with the software (63). Data fits usually included all data up to and 
including 20 nM injections, excluding samples in which air bubbles or other deviations 
marred the sensorgrams. Most fitting could be performed without invoking significant mass 
transport limitations (mass transport constant kt ≥ 1010). However, all data taken on Hpg-
containing fragments showed evidence of substantial mass transport limitation (kt ~106–
108), meaning that the values for kon and koff reported here for these scFvs may be slightly 
different from values determined in the absence of significant mass transport limitations 
(64). All data reported here are the averages of independent experiments performed on the 
two chips prepared as described above, with a total of four determinations of kinetic 
parameters through data fitting on each chip surface containing immobilized BSA-Dig. 
 
High-throughput sequencing. Frozen aliquots of Lib1_1a Hpg3x, Lib2 Hpg4x, Lib2 
Aha4x, and Lib2 Nrl4x were thawed, diluted 1:200 into 200 mL 2×YT KA, and grown at 
37 °C until the OD600s of each culture exceeded 1.0. The cultures were pelleted (5000 × g, 
15 min, 4 °C), decanted, and frozen at −20 °C for at least 12 hours. Plasmid DNA from 
each sorted population was then isolated using a Maxiprep kit. All DNA was digested 
using restriction enzymes BglII and PstI, and fragments containing the Lpp-OmpA-scFv 
fusion gene (excluding Lpp and His tag portions of the gene) were separated from other 
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DNA fragments via gel electrophoresis. Approximately 1–3 µg DNA of each library 
population was submitted to the Millard and Muriel Jacobs Genetics and Genomics 
Laboratory at the California Institute of Technology for fragmentation and high-throughput 
sequencing using the Illumina Genome Analyzer IIx platform (Illumina, San Diego, CA). 
DNA samples were subjected to fragmentation and cluster generation according to the 
manufacturer’s recommendations, and 38-base sequencing runs were performed on each 
sample (one lane/sample). Each run yielded over 30 million sequencing reads on an 
estimated 3.5–4.2 × 105 clusters. All data was aligned to the DNA sequence of Base, and 
the total number of calls of A, C, G, T, and N, at every position of each population were 
tallied using a script developed at the genomics laboratory. Every position within the 
construct was read at least 8,500 times in all populations. Substantial variations in the total 
numbers of reads at each position were observed (ranging from approximately 8,500 to 
greater than 1 million), most likely due to nonuniform fragmentation of the restriction 
fragment. However, even the minimum coverage of 8500 yields good sampling of the 
populations to be characterized, which are the result of repeated isolations of no more than 
20,000–30,000 sequence variants via flow cytometry. All sequencing data was searched for 
positions at which 5% or more of the total reads indicated mutations from the nucleotide 
present in the base construct in a given population using scripts developed in Matlab (only 
single nucleotide mutations were considered in this analysis). Data are presented here on all 
positions at which at least one population displayed 5% deviation from Base with the 
additional criteria that the base call quality (Q, as defined by the Illumina analysis software) 
of at least one nucleotide (A, C, G, or T) at the position of interest exceeded 30. 
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Scheme 4.1. Compounds used in study. 1, methionine (Met). 2, homopropargylglycine 
(Hpg). 3, azidohomoalanine (Aha). 4, norleucine (Nrl). 5, BODIPY FL Digoxigenin. 6, 
Alexa Fluor 488 dibenzocyclooctyne (DIBO 488). The structure of the linker has not been 
disclosed by Invitrogen. 7, biotin cyclooctyne. 
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Scheme 4.2. Chemistries used in modifying azide- and alkyne-containing ncAAs. Copper-
catalyzed azide-alkyne cycloaddition reaction (CuAAC, top) and strain-promoted 
cycloaddition reaction (bottom). 
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Figure 4.1. Flow cytometry studies of the binding properties of cell surface displayed 
scFvs. (A–D) Base construct expression in Met (A), Hpg (B), Aha (C), and Nrl (D) 
contexts, followed by exposure of cells to fluorescently labeled antigen 5. (E–H) Mut2 
construct expression in Met (E), Hpg (F), Aha (G), and Nrl (H) contexts, followed by 
exposure of cells to fluorescently labeled antigen 5. (I) Schematic representation of cells 
displaying scFvs containing Met or ncAA analogs of Met and binding to labeled antigen. µ, 
mean fluorescence. 
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Figure 4.2. Fluorescence activated cell sorting of Lib1_1a for clones that function when 
Met is replaced by Hpg. Expression of cells harboring the naïve library and sorted 
populations was performed in minimal media containing concentrations of Met and Hpg as 
indicated. After treatment of induced cells with 5, the fluorescence of each sample was 
measured on the flow cytometer. Boxed populations were sorted, and events falling into the 
top ~0.1% of fluorescence measurements in the BODIPY channel were retained for the 
next round of sorting. Note that the naïve library was sorted after induction of expression in 
medium containing a small amount of Met in addition to Hpg (16). AA, amino acid. µ, 
Mean fluorescence. 
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Figure 4.3. Fluorescence activated cell sorting of Lib2 for clones that function when Met is 
replaced by ncAAs. Expression of the naïve library and sorted populations was performed 
in minimal media containing concentrations of ncAAs as indicated. The fluorescence of 
each population was measured on the flow cytometer. Starting with “Sort 2” in each amino 
acid context, cells were washed twice prior to flow cytometry. Each sample was subjected 
to labeling and kinetic competitions as outlined in table 4.3; the top ~0.1%–1.0% of 
fluorescent events were retained. AA, amino acid. µ, mean fluorescence. 
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Figure 4.4. Population-level sequence characterization of scFv mutants using high-
throughput sequencing. (A) Frequently mutated amino acids in sorted scFv populations 
(Kabat numbering). (B) Structural positions of mutations to scFv in crystal structure of 26-
10 Fab-digoxin complex solved by Jeffrey et al. (32). The backbone of the Fv portion of 
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the Fab is outlined with a ribbon diagram (gray), with amino acids of interest shown as 
space filling and the antigen shown as sticks in white. Unless otherwise noted, labeled 
residues are frequently mutated. H, heavy chain. L, light chain. Space filling colored by 
elements: carbon, gray; oxygen, red; nitrogen, blue; sulfur, yellow. Structure produced 
from the “A” and “B” chains of PDB structure 1IGJ with MacPyMOL. 
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Figure 4.5. Summary of directed evolution of cell surface-displayed scFvs. Error-prone 
PCR using the DNA of Base (both display anchor and scFv) enabled construction and 
expression of Lib1_1a on the surface of E. coli cells. The library was screened for clones 
retaining binding function after the replacement of Met with Hpg. After three rounds of cell 
sorting, Lib1_1a Hpg3x contained a large fraction of Hpg-tolerant clones. This population 
was used as the basis for the construction of Lib2. Lib2 was screened for functional scFvs 
after the replacement of Met with Hpg, Aha, and Nrl in separate screens. Individual clones 
characterized in this work are noted below the populations from which they were isolated. 
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Figure 4.6. Examples of data used in estimating ncAA incorporation levels in scFvs with 
matrix-assisted laser desorption ionization (MALDI) mass spectrometry. (A, B) Portion of 
MALDI spectrum of trypsinized Hpg4x3 containing Hpg before (A) and after (B) 
processing that includes the peptide FSGNIFTDFYMNWVR. Replacement of Met by Hpg 
causes a peptide mass shift of approximately 22 Da. [M+H]+’s in unprocessed spectrum: 
Met form, 1896.87 Da calculated, 1897.17 Da observed. Hpg form, 1874.88 Da calculated, 
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1875.18 Da observed. (C, D) Portion of MALDI spectrum of trypsinized Aha3x2 
containing Aha before (C) and after (D) processing that includes the peptide 
SSGYISTDFYMNWVR. Replacement of Met by Aha results in a peptide mass shift of 
approximately 5 Da. The peak with a mass 26 Da lower than the substituted peak is 
characteristic of azide-containing peptides in MALDI and corresponds to the Aha-
containing peptide after loss of dinitrogen and gain of two hydrogen atoms (62). [M+H]+’s 
in unprocessed spectrum: Met form, 1825.82 Da calculated, 1825.77 Da observed. Aha 
form, 1820.82 and 1794.84 Da (loss of dinitrogen and gain of two hydrogen atoms) 
calculated, 1820.77 and 1794.82 Da observed, respectively. (E, F) Portion of MALDI 
spectrum of trypsinized Mut2 containing Nrl before (E) and after (F) processing containing 
the peptide SSGYIFTDFYMNWVR. Replacement of Met by Nrl results in a peptide mass 
shift of approximately 18 Da. [M+H]+’s in unprocessed spectrum: Met form, 1885.86 Da 
calculated, 1885.98 Da observed. Nrl form, 1867.90 Da calculated, 1868.04 Da observed. 
Prior to estimating incorporation levels, all spectra were baseline corrected and deisotoped, 
with results shown as in (B), (D), and (F). The fraction of peptides bearing the ncAA 
substitution was calculated and used as a means of estimating amino acid replacement 
levels. In most cases, the deisotoping procedure resulted in the presence of single peaks at 
the substituted and unsubstituted positions. In cases where the deisotoping still resulted in 
multiple peaks (Aha-containing peptides or imperfect deisotoping), the counts of all peaks 
corresponding to unsubstituted and substituted peptides were summed prior to calculating 
the fraction of substituted peaks. (G) Portion of MALDI spectrum of trypsinized Aha4x4 
containing Aha that includes the peptide 
WAMDYWGHGASVTVSSGGGGSGGGGSGGGGSDIVLTQSPASLAVSLGQR. The 
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only peptide containing Met (Aha) within the range of the higher-resolution acquisition 
used to estimate ncAA incorporation levels of all other proteins did not appear at high 
enough intensities to allow for quantification of substitution with Aha4x4 containing Aha. 
However, the pattern of substituted peak intensities observed in the unprocessed spectrum 
shown in (G) is similar to the pattern observed in other Aha-substituted peaks (C), 
suggesting a high level of substitution. The deisotoping algorithm could not resolve the 
unsubstituted and substituted peaks at observed m/z values of 4534.58 and 4529.66 Da, 
respectively, making quantification of substitution levels unfeasible. [M+H]+’s: Met form, 
4535.23 Da calculated, 4534.58 Da observed. Aha form, 4530.14 and 4504.14 Da (loss of 
dinitrogen and gain of two hydrogen atoms) calculated, 4529.66 and 4503.57 Da observed. 
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Figure 4.7. Positions of Met residues and residues mutated to Met in scFv. Each residue in 
the protein that exists as Met in at least one solubly produced variant is shown in space 
filling, with calculated surface accessibilities from GetArea (40) listed beneath the residue 
of interest. The accessibility numbers reported here are the average of three calculations 
performed using PDB files 1IGI (1 Fab molecule/unit cell) and 1IGJ (2 Fab molecules/unit 
cell, complexed to ligand) (32). The backbone of the Fv portion of the Fab is outlined with 
a ribbon diagram (gray), with amino acids of interest shown as space filling and the antigen 
is shown as sticks in white. Unless otherwise noted, labeled residues are frequently 
 261 
mutated. H, heavy chain. L, light chain. Space filling colored by elements: carbon, gray; 
oxygen, red; nitrogen, blue; sulfur, yellow. 
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Figure 4.8. Copper-catalyzed azide-alkyne cycloadditions (CuAAC). All reactions were 
performed with solutions of 1.0–1.75 µM protein using reaction conditions as 
recommended by Hong et al. (58). After one hour, room temperature reactions, all reactions 
were quenched using 10 mM 3-azidopropanol. Reacted samples were run on SDS-PAGE 
gels and imaged for fluorescence. The quantity of fluorescence and protein in each lane 
was quantified using ImageQuant software (table 4.10) (A) Reactions of azide-containing 
proteins with a fluorescent TAMRA-alkyne dye (Invitrogen). EDTA removal from scFv 
solutions was performed using a single desalting column (Zeba desalting column, Thermo 
Fisher). The dye was added to the reaction mixtures at a final concentration of 200 µM. 
Lanes: 1, Aha form of GFPrm_AM (positive control), a variant of green fluorescent protein 
coding for seven Met (Aha) residues (55). 2, blank. 3, Met form of Mut2. 4, Aha form of 
Mut2. 5, blank. 6, Met form of Aha3x2. 7, Aha form of Aha3x2. 8, blank. 9, Met form of 
Aha4x4. 10, Aha form of Aha4x4. 11, blank. 12, Met form of Aha4x5. 13, Aha form of 
Aha4x5. (B) Dye labeling of Aha-containing scFvs was not substantially improved with 
multiple buffer exchanges. scFvs were exchanged once or twice as noted and reacted with 
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TAMRA-alkyne added to a final concentration of 20 µM. Lanes: 1, Aha form of 
GFPrm_AM (positive control). 2, blank. 3, Aha form of Aha4x5, EDTA removal with one 
desalting column. 4, blank. 5, Met form of Aha4x5, EDTA removal with two desalting 
columns. 6, Aha form of Aha4x5, EDTA removal with two desalting columns. (C, D) 
Reactions of alkyne-containing proteins with a fluorescent lissamine-rhodamine dye (57). 
EDTA removal from scFv solutions was performed using two desalting columns, and the 
dye was added to the reaction mixture at a final concentration of 20 µM. Lanes in (C): 1, 
Hpg form of GFPrm_AM (positive control) (55). 2, blank. 3, Met form of Mut2. 4, Hpg 
form of Mut2. 5, blank. 6, Met form of Hpg3x1. 7, Hpg form of Hpg3x1. 8, blank. 9, Met 
form of Hpg3x3. 10, Hpg form of Hpg3x3. Lanes in (D): 1, Hpg form of GFPrm_AM 
(positive control). 2, blank. 3, Met form of Hpg4x3. 4, Hpg form of Hpg4x3. 5, blank. 6, 
Met form of Hpg4x8. 7, Hpg form of Hpg4x8. 
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Figure 4.9. Strain-promoted click chemistry on scFvs using fluorescently labeled 
compound 6. (A) SDS-PAGE on Met and Aha forms of scFv variants after reactions with 6. 
(B) MALDI mass spectrometry on the Aha form of intact Aha4x5 before and after reaction 
with 6. The ladders of signals detected are spaced apart by approximately 834 Da, 
corresponding to the molecular weight of 6 (the baseline and counts of the unmodified 
spectrum have been adjusted so that the two unmodified peaks overlay; no changes were 
made to m/z). [M+H]+’s: unmodified: 29202 Da calculated, ~29130–29210 Da observed. 
Singly modified: ~30036 Da calculated, ~29981–30057 Da observed. Doubly modified: 
~30870 Da calculated, ~30813–30888 Da observed. (C) MALDI mass spectrometry on 
trypsinized samples of the Aha form of Aha4x5 before and after reaction with 6. The peak 
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identified as “Unmodified” includes the Aha residue located at position H34 and has 
sequence SSGYISTDFYAhaNWVR ([M+H]+ calculated: 1820.83 Da, [M+H]+ observed 
(unclicked): 1820.65 Da). The peak labeled “Modified” is the same peptide after reaction 
with 6 ([M+H]+ calculated: ~2654.96 Da, [M+H]+ observed (clicked): 2656.22 Da), and is 
only present in the mass spectrum after performing click chemistry (“click” spectrum offset 
by 10 Da and 1000 counts for clarity). 
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Figure 4.10. MALDI mass spectrometry on scFvs before and after strain-promoted click 
chemistry. (A) MALDI mass spectrometry on the Aha form of intact Aha3x2 before and 
after reaction with 6. The ladders of signals detected are spaced apart by approximately 834 
Da, corresponding to the molecular weight of 6 (the unmodified sample spectrum has been 
adjusted in intensity and position so that the two unmodified peaks overlay; no changes 
were made to m/z). [M+H]+’s: unmodified: 29207 Da calculated, ~29127–29188 Da 
observed. Singly modified: ~30041 Da calculated, ~29986–30048 Da observed. Doubly 
modified: ~30860 Da calculated, ~30862–30897 Da observed. Triply modified: ~31694 Da 
calculated, 31694–31760 Da observed. (B) MALDI mass spectrometry on trypsinized 
samples of the Aha form of Aha3x2 before and after reaction with 6. The peak identified as 
“Unmodified” includes the Aha residue located at position H34 and has sequence 
SSGYISTDFYAhaNWVR ([M+H]+ calculated: 1820.83 Da, [M+H]+ observed 
(unclicked): 1820.26 Da). The peak labeled “Modified” is the same peptide after reaction 
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with 6 ([M+H]+ calculated: ~2654.96 Da, [M+H]+ observed (clicked): 2656.43 Da), and is 
only present in the mass spectrum after performing click chemistry (“click” spectrum offset 
by 10 Da and 1000 counts for clarity). (C) MALDI mass spectrometry on the Aha form of 
intact Aha4x4 before and after reaction with 6 (the unmodified spectrum has been adjusted 
in intensity and position so that the two unmodified peaks overlay; no changes were made 
to m/z). Consistent with the lower extents of modification observed via SDS-PAGE, 
modifications to the Aha form of Aha4x4 are not evident in mass spectrometry samples. 
[M+H]+’s: unmodified: 29359 Da calculated, ~29290–29366 Da observed. Singly 
modified: ~30193 Da calculated, none observed. Doubly modified: ~31027 Da calculated, 
none observed. (D) MALDI mass spectrometry on trypsinized samples of the Aha form of 
Aha4x4 before and after reaction with 6. The peak identified as “Unmodified” includes 
position H34 (Met (Aha) mutated to Ile) and has sequence YSGYIFTDFYINWVR 
([M+H]+ calculated: 1943.94 Da, [M+H]+ observed: 1943.86 Da).  No new peaks are 
visible in the mass spectrum of the “clicked” sample. 
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Figure 4.11. Western blotting using fluorescently labeled scFvs. (A) Probing nitrocellulose 
membranes for digoxigenin-labed BSA (BSA-Dig) using Aha and Met forms of Aha4x5 
subjected to reaction with 6 and detection of Alexa-Fluor 488 fluorescence. Each lane of 
the SDS-PAGE gel transferred onto the blot was loaded with ~5 µg E. coli lysate and the 
following protein samples: Lane 1, 1000 ng BSA (unlabeled). Lanes 2–8: 1000, 500, 100, 
50, 10, 5, and 1 ng BSA-Dig, respectively. (B) Probing for BSA-Dig using labeled scFvs 
subjected to reaction with 6 and secondary detection of scFvs using Alexa Fluor 647-
labeled anti-Penta-His antibodies. These controls confirm that scFvs do not appear to lose 
their binding function after reaction with 6. Lanes same as in (A). 
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Figure 4.12. Western blotting using fluorescently labeled scFvs, part 2. 1000 ng of BSA or 
digoxigenin-labeled BSA (BSA-Dig) were run on SDS-PAGE gels, with 5.5 µg E. coli 
lysates added to protein samples as specified. Gels were transferred to nitrocellulose 
membranes, blocked, and probed for the presence of digoxigenin using scFvs labeled with 
6. Lanes in all panels: 1, protein standard. 2, BSA. 3, BSA-Dig. 4, BSA plus lysate. 5, 
BSA-Dig plus lysate. Blots were probed with (A) Aha form of Aha3x2, (B) Met form of 
Aha3x2, (C) Aha form of Aha4x4, (D), Met form of Aha4x4, (E) Aha form of Aha4x5, 
(F), Met form of Aha4x5 after quenching dye labeling reactions, but without separating 
unreacted 6 from protein samples. Molecular weights of marker proteins are given in 
kilodaltons. 
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Figure 4.13. Flow cytometry of cell surface-displayed Aha4x5 to probe binding function 
and chemical modification with strained alkynes. The two-dimensional dot plots show the 
simultaneous measurements of the amount of 5 bound to cells (a measurement of binding 
function) and streptavidin-phycoerythrin (SA-PE) bound, an indirect estimation of the 
amount of 7 that has been chemically attached to cells. (A) Cells displaying the Met form of 
Aha4x5 without any dyes. (B) Probes of binding function of cells using 5, with amino acid 
context and exposure to 7 (i.e., strain-promoted click chemistry) as noted in panels. (C) 
Probes of extent of modification of cells using SA-PE, with amino acid context and 
exposure to 7 as noted in panels. (D) Use of 5 and SA-PE to probe binding and function 
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simultaneously, with amino acid context and exposure to 7 as noted in panels. 
Simultaneous examination of these two properties on cell surfaces gives the same results as 
when these properties are assessed separately. (E) Adding unlabeled digoxin to the Aha 
form of cells expressing Aha4x5 clicked with 7 prior to exposure to 5 and SA-PE results in 
cells unable to bind to fluorescent antigen while retaining their modification. (F) Use of 5 
and SA-PE to probe the function and modification of uninduced cells harboring plasmids 
bearing the Aha4x5 cell surface display construct. Amino acid context and exposure to 7 as 
noted in panels. Cells grown in Aha and reacted with 7 bind to a moderate amount of SA-
PE, although far less than when the scFv construct is expressed. (G) Use of 5 and SA-PE to 
probe for the binding and modification of cells lacking the plasmid for the cell surface-
displayed Aha4x5 construct. Amino acid context and exposure to 7 as noted in panels. 
Uninduced cells and cells lacking copies of the cell surface display vector behave 
identically, suggesting that labeling of cells incubated with Aha with 7 is the result of 
incorporation of Aha into other cellular membrane proteins, albeit at a level far lower than 
when scFv constructs are present on the cell surface. 
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Figure 4.14. Fluorescence activated cell sorting for isolation of functional, modified 
proteins. (A) Two-dimensional dot plot of a mixture of four populations of cells. Each 
cellular population was reacted with 7 and exposed to streptavidin-phycoerythrin (SA-PE) 
and 5 for detection of chemical modification and binding, respectively, prior to flow 
cytometry. The four cell populations in the mixture are Aha4x5 expressed in Met (binding 
but no chemical modification), Aha4x5 expressed in Aha (binding and modification), 
Aha4x5 expressed in Aha blocked with nonfluorescent digoxin (chemical modification but 
no binding), and Aha4x5 grown in Aha without induction (no chemical modification or 
binding). (B–E) Sorted populations of cells. Stringent sorting using elliptical regions R2–
R5 led to the isolation of populations of cells having distinct fluorescence characteristics 
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based on their functional and chemical modification characteristics. The quadrant defining 
regions R6–R9 was set based on the fluorescence properties of cells sorted from R5. In all 
panels, the reported percentages correspond to the fraction of cells appearing within regions 
R6–R9. 
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Table 4.1. Amino acid mutations in clones isolated from Lib1_1a Hpg3x 
 Clone M(H20) S(H24) M(H80) L(H82C) I(L2) A(L12) 
1 - P L - V - 
3 - - L - - - 
6 I - L - - T 
7 - - L - - - 
10 - - L - - - 
2 I - L M - - 
4 I - L M - - 
5 I - L M - - 
8 I - L M - - 
9 I - L M - - 
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Table 4.2. Amino acid mutations in cell surface-displayed scFvs isolated from Lib1_1a 
including mutations in display anchor* 
Clone E54 V63 F109 T118 W129 M(H20) S(H20) M(H80) L(H82C) I(L2) A(L12) 
1 - A - - - - P L - V - 
3 - - - - - - - L - - - 
6 D - L I - I - L - - T 
7 - - - - - - - L - - - 
10 - - - - R - - L - - - 
2 - - Y - - I - L M - - 
4 - - Y - - I - L M - - 
5 - - Y - - I - L M - - 
8 - - Y - - I - L M - - 
9 - - Y - - I - L M - - 
*Numbering scheme: numbers in parentheses are located within the scFv and are 
numbered according to the Kabat numbering scheme (H, heavy chain. L, light chain). 
All other mutations are numbered according to their position in the cell surface display 
construct with position 1 signifying the initiator Met in the signal sequence. 
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Table 4.3. Summary of conditions used in flow cytometry sorting of Lib2 
  Expression in Medium Containing 
Population Hpg (2.5 mM) Aha (0.28 mM) Nrl (0.30 mM) 
High Fluorescence High Fluorescence High Fluorescence 
Naïve Lib2 
      
High Fluorescence High Fluorescence High Fluorescence 
1x sort 
Lower Antigen Conc. Lower Antigen Conc. Lower Antigen Conc. 
Fluorescence, Viability Fluorescence, Viability Fluorescence, Viability 
2x sort 
15 min. competition 40 min. competition 8 min. competition 
Fluorescence, Viability Fluorescence, Viability Fluorescence, Viability 
3x sort 
40 min. competition 100 min. competition 15 min. competition 
   4x sort 
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Table 4.4. ScFv off rate estimates performed using cell 
surface-displayed scFvs * 
Hpg4x Clones 
Sample AA Context koff (10
-3 s−1) Remarks 
Mut2 Hpg 1.097 ± 0.081 † 
Base Met 0.672 ± 0.047  
Mut2 Met 0.528 ± 0.029  
Hpg4x1 Hpg 0.795 ± 0.059  
Hpg4x2 Hpg 1.153 ± 0.175 † 
Hpg4x3 Hpg 0.695 ± 0.021  
Hpg4x4 Hpg 0.912 ± 0.030  
Hpg4x5 Hpg 0.626 ± 0.016 ‡ 
Hpg4x6 Hpg 0.966 ± 0.070  
Hpg4x7 Hpg 1.368 ± 0.059  
Hpg4x8 Hpg 0.883 ± 0.040  
Hpg4x9 Hpg 0.914 ± 0.051  
Hpg4x10 Hpg 1.274 ± 0.090  
Hpg4x11 Hpg 0.871 ± 0.039  
Hpg4x12 Hpg 1.241 ± 0.087   
Hpg3x Clones 
Sample AA Context koff (10
-3 s–1) Remarks 
80L HisGS Met 0.490 ± 0.046  
Hpg3x1 Hpg 0.563 ± 0.012  
Hpg3x2 Hpg 1.372 ± 0.061  
Hpg3x3 Hpg 0.668 ± 0.033  
Hpg3x4 Hpg 0.906 ± 0.055  
Hpg3x5 Hpg 0.912 ± 0.026 † 
Hpg3x6 Hpg 1.021 ± 0.030  
Aha3x and Aha4x Clones 
Sample AA Context koff (10
–3 s–1) Remarks 
Base Met 0.661 ± 0.071  
Mut2 Met 0.506 ± 0.026  
Mut2 Aha 0.200 ± 0.007  
Aha3x1 Aha 0.054 ± 0.017  
Aha3x2 Aha 0.092 ± 0.019  
Aha3x3 Aha 0.161 ± 0.089  
Aha3x4 Aha 0.131 ± 0.016  
Aha3x5 Aha 0.193 ± 0.024  
Aha3x6 Aha 0.143 ± 0.013  
Aha4x1 Aha 0.061 ± 0.008  
Aha4x2 Aha 0.086 ± 0.014 ‡ 
Aha4x4 Aha 0.122 ± 0.021  
Aha4x5 Aha 0.076 ± 0.018  
Aha4x6 Aha 0.154 ± 0.024  
Nrl4x Clones 
Sample AA Context koff (10
–3 s–1) Remarks 
Base Met 0.736 ± 0.061  
Mut2 Met 0.533 ± 0.030  
Base Nrl 1.364 ± 0.047  
Mut2 Nrl 1.224 ± 0.023  
Nrl4x1 Nrl 0.509 ± 0.019  
Nrl4x2 Nrl 0.518 ± 0.026  
Nrl4x3 Nrl 0.366 ± 0.056  
Nrl4x4 Nrl 0.745 ± 0.025  
Nrl4x5 Nrl 0.787 ± 0.045  
Nrl4x6 Nrl 1.025 ± 0.243  
Nrl4x7 Nrl 0.435 ± 0.030  
Nrl4x8 Nrl 0.514 ± 0.024  
Nrl4x9 Nrl 0.494 ± 0.047  
Nrl4x10 Nrl 0.548 ± 0.022  
Nrl4x11 Nrl 0.262 ± 0.020  
*Cells displaying scFvs were subjected to off rate 
characterizations using an adaptation of the method of 
Daugherty et al. (30) (see materials and methods). 
Cells displaying the Nrl forms of scFvs were subjected 
to a less stringent wash procedure prior to estimating 
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off rates. Errors reported are the 95% confidence 
intervals in the fits as determined by the program Igor 
(Wavemetrics, Lake Oswego, OR). 
†A large portion of 5 appeared to have dissociated 
from cells prior to kinetic competition. 
‡Truncated antibody fragment. 
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Table 4.5. Amino acid mutations in clones isolated from Lib2* 
Colony Notes V35 M39 Y41 D42 P48 E54 N55 G56 K59 Q61 V63 L65 T66 
Hpg4x1  - - - - - - - - - - - - - 
Hpg4x3  - - - - - - - - - - - - S 
Hpg4x4  - - - - - - - - - - - - - 
Hpg4x5 † - - - - - - - - - - - - - 
Hpg4x6  - - - - - - - - - - - - - 
Hpg4x7  - - - - - - - - - - - - - 
Hpg4x8  - - - - - - - - - - - - - 
Hpg4x9  - - - - - - - - - - - - - 
Hpg4x10  - - - - L - - - - R - - - 
Hpg4x11  - - - - - - - - - - - - S 
Hpg4x12 ‡ - - - - - D - - - - - - - 
Hpg3x1  - - - - - - - - - - - - - 
Hpg3x2  - - N - - - - - - - - - - 
Hpg3x3  - - - - - - - - - - I - - 
Hpg3x4  - - - - - - - - - - - - - 
Hpg3x5  - - - - - - - - - - - - - 
Hpg3x6  - - - - - - - - - - - - - 
Aha3x1  - - - Y - - - - - - - - - 
Aha3x2  - - - - - - - - - - - - - 
Aha3x3  - - - - - - - - - - - - - 
Aha3x4  - - - - - - - - - - - - - 
Aha3x5  - - - - - - - - - - - - - 
Aha3x6  - - - - - - - - - - - - - 
Aha4x1  - - - - - - - - - - - - - 
Aha4x2 † - - - - - - - - - R - - - 
Aha4x4  - - - - - - - - - - - - - 
Aha4x5  - - - - - - - - - - - - - 
Aha4x6  - - - - - - - - - - - - - 
Nrl4x1  - - - - - - - - - - - - S 
Nrl4x2  D V - - - - - - - - - - - 
Nrl4x3  - - - - - - - - - - - P - 
Nrl4x4  - - - - - D S N Q - - - - 
Nrl4x5  - - - - - - - - - - - - - 
Nrl4x6  - - - - - - - - - - - - - 
Nrl4x7  - - - - - - - - - - A - - 
Nrl4x8  - - - - - - - - - - - - S 
Nrl4x9  - - - - - - - - - - - - - 
Nrl4x10  - - - - - - - - - - - - S 
Nrl4x11  - - - - - - - - - - A - - 
*Numbering scheme: numbers in parentheses are located within the scFv and are numbered 
according to the Kabat numbering scheme (H, heavy chain. L, light chain). Positions in 
between the heavy and light chains are in the linker region and are numbered accordingly. 
All other mutations are numbered according to their position in the cell surface display 
construct (position 1: initiator Met in the signal sequence). 
†Truncated fragment. 
‡Missing amino acids 400−404. 
 280 
 
Colony Notes A67 P72 D76 D78 Y80 T81 G84 G85 D91 N95 K99 
Hpg4x1  - - - - - A - - - - - 
Hpg4x3  - - - - - - - - - - - 
Hpg4x4  - - - - - - - - - - - 
Hpg4x5 † - - - - - - - - - - - 
Hpg4x6  - - N - - - - - - - - 
Hpg4x7  - - - - - - - - - - - 
Hpg4x8  - - - - - - S - - - - 
Hpg4x9  - - - - - - - - - - - 
Hpg4x10  - - - - - - - - - - - 
Hpg4x11  - - - - - - - - - - - 
Hpg4x12 ‡ - - - - - - - - - - - 
Hpg3x1  - - - - - - - - - - - 
Hpg3x2  - - - - - - - - - - - 
Hpg3x3  - - - - - - - - - - - 
Hpg3x4  - S - - - - - - - - - 
Hpg3x5  - - - - H - - - - - - 
Hpg3x6  - - - - - - - - - - - 
Aha3x1  - - - - - - - - - - - 
Aha3x2  - - - - - - - - - - - 
Aha3x3  - - - - - - - - - - - 
Aha3x4  - - - - - - - - - - - 
Aha3x5  - - - - - - - - - Y - 
Aha3x6  - - - - - - - - - - - 
Aha4x1  - - - - - - - - - - - 
Aha4x2 † - - - - - - - - - - - 
Aha4x4  - - - - - - - - - - - 
Aha4x5  - - - - - - - - - - - 
Aha4x6  - - - - - - - - - - - 
Nrl4x1  - - - - - - - - - - - 
Nrl4x2  - - - - - - - - - - - 
Nrl4x3  - - - - - - - - - - - 
Nrl4x4  - - - - - - - - - - - 
Nrl4x5  - - - - - - - D - - - 
Nrl4x6  T - - A - - - - - - - 
Nrl4x7  - - - - - - - - - - - 
Nrl4x8  - - - - - - - - - - - 
Nrl4x9  - - - - - A - - - - - 
Nrl4x10  - - - - - - - - - - - 
Nrl4x11  - - - - - - - - Y - N 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Colony Notes N100 F109 E114 I117 T118 E120 A122 Q128 
Hpg4x1  - - - - - - - - 
Hpg4x3  - - G - - - - - 
Hpg4x4  - - - - - - - - 
Hpg4x5 † - Y - - - - - - 
Hpg4x6  - - - - - - - - 
Hpg4x7  - - - - - - - - 
Hpg4x8  - - - - - - - - 
Hpg4x9  Y - - - - - - - 
Hpg4x10  - - - T - - - - 
Hpg4x11  - - G - - - - - 
Hpg4x12 ‡ K Y - - - - - - 
Hpg3x1  - Y - - - - - - 
Hpg3x2  - - - - - - - - 
Hpg3x3  - - - - - - - - 
Hpg3x4  - - - - - - - - 
Hpg3x5  - Y - - - F - - 
Hpg3x6  - - - - - - - - 
Aha3x1  - - - - - - - - 
Aha3x2  - Y - - - - - - 
Aha3x3  - Y - - - - - - 
Aha3x4  - L - - - - - K 
Aha3x5  - - - - - - - - 
Aha3x6  - - - - - - - - 
Aha4x1  - Y - - - - - - 
Aha4x2 † - - - - - - - - 
Aha4x4  - - - - - - - - 
Aha4x5  - - - - - - - - 
Aha4x6  - - - - P - - - 
Nrl4x1  - - G - - - - - 
Nrl4x2  - - - - - D - - 
Nrl4x3  - - - - - - G - 
Nrl4x4  - - - - - - - - 
Nrl4x5  - Y - - - - - H 
Nrl4x6  - Y - - - - - - 
Nrl4x7  - - - - - - - - 
Nrl4x8  - - G - - - - - 
Nrl4x9  - Y - - - - - - 
Nrl4x10  - - G - - - - - 
Nrl4x11  - Y - - - - - - 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Colony Notes W129 N131 A136 G140 T141 E149 
Hpg4x1  - - - - - - 
Hpg4x3  - - - - - - 
Hpg4x4  - - - - - - 
Hpg4x5 † - - - S - - 
Hpg4x6  R - V - - - 
Hpg4x7  R - - - - - 
Hpg4x8  R - - - - - 
Hpg4x9  - - - - - - 
Hpg4x10  R K - - - - 
Hpg4x11  - - - - - - 
Hpg4x12 ‡ - - - - - - 
Hpg3x1  - - - - - - 
Hpg3x2  R - - - - - 
Hpg3x3  - - - - - - 
Hpg3x4  - - - - - - 
Hpg3x5  - - - - - - 
Hpg3x6  R - - - - - 
Aha3x1  R - - - - - 
Aha3x2  - - - - - - 
Aha3x3  R - - - - - 
Aha3x4  - - - - - - 
Aha3x5  R - - D - - 
Aha3x6  - - - - - - 
Aha4x1  R - - - P - 
Aha4x2 † R - - - - - 
Aha4x4  R - - - - - 
Aha4x5  R - - - - - 
Aha4x6  R - - - - - 
Nrl4x1  - - - - - - 
Nrl4x2  - - - - - - 
Nrl4x3  - - - - - G 
Nrl4x4  - - - - - - 
Nrl4x5  - - - - - - 
Nrl4x6  - - - - - - 
Nrl4x7  - - - - - - 
Nrl4x8  - - - - - - 
Nrl4x9  - - - - - - 
Nrl4x10  - - - - - - 
Nrl4x11  - - - - - - 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Colony Notes E(H10) L(H11) M(H20) S(H24) Y(H27) F(H29) M(H34) H(H41) D(H46) Y(H53) Q(H61) 
Hpg4x1  - - I Y - - - - - - - 
Hpg4x3  - - I F N - - - - - - 
Hpg4x4  - - I - N S - - - - - 
Hpg4x5 † - - I - - S - - - - - 
Hpg4x6  - - I - - - - - - - - 
Hpg4x7  - - I - - - - - - - - 
Hpg4x8  - - I Y - S - - - - - 
Hpg4x9  D - I - - - - - - - - 
Hpg4x10  - - L - - - - - - - - 
Hpg4x11  - - I F N - - - - - - 
Hpg4x12 ‡ - - I - - - - - - - R 
Hpg3x1  - M I Y - - - N - - - 
Hpg3x2  - - I - - - - - E - - 
Hpg3x3  - S I - - - - - - - - 
Hpg3x4  - - I - - S - - - - - 
Hpg3x5  - - I - - - - - - - - 
Hpg3x6  - - I F - - - - - - - 
Aha3x1  - - I - - - - - - - - 
Aha3x2  - - I - - S - - - - - 
Aha3x3  - - I - - - - - - - - 
Aha3x4  - - I - - S - - - - - 
Aha3x5  - - L - - S - - - - - 
Aha3x6  - - I - - - - - - - - 
Aha4x1  - - I Y - - - - - - - 
Aha4x2 † - - I Y - - - - - - - 
Aha4x4  - - I Y - - I - - - - 
Aha4x5  A - I - - S - - - - - 
Aha4x6  - - I - - - - - - - - 
Nrl4x1  - - I F N - - - - - - 
Nrl4x2  - - - Y - - - - - - - 
Nrl4x3  - - I F - S - - - N - 
Nrl4x4  - - I - - S - - E - - 
Nrl4x5  - - - - - S - - - - - 
Nrl4x6  - - - Y - S - - - - - 
Nrl4x7  - - I Y - - - - - - - 
Nrl4x8  - - I F N - - - - - - 
Nrl4x9  - - I - - S V - - - - 
Nrl4x10  - - I F N - - - - - - 
Nrl4x11  - - L Y - S - - - - - 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Colony Notes M(H80) L(H82C) Y(H102) A(H107) S(H113) G(Linker1) G(Linker7) G(Linker9) I(L2) A(L12) S(L22) 
Hpg4x1  L M - - - - - - - - - 
Hpg4x3  L M - - - - - - - - - 
Hpg4x4  L M - - - - - - - - - 
Hpg4x5 † L M - - - S - - - - - 
Hpg4x6  L M - - - - - - - - - 
Hpg4x7  L M - - - - - - - - F 
Hpg4x8  L M N - - - - - - - - 
Hpg4x9  L M - - - - - - - - - 
Hpg4x10  L M - T - - - - - - - 
Hpg4x11  L M - - - - - - - - - 
Hpg4x12 ‡ L M - - - - - - - - - 
Hpg3x1  L M - - - - - R - - - 
Hpg3x2  L M - - - - - - - - - 
Hpg3x3  L M - - - - - - - - - 
Hpg3x4  L M - - - - - - - - - 
Hpg3x5  L M - - - - - - - - - 
Hpg3x6  L M - - - - - - - - - 
Aha3x1  L M - - - - - - - - - 
Aha3x2  L M - - - - - - - - - 
Aha3x3  L M - - - - - - - - - 
Aha3x4  L M - - - - - - - - - 
Aha3x5  L - - - - - - - - T - 
Aha3x6  L M - - - - - - - - - 
Aha4x1  L M - - - - - - - - - 
Aha4x2 † L M - - - - - - - T - 
Aha4x4  L M - - - - - - - - - 
Aha4x5  L - - - - - - V - - - 
Aha4x6  L M - - - - - - - - - 
Nrl4x1  L M - - - - - - - - - 
Nrl4x2  L - - - - - - - - - - 
Nrl4x3  L M - - - - - - - - - 
Nrl4x4  L M - - - - - - - - - 
Nrl4x5  L - - - - - - - V - - 
Nrl4x6  L - - - - - - - - - - 
Nrl4x7  L - - - - - - - V - - 
Nrl4x8  L M - - - - - - - - - 
Nrl4x9  L M - - - - R - - - - 
Nrl4x10  L M - - - - - - - - - 
Nrl4x11  L - - - F - - - - - - 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Colony Notes S(L25) Q(L27) P(L40) N(L53) S(L64) E(L68) F(L71) T(L74) 
Hpg4x1  - - - - - - - - 
Hpg4x3  - - - - - - - - 
Hpg4x4  - - - - - - - - 
Hpg4x5 † - - - - - - - - 
Hpg4x6  - - - - - - - - 
Hpg4x7  - - - - - - - - 
Hpg4x8  - - - - - - - - 
Hpg4x9  - - - - - - - - 
Hpg4x10  - - - Y - - - - 
Hpg4x11  - - - - - - - - 
Hpg4x12* ‡ - - - - - - - - 
Hpg3x1  - - - - - - - S 
Hpg3x2  - - - - - - - - 
Hpg3x3  - - - - - - - - 
Hpg3x4  - - - - - - - - 
Hpg3x5  - - - - - - - - 
Hpg3x6  - - - - - - - - 
Aha3x1  - - - - - - - - 
Aha3x2  - - - - - D - - 
Aha3x3  - - - - - - - - 
Aha3x4  - - - - - - - - 
Aha3x5  - - - - - - - - 
Aha3x6  - - - - - - Y - 
Aha4x1  - - - - - - - - 
Aha4x2 † - K - - - - - - 
Aha4x4  T - - - - - - - 
Aha4x5  - - - - - - - - 
Aha4x6  - - - - - - - - 
Nrl4x1  - - - - - - - - 
Nrl4x2  - - S - - - - - 
Nrl4x3  - - - - - - - - 
Nrl4x4  - - - - - - - - 
Nrl4x5  - - - - T - - - 
Nrl4x6  - - - - - - - - 
Nrl4x7  - - - - - - - - 
Nrl4x8  - - - - - - - - 
Nrl4x9  - - - - - - - - 
Nrl4x10  - - - - - - - - 
Nrl4x11  - - - - - - - - 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Colony Notes D(L76) V(L78) I(L85) 394 R395 404 
Hpg4x1  - - - - - - 
Hpg4x3  - M - - - - 
Hpg4x4  - - - - - - 
Hpg4x5 † - - - Stop - - 
Hpg4x6  - - - - - - 
Hpg4x7  - - - - - - 
Hpg4x8  - - - - - - 
Hpg4x9  - - - - - - 
Hpg4x10  - - - - - - 
Hpg4x11  - M - - - - 
Hpg4x12* ‡ N - - - H - 
Hpg3x1  N - - - - - 
Hpg3x2  - - - - - - 
Hpg3x3  - - - - - - 
Hpg3x4  - - - - - - 
Hpg3x5  - - - - - - 
Hpg3x6  - - - - - - 
Aha3x1  - - - - - - 
Aha3x2  - - - - - - 
Aha3x3  - - - - - - 
Aha3x4  - - - - - - 
Aha3x5  - - - - - - 
Aha3x6  - - - - - - 
Aha4x1  - - - - - - 
Aha4x2 † - - - - - Stop 
Aha4x4  - - - - - - 
Aha4x5  - - - - - - 
Aha4x6  - - - - - - 
Nrl4x1  - M - - - - 
Nrl4x2  - - K - - - 
Nrl4x3  - - - - - - 
Nrl4x4  - - - - - - 
Nrl4x5  - - - - - - 
Nrl4x6  - - - - - - 
Nrl4x7  - - - - - - 
Nrl4x8  - M - - - - 
Nrl4x9  - - - - - - 
Nrl4x10  - M - - - - 
Nrl4x11  - - - - - - 
†Truncated fragment. 
‡Missing amino acids 400−404. 
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Table 4.6. Frequently mutated positions (>5%) of scFvs identified in 
high-throughput sequencing of sorted populations 
Mutational Frequency 
Position Base* Frequent Mutation 
Amino Acid 
Mutation† Lib1_1a Hpg 
Sort 3 
Lib2 
Hpg4x 
Lib2 
Aha4x 
Lib2 
Nrl4x 
342 c t  0.01 0.06 0.01 0.02 
351 a c E54R 0.10 0.11 0.03 0.06 
357 t a  0.01 0.04 0.00 0.16 
371 a g Q61R 0.00 0.03 0.13 0.00 
  t Q61L 0.00 0.00 0.09 0.00 
377 t c V63A 0.06 0.02 0.01 0.16 
385 a t T66S 0.00 0.03 0.00 0.16 
390 t a  0.00 0.03 0.14 0.00 
414 c t  0.63 0.47 0.59 0.36 
439 g a G84S 0.01 0.06 0.00 0.02 
443 g a G85D 0.02 0.02 0.01 0.10 
446 t c M86T 0.00 0.02 0.00 0.06 
460 g t D91Y 0.00 0.02 0.00 0.05 
514 t c F109L 0.09 0.05 0.02 0.02 
515 t a F109Y 0.64 0.29 0.30 0.37 
530 a g E114G 0.00 0.04 0.01 0.16 
542 c t T118I 0.09 0.03 0.05 0.01 
543 t c  0.04 0.32 0.38 0.08 
555 t c  0.04 0.33 0.39 0.09 
574 t a,c W129R 0.05 0.38 0.52 0.11 
601 a g T138A 0.01 0.01 0.10 0.03 
624 c t  0.09 0.05 0.02 0.02 
678 c t  0.00 0.04 0.13 0.00 
693 g a,c M(H20)I 0.73 0.86 0.94 0.57 
703 t c S(H24)P 0.06 0.03 0.01 0.02 
704 c a S(H24)Y 0.03 0.18 0.32 0.34 
  t S(H24)F 0.01 0.11 0.24 0.21 
712 t a S(H27)N 0.00 0.03 0.01 0.12 
  c S(H27)H 0.00 0.01 0.00 0.01 
719 t c F(H29)S 0.02 0.32 0.29 0.56 
721 a c T(H30)P 0.01 0.05 0.07 0.02 
733 a g M(H34)V 0.00 0.02 0.01 0.18 
735 g a M(H34)I 0.00 0.02 0.05 0.04 
771 c a D(H46)E 0.01 0.13 0.03 0.05 
803 t c V(H56)A 0.00 0.01 0.00 0.06 
847 g t V(H71)F 0.00 0.01 0.01 0.03 
  a V(H71)I 0.00 0.00 0.00 0.02 
861 c a,t,g  0.00 0.05 0.00 0.05 
874 a t,c M(H80)L 0.90 0.99 0.99 0.86 
889 t a L(H82C)M 0.62 0.71 0.78 0.50 
955 t c Y(H102)H 0.00 0.00 0.00 0.03 
  a Y(H102)N 0.00 0.05 0.01 0.03 
970 g a A(H107)T 0.01 0.08 0.11 0.00 
1002 c t  0.00 0.01 0.08 0.00 
1018 t g S(Linker10)A 0.01 0.00 0.01 0.01 
  c S(Linker10)P 0.00 0.00 0.08 0.00 
1039 a g I(L2)V 0.06 0.09 0.05 0.13 
1069 g a A(L12)T 0.08 0.05 0.07 0.09 
1078 c a L(L15)I 0.01 0.05 0.15 0.00 
1086 a g  0.00 0.00 0.05 0.01 
1095 g a  0.01 0.00 0.06 0.06 
1099 t c S(L22)P 0.03 0.00 0.24 0.24 
1108 t a S(L25)T 0.00 0.01 0.06 0.00 
1110 c a  0.00 0.01 0.00 0.07 
1114 c a Q(L27)K 0.00 0.04 0.15 0.00 
1209 c t  0.06 0.07 0.04 0.02 
1236 c t  0.00 0.03 0.00 0.14 
1257 a g,t  0.00 0.02 0.13 0.00 
1282 g a V(L78)M 0.00 0.03 0.00 0.16 
1296 t c  0.00 0.00 0.08 0.00 
1350 g t  0.00 0.00 0.06 0.01 
1399 g t E404Stop 0.00 0.05 0.17 0.00 
  a E404K 0.00 0.01 0.00 0.00 
*Nucleotide identity in DNA sequence of Base at specified position in plasmid. 
†Numbering scheme same as in table 4.2. 
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Table 4.7. Amino acid mutations in scFvs studied in soluble form (Kabat numbering) 
 E(H1) E(H10) L(H11) M(H20) S(H24) Y(H27) F(H29) T(H30) M(H34) H(H41) D(H46) Y(H53) 
Base - - - - - - - - - - - - 
Mut2 - - - I - - - - - - - - 
Nrl4x3 G - - I F - S - - - - N 
Nrl4x4 - - - I - - S - - - E - 
Nrl4x11 - - - L Y - S - - - - - 
Hpg3x1 - - M I I - - - - N E - 
Hpg3x3 - - S I F - - S - - - - 
Hpg4x3 - - - I F N - - - - - - 
Hpg4x8 - - - I - - S - - - - - 
Aha3x2 - - - I - - S - - - - - 
Aha4x4 - - - I Y - - - I - - - 
Aha4x5 - A - I - - S - - - - - 
 
 M(H80) L(H82C) Y(H102) S(H113) G(Linker9) S(L25) E(L68) T(L74) D(L76) V(L78) 
Base - - - - - - - - - - 
Mut2 L M - - - - - - - - 
Nrl4x3 L M - - - - - - - - 
Nrl4x4 L M - - - - - - - - 
Nrl4x11 L - - F - - - - - - 
Hpg3x1 L M - - R - - S N - 
Hpg3x3 L M - - - - - - - - 
Hpg4x3 L M - - - - - - - M 
Hpg4x8 L M N - - - - - - - 
Aha3x2 L M - - - - D - - - 
Aha4x4 L M - - - T - - - - 
Aha4x5 L - - - V - - - - - 
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Table 4.8. Characterization of soluble scFvs: expression yields, binding kinetics, and amino acid replacement 
estimates 
AA Context Met Hpg 
Clone Exp. Yield (mg/L)* kon (10
6 M–1s–1)† koff (10
–3 s–1) Exp. Yield (mg L–1) % Met replacement‡ kon (10
6 M–1s–1) koff (10
–3 s–1) 
Base 0.63 1.35 ± 0.08 1.85 ± 0.15     
Mut2 1.43 1.50 ± 0.16 1.72 ± 0.17 0.73 86 ± 4 2.23 ± 0.44 8.09 ± 0.53 
Hpg3x1 1.17 1.29 ± 0.40 1.92 ± 0.29 1.47 90 ± 2 2.31 ± 0.34 6.54 ± 1.41 
Hpg3x3 0.77 1.42 ± 0.12 0.93 ± 0.07 0.62 89 ± 0.4 1.80 ± 0.21 4.63 ± 0.34 
Hpg4x3 2.44 1.45 ± 0.10 1.08 ± 0.09 0.26 87 ± 3 1.37 ± 0.12 6.61 ± 0.73 
Hpg4x8 1.61 1.59 ± 0.05 1.03 ± 0.09 0.47 89 ± 4 1.31 ± 0.08 5.59 ± 1.42 
        
AA Context Met Aha 
Clone Exp. Yield (mg/L) kon (10
6 M–1s–1) koff (10
–3 s–1) Exp. Yield (mg L–1) % Met replacement kon (10
6 M–1s–1) koff (10
–3 s–1) 
Base 0.63 1.35 ± 0.08 1.85 ± 0.15     
Mut2 1.43 1.50 ± 0.16 1.72 ± 0.17 0.98 84 ± 1 1.20 ± 0.11 0.96 ± 0.16 
Aha3x2 1.59 1.72 ± 0.08 1.50 ± 0.14 1.34 80 ± 4 1.58 ± 0.18 0.81 ± 0.12 
Aha4x4 2.31 1.41 ± 0.09 1.00 ± 0.19 1.21 Not determined 1.44 ± 0.28 0.70 ± 0.15 
Aha4x5 1.44 1.55 ± 0.15 1.31 ± 0.29 0.86 83 ± 4 1.93 ± 0.47 0.68 ± 0.11 
        
AA Context Met Nrl 
Clone Exp. Yield (mg/L) kon (10
6 M–1s–1) koff (10
–3 s–1) Exp. Yield (mg L–1) % Met replacement kon (10
6 M–1s–1) koff (10
–3 s–1) 
Base 0.63 1.35 ± 0.08 1.85 ± 0.15 Not determined 86 0.54 ± 0.36 2.31 ± 0.39 
Mut2 1.43 1.50 ± 0.16 1.72 ± 0.17 1.12 88 ± 5 1.34 ± 0.07 2.07 ± 0.20 
Nrl4x3 4.98 1.73 ± 0.06 1.08 ± 0.04 2.22 87 ± 5 1.90 ± 0.14 1.16 ± 0.10 
Nrl4x4 4.07 1.39 ± 0.03 2.23 ± 0.19 1.53 93 ± 2 1.58 ± 0.16 2.51 ± 0.07 
Nrl4x11 0.91 1.26 ± 0.12 0.93 ± 0.09 0.64 89 ± 3 1.19 ± 0.02 1.08 ± 0.07 
*Expression yields were calculated based on bicinchoninic acid (BCA) assays of concentrated protein samples 
after size exclusion chromatography. 
†Binding kinetics were determined using a Biacore T100 instrument. Digoxigenin (antigen) was immobilized 
on the surface of CM5 chips using a two-step immobilization process. First, antigen was conjugated to bovine 
serum albumin (BSA) in order to form BSA-Dig. This conjugate was then attached to the chip using standard 
amine coupling procedures. Multicycle kinetic assays using a range of scFv concentrations from 0.3125 to 20 
nM were used to obtain kinetic parameters. The parameters reported here are the result of two independent 
assays performed on four chip surfaces having a range of ligand densities, displayed as averages plus or minus 
standard deviations. Kinetics were well-described by a standard 1:1 binding transport model. In the case of 
Hpg-containing fragments, a significant mass transport constant was invoked in the best fits of the data. All 
other data was found to be free of substantial mass transport limitations. 
‡Amino acid replacement levels were estimated based on matrix-assisted laser desorption ionization (MALDI) 
mass spectrometry of trypsinized scFv samples as described in figure 4.6 and materials and methods. Data is 
reported as the mean plus or minus the standard deviation of two or more independent trypsinizations and 
MALDI mass spectrum acquisitions. 
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Table 4.9. Dissociation kinetic rate constants of selected scFvs in Met and ncAA forms 
Clone koff (10–3 s–1) 
AA Context Met Hpg Aha Nrl 
Base 1.85 ± 0.15   2.31 ± 0.39 
Mut2 1.72 ± 0.17 8.09 ± 0.53 0.96 ± 0.16 2.07 ± 0.20 
Hpg3x3 0.93 ± 0.07 4.63 ± 0.34   
Aha4x4 1.00 ± 0.19  0.70 ± 0.15  
Nrl4x11 0.93 ± 0.09   1.08 ± 0.07 
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Table 4.10. Copper-catalyzed click chemistry (CuAAC) on Aha- and Hpg-containing proteins with 
TAMRA-alkyne and lissamine-rhodamine azide dyes, respectively* 
TAMRA-Alkyne Functionalization 
Experiment 1** 
Protein GFPrm_AM Mut2 Aha3x2 Aha4x4 Aha4x5 
AA context Aha Met Aha Met Aha Met Aha Met Aha 
Normalized 
Fluorescence† 15.05 0.03 0.03 0.03 0.04 0.02 0.03 0.03 0.29 
Experiment 2‡       
Protein GFPrm_AM Aha4x5       
AA context Aha 
Aha, 
1 ex. 
Met, 
2 ex. 
Aha, 
2 ex.       
Normalized Fluorescence 1.88 0.02 0.07 0.19           
Lissamine-Rhodamine Azide Functionalization§   
Protein GFPrm_AM Mut2 Hpg3x1 Hpg3x3   
AA context Hpg Met Hpg Met Hpg Met Hpg   
Normalized Fluorescence 3.18 0.00 0.48 0.00 0.51 0.00 0.16   
Protein GFPrm_AM Hpg4x3 Hpg4x8      
AA context Hpg Met Hpg Met Hpg      
Normalized Fluorescence 3.33 0.05 0.24 0.04 0.05       
*All reactions were performed at room temperature for one hour following CuAAC conditions outlined 
by Hong et al. (58) (see figure 4.8 caption and materials and methods for details). GFPrm_AM was 
obtained in phosphate-buffered saline. ScFvs were purified in HEPES-buffered saline containing 3 mM 
EDTA and were buffer exchanged into phosphate-buffered saline prior to chemical reactions as noted. 
†Samples were run on SDS-PAGE gels and imaged using a Typhoon Trio imaging system to assess 
functionalization. First, fluorescence detection of dyes was used to interrogate the efficiency of 
reaction. Second, all gels were stained in colloidal blue and imaged to assess protein quantities. The 
normalized data reported here is the intensity of the fluorescence of a sample divided by the intensity of 
colloidal blue staining in the same sample. 
**Single buffer exchange to remove EDTA prior to reaction, 200 µM dye used during reaction. 
‡One or two buffer exchanges to remove EDTA prior to reaction as noted (1 ex. or 2 ex.), 20 µM dye 
used during reaction. 
§Two buffer exchanges to remove EDTA prior to reaction, 20 µM dye used during reaction. 
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Table 4.11. Dye labeling of Met- and Aha-containing proteins with 6 
Protein Aha3x2 Aha4x4 Aha4x5 
AA Context Met Aha Met Aha Met Aha 
Dyes/Protein 0.00 ± 0.00 0.43 ± 0.15 0.00 ± 0.00 0.04 ± 0.05 0.00 ± 0.00 0.38 ± 0.20 
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Table 4.12. Kinetic characterization of scFvs before and after reaction with 6 
(strain-promoted click chemistry)* 
AA Context Met 
 No Click Chemistry Click Chemistry 
Clone kon (106 M–1s–1) koff (10–3 s–1) kon (106 M–1s–1) koff (10–3 s–1) 
Aha3x2 1.72 ± 0.08 1.50 ± 0.14 1.03 ± 0.03 1.38 ± 0.14 
Aha4x4 1.41 ± 0.09 1.00 ± 0.19 0.75 ± 0.15 0.92 ± 0.25 
Aha4x5 1.55 ± 0.15 1.31 ± 0.29 1.16 ± 0.16 1.29 ± 0.23 
AA Context Aha 
 No Click Chemistry Click Chemistry 
Clone kon (106 M–1s–1) koff (10–3 s–1) kon (106 M–1s–1) koff (10–3 s–1) 
Aha3x2 1.58 ± 0.18 0.81 ± 0.12 0.79 ± 0.07 0.70 ± 0.10 
Aha4x4 1.44 ± 0.28 0.70 ± 0.15 0.93 ± 0.15 0.63 ± 0.17 
Aha4x5 1.93 ± 0.47 0.68 ± 0.11 1.09 ± 0.08 0.71 ± 0.14 
*Kinetic characterizations were performed as described in table 4.8 and 
materials and methods. Clicked scFv samples were prepared for Biacore assays 
without separating unreacted dyes or quenching reagents from solution. 
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Table 4.13. Oligonucleotides used in study 
Name Sequence 
EcoRiElimFwd 5’-GTTTTTTTGGGCTAGCGTTTTCGAGCTCGGTACC-3’ 
EcoRIElimRev 5'-GGTACCGAGCTCGAAAACGCTAGCCCAAAAAAAC-3' 
Lpp-OmpA-antidigFwd 5’-GAATTCGAGCTCGGTACCCGGGCTAGAG-3’ 
Lpp-OmpA-antidigRev1 5’-GTGATGAGAACCACGGTCCTCGGGGTCTTCCGGG-3’ 
Lpp-OmpA-antidigRev1 5’-TGCTCTAAGCTTACTAGTGATGGTGATGGTGATGAGAACCACGGTCCTC-3’ 
HindIIIElimFwd 5’-GAAACCAGGACAGCCACCCAAACTACTCATCTATAAGGTATCC-3’ 
HindIIIElimRev 5’-GGATACCTTATAGATGAGTAGTTTGGGTG GCTGTCCTGGTTTC-3’ 
LppHisRescue 5’- CGTGGTTCTCATCACCATCACCATCACGGCTCGTAGTAAGCTTAGAGCA-3’ 
80LLibFwd 5’-CAATTGTGAGCGGATAACAATTTCAC-3’ 
80LLibRev 5’-GCTCCTGAAAATCTCGCCAAGCTAGC-3’ 
PstIAddFwd 5’-CTAAAATCGATCAGGGAATTAACCTGCAGGTTGGCTTTGAAATGGGTTAC-3’ 
PstIAddRev 5’-GTAACCCATTTCAAAGCCAACCTGCAGGTTAATTCCCTGATCGATTTTAG-3’ 
PstIElimFwd 5’-GATGATGCTGCAATATATTATTGTAGCCAAACTACGCATGTTCC-3’ 
PstIElimRev 5’-GGAACATGCGTAGTTTGGCTACAATAATATATTGCAGCATCATC-3’ 
BglIIAddFwd 5’-GCCAGCCAGAACTCGCCCCGGAAGATCTCGAGGACCGTGGTTCTCATC-3’ 
BglIIAddRev 5’-GATGAGAACCACGGTCCTCGAGATCTTCCGGGGCGAGTTCTGGCTGGC-3’ 
AntidigpAK400Fwd 5'-ATATAAGGCCCAGCCGGCCATGGCGGGAATTCGTGAAGTTCAACTGCAAC-3' 
AntidigpAK400Rev 5'-CTCGCCCCGGAAGATCTCGAGGACGCGGCCTCGGGGGCCAATATA-3' 
AntidigpAK400FwdNrl4x3 5'-ATATAAGGCCCAGCCGGCCATGGCGGGAATTCGAGGAGTTCAACTGCAAC-3' 
 
